Home Blog Page 180

Of global economics and pharmaceutical innovation in Nigeria

0

Of global economicsEarlier this year in April 2014, the Federal Government of Nigeria rejected the Economic Partnership Agreement (EPA) ­ between West African States and the European Union (EU). This decision, hailed by the Manufacturers Association of Nigeria, is estimated to have saved the country from losing N208 trillion ($1.3 trillion) revenue in one year alone, had the partnership materialised.

Economic Partnership Agreements (EPAs) are legally binding bilateral contracts between the EU and individual African countries. They are free trade agreements which the EU is negotiating with countries in Africa, the Caribbean and the Pacific. Once signed, EPAs warrant that, within a decade, about 80 per cent of the country’s market should open to European goods and services.

Essentially, the EPA represents the concept of trade liberalisation, a concept that has come to represent the current global economic pill of “reform” agendas that developing nations have been made to swallow. Nigeria got its first dose of the bitter pill with the Structural Adjustment Programme (SAP) of the 80s. Fortunately for us this time, the current Minister of Trade and Investment, Dr Olusegun Aganga, is of the same mind with some of us that a second “bailout” might just kill us completely.

Trade liberalisation in context

Most industrialised nations – United Kingdom, USA, France, Germany, Japan etc. -developed on the principle of protectionism. Essentially, protectionism is the economic policy of restraining trade between states (countries) through methods such as tariffs on imported goods, restrictive quotas, and a variety of other government regulations designed to allow fair competition between imports and goods and services produced domestically. In summary, the goal of protectionism is to protect the domestic industry.

A strong central government is required to achieve such, with the duty to promote and protect the nation’s manufacturing industries. In America, for instance, the leaders established a healthy credit system by the creation of a national bank to facilitate the expansion of both public and private credit. Also, they instituted a subsidy regime for domestic industries, promoting internal developments and imposed tariffs or duties on foreign products. Similar protectionist interventions were undertaken in Japan to protect domestic economy from foreign competition.

Against this protectionist agenda is the concept of Free Trade and Trade Liberalisation. Free trade is a policy in international markets in which governments do not restrict imports or exports. Essentially, the EPA that Nigeria rejected was to achieve free trade which is founded on the principle of comparative advantage.

Comparative advantage, a product of David Ricardo’s original insights, stresses that nations need not produce everything which they have the capacity to produce, but rather those for whom they have the greater comparative advantage. Basically, Ricardo showed that even when one country (say country ‘A’) can produce each of two products at less cost than another country (country ‘B’); it will still be worthwhile for them to trade.

Ricardo’s conclusion is that, in the long run, both countries win and this assumption is the backbone of liberalisation policies – that the state, acting in its best interest should compete where it has the best comparative advantage. The belief is that market forces will lead to efficiency.

This theory assumes that all nations have similar competencies in knowledge base, infrastructure and stable political structures. This mindset is noticeable in the IMF-led reforms in the 1980s which stressed trade liberalisation, privatisation, deregulation and removal of protectionist policies. They brought disaster to a lot of developing countries, including Nigeria. Free trade neglects a solid fact upon which most protectionist agendas are based, which is that it is not wealth per se that is important to a nation, but ‘productive power’.

What is implied by ‘productive power’ is the capacity to actually make or manufacture a good, rather than the mere possession of that good or of the specie—e.g., gold and silver—to buy it. This power to produce is important because it develops the necessary foundation of human skills, technological know-how, and industrial expertise necessary for long-term prosperity.

To develop this capacity, however, is not so simple. It requires a nation to sacrifice and give up a measure of material prosperity in the short run in order to gain culture, skill, and powers of united production in the long run.

For a developing nation to develop this capacity, the leadership would need to have a strong central government because people, on their own, would not sacrifice material prosperity for the sake of the nation at large; even when they do sometimes, they would not channel the extra resources into the ‘right’ areas.

The advantage of having a strong central government intervening to increase the productive power is what is consistently being weakened by most “global economic reforms”with their emphasis on subsidy removals, tariffs removal and privatisation. It is therefore not surprising that the biggest advocates of trade liberalisation are not developing nations; they are the already developed ones – it is in their best interest.

 We are just not in a position to compete

Trade liberalisation is a great idea between states of similar competence; but between developed and developing nations, it would be tantamount to sugarcoated exploitation, especially when there are no restrictions from the developing nation for particular industry segments.

That said, trade liberalisation is already a fact of our existence, Nigeria is already a signatory to some international trade agreements that limits the capacity of the central government to protect domestic industry. Note, however, that the presence of protection is not a guarantee that an industry would develop quickly, but that, without it, the industry may not even exist.

In a paper presented at the 2011 national conference of the Nigerian Association of Industrial Pharmacists (NAIP), Professor Chukwuma Charles Soludo, erstwhile Governor of the Central Bank of Nigeria, stated, in clear terms, that one of the major challenges of the Nigerian manufacturing industry is that the operating environment is simply not competitive. He specifically outlined that the EPA, which was then being debated, would simply reduce Nigeria to a mere consumption post.

The big challenge for policy makers and business owners is to figure out how to create islands of competitiveness, with states like those in the EU breathing down our backs with their EPA offer and the Asian countries making the most of existing trade agreements. This is not only a Nigerian challenge; it is a challenge for all developing nations.

 Pharmaceutical innovation

There is a lot to learn from the industrialisation of Japan. Their development was not from any foreign direct investment or grant but more from indigenous fortitude, nationalism and a fondness for making things. Much more than government policies, which must find room for “protectionist” interventions – the kind we are seeing with the National Automotive Industry Development Plan – there is need for a cultural shift.

For example, though the cost of automobiles in Nigeria could rise from increased import duties and tariffs on fairly used cars, it would eventually lead to increased domestic productivity. It would require a cultural shift to accept to pay this price for increased productivity.

The argument that the introduction of protectionist measures to boost the Nigerian pharmaceutical industry manufacturing capacity would lead to an increased cost of medicines in a “poverty-ridden” country has been the strongest position against greater government intervention. This argument exists because the “market” has been made the decision maker for global economics. In other words, the market should decide who would become a manufacturing economy and who should continue to be a consumption-driven economy.

Considering that all nations still retain sovereignty and have the promotion of the wellness and prosperity of their citizens as the core objectives of their governments, this argument is a suitable one only for an already developed nation. It offers no long–term solution to developing nations like Nigeria, as a consumption mode is simply not sustainable regardless of whether the market requires it or not.

The decision of the United States to deny us access to antibody serums for the treatment of Ebola (even though it is not yet fully tested) and the more recent decision not to sell sophisticated military weapons to Nigeria buttresses my point – that a position of consumption is a dangerous one if we believe ourselves to be a sovereign state not eager to be recolonised.

 What can we do?

We need a stronger government and we need it now! Next, we need a cultural shift – that is the “we” consciousness. It takes a cultural change to make the sacrifices that must be made for us to leave this treacherous position of consumerism.

Japan, for example was not built by just having the right government policies; it was more from the resilience and nationalistic spirit of the private sector that simply loved Japan. They had a love for making things and for making them in Japan. Also, they succeeded in fostering massive domestic private investment.

In my opinion, Nigeria doesn’t need the volume of foreign direct investments it thinks it needs to really develop. What we need to achieve is more of capacity development, indigenous investment and technology transfer than anything else. It takes a cultural shift to achieve this as most times, the focus on technology transfer and capacity development is a decision made not by the government policies but in the board room, by entrepreneurs who would have to consider whether they could suffer a little in the hands of market forces but ultimately help us overcome our present challenges. The government on its part would have to structure models for increasing access to capital.

 

 

Improved data reveals higher global burden of tuberculosis – WHO

6

Recent intensive efforts to improve collection and reporting of data on tuberculosis (TB) are shedding new light on the epidemic, revealing that there are almost half a million more cases of the disease than previously estimated. WHO’s ”Global Tuberculosis Report 2014″, published recently, shows that 9 million people developed TB in 2013, and 1.5 million died, including 360 000 people who were HIV positive.

The report stresses, however, that the mortality rate from TB is still falling and has dropped by 45 per cent since 1990, while the number of people developing the disease is declining by an average 1.5 per cent a year. An estimated 37 million lives have been saved through effective diagnosis and treatment of TB since 2000.

“Following a concerted effort by countries, by WHO and by multiple partners, investment in national surveys and routine surveillance efforts has substantially increased. This is providing us with much more and better data, bringing us closer and closer to understanding the true burden of tuberculosis,” says Dr Mario Raviglione, Director of the Global TB Programme, WHO.

Although higher, these revised figures fall within the upper limit of previous WHO estimates. The report, however, underlines that a staggering number of lives are being lost to a curable disease and confirms that TB is the second biggest killer disease from a single infectious agent. In addition, around 3 million people who fall ill from TB are still being ‘missed’ by health systems each year either because they are not diagnosed, or because they are diagnosed but not reported.

Insufficient funding is hampering efforts to combat the global epidemic. An estimated US$ 8 billion is needed each year for a full response, but there is currently an annual shortfall of US$ 2 billion, which must be addressed.

 

Don’t relent on Ebola fight, pharmacist counsels Nigerians

0

Following the recent declaration by the World Health Organisation (WHO) that Nigeria had become free of the dreaded Ebola Virus Disease (EVD), prominent pharmacist, Pharm. Uche Eddy Igwe, has called on Nigerians to remain watchful, as the disease could still find its way back into the country if proper care is not taken.

Pharm. Igwe disclosed this while presenting a paper titled “Ebola Virus Awareness Campaign” at the 87th Annual National Conference of the Pharmaceutical Society of Nigeria (PSN), held in Uyo, Akwa Ibom State.

Igwe particularly advised health workers who, according to him, were more at risk of contracting the disease, to observe universal basic precautions when attending to suspected or confirmed cases and refer such to the appropriate care centre for treatment.

Explaining that there was no specific treatment for Ebola virus disease, Pharmacist Igwe further explained that blood infusion of recovered patients were being evaluated, while immune therapies were also being examined.

“No vaccines are approved yet for the diseases, but supportive care, rehydration with oral or intravenous fluids coupled with early treatment of specific symptoms improves survival rate, while immunity status equally influences the survival rate”, he said.

He added further that for Nigeria to maintain its Ebola-free status, complacency must be avoided by all.

“We must remain watchful, especially at our various borders. We also enjoin the people to continue to maintain high personal and public hygiene, as if the disease is still around. Government should also not relax in regularly dishing out necessary public health information. We should keep up all those good practices that contributed to the Ebola success story. All states and local governments should strive to ensure high level of public hygiene in their domain, and continue to pay special attention to the prevention of the spread of diseases in their schools and other public places,” he counselled.

 

 

New approaches in HIV/AIDS and STDs treatment

3

Worried by the high prevalence of HIV/AIDS in country, various international and national organisations have launched programmes to combat the incurable disease at different times – though not much impact has been felt in the country, as Nigeria still remains the second largest country with the highest incidence of the disease.

Recently, the country witnessed the launch of the national operational plan for the elimination of mother to child transmission of HIV in Nigeria (2015-2016) with the theme, “No child should be born with HIV in Nigeria.” Lamenting the scourge of the virus at the launch, President Goodluck Jonathan explained that the epidemic had gone beyond the health sector and had significantly threatened the economies and developmental efforts of many countries in the world, including those in the sub-Saharan countries with over three million people living with HIV, having more than half of the people infected as women and young people within the productive age group.

The president, who assured Nigerians that the government would step up its support systems to quicken the eradication of mother-to-child HIV/AIDS transmission by the year 2016, said government had begun the release of fund for the implementation of the President’s Comprehensive Response Plan for HIV/AIDS (PCRP).

 Understanding HIV/AIDS

Human immunodeficiency virus, or HIV, is the virus that causes acquired immune deficiency syndrome (AIDS). The virus weakens a person’s ability to fight infections and cancer. People with HIV are said to have AIDS when they develop certain infections or cancers or when their CD4 (T-cell) count is less than 200. CD4 count is determined by a blood test in a doctor’s office.

Having HIV does not always mean that you have AIDS. It can take many years for people with the virus to develop AIDS. HIV and AIDS cannot be cured. However, with the medications available today, it is possible to have a normal lifespan with little or minimal interruption in quality of life. There are ways to help people stay healthy and live longer.

HIV attacks and destroys a type of white blood cell called a CD4 cell, commonly called the T-cell. This cell’s main function is to fight disease. When a person’s CD4 cell count gets low, they are more susceptible to illnesses.

AIDS is the more advanced stage of HIV infection. When the immune system CD4 cells drop to a very low level, a person’s ability to fight infection is lost. In addition, there are several conditions that occur in people with HIV infection with this degree of immune system failure – these are called AIDS-defining illnesses.

 Transmission of HIV

A person gets HIV when an infected person’s body fluids (blood, semen, fluids from the vagina or breast milk) enter his or her bloodstream. The virus can enter the blood through linings in the mouth, anus, or sex organs (the penis and vagina), or through broken skin.Both men and women can spread HIV. A person with HIV can feel alright and still give the virus to others. Pregnant women with HIV also can give the virus to their babies.

 Means of contracting HIV:

  • Sharing a needle to take drugs
  • Having unprotected sex with an infected person

You cannot get HIV from:

  • Touching or hugging someone who has HIV/AIDS
  • Public bathrooms or swimming pools
  • Sharing cups, utensils, or telephones with someone who has HIV/AIDS
  • Bug bites

Anyone can get HIV if they engage in certain activities. You may have a higher risk of getting HIV if you:

  • Have unprotected sex. This means vaginal or anal intercourse without a condom or oral sex without a latex barrier with a person infected with HIV.
  • Share needles to inject drugs or steroids with an infected person.The disease can also be transmitted by dirty needles used to make a tattoo or in body piercing.
  • Receive a blood transfusion from an infected person.
  • Are born to a mother with HIV infection. A baby can also get HIV from the breast milk of an infected woman.

Health care workers are at risk on the job and should take special precautions. Some health care workers have become infected after being stuck with needles containing HIV-infected blood, or less frequently, after infected blood comes into contact with an open cut or through splashes into the worker’s eyes or inside his or her nose.

 Statistics of people living with HIV/AIDS in Nigeria

According to the Director General of the National Agency for the Control of AIDS (NACA), Professor John Idoko, 3.4 million Nigerians are living with HIV/AIDS, with Benue emerging as the state with the highest number of HIV/AIDS cases, while Kebbi is the lowest.

Clinical experiences have shown that young women have higher risks of contracting the virus than young men. Young adults in Nigeria are more susceptible to contracting HIV/AIDS, possibly due to being more sexually active. Some of the factors that predispose Nigerians to contracting the HIV/AIDS virus include the high prevalence of other STIs (Sexually Transmitted Diseases), prostitution, clandestine high-risk homosexual and heterosexual practices, international women trafficking, irregular and inept blood screening and risky practices among itinerant workers.

From a 2011 report, Nigeria accounts for 10 per cent of the global HIV burden, as It is estimated that about 210,000 people die yearly in Nigeria from the condition. In Men who have sex with men (MSM), the HIV prevalence in Nigeria is 17.2 per cent. Brothel and non-brothel female sex workers (FSW) have a HIV prevalence of 24.5 per cent, while people who take intravenous drugs (IDUs) have a HIV prevalence of 4.2 per cent.

 HIV tests

The only way to know if you have HIV is to take an HIV test. Most tests look for signs of HIV in your blood. A small sample of blood is taken from your arm. The blood is sent to a lab and tested for HIV.

Clinics that do HIV tests keep your test results secret. Some clinics even perform HIV tests without ever taking your name (anonymous testing). You must go back to the clinic to get your results. A positive test means that you have HIV. A negative test means that no signs of HIV were found in your blood.

  • Standard tests. These blood tests check for HIV antibodies. Your body makes antibodies in response to the HIV infection. These tests can’t detect HIV in the blood soon after infection because it takes time for your body to make these antibodies. It generally takes two to 8 weeks for your body to produce antibodies, but in some cases it can take up to six months.
  • In standard tests, a small sample of your blood is drawn and sent to a lab for testing. Some of the standard tests use urine or fluids that are collected from the mouth to screen for antibodies.
  • Rapid antibody tests. Most of these are blood tests for HIV antibodies. Some can detect antibodies in saliva. Results are available in under 30 minutes and are as accurate as standard tests.
  • Antibody/antigen tests. These tests can detect HIV up to 20 days earlier than standard tests. They check for HIV antigen, a part of the virus that shows up 2-4 weeks after infection. These tests can also detect HIV antibodies. A positive result for the antigen allows treatment to begin earlier and the patient to avoid infecting others. These are blood tests only.
  • Rapid antibody/antigen test. One antibody/antigen tests delivers results in 20 minutes.
  • In-home test kits. These kits screen blood and saliva for HIV antibodies. The Home Access HIV-1 Test System requires a small blood sample that is collected at home and sent to a lab. The OraQuick In-Home HIV Test can detect HIV antibodies in saliva, if the antibodies are present (which can take up to 6 months). The user swabs the upper and lower gums of their mouths, places the sample in a developer vial, and can get results in 20-40 minutes. A follow-up test should be done if the result is positive.
  • HIV Testing for Pregnant Women. If a woman has HIV while pregnant, she can work with her health care provider to help reduce the risk that her baby will have HIV, too. With treatment, less than 2 out of 100 babies born to women who have HIV will be infected. Without treatment, about 25 out of 100 babies will be infected.

 

Symptoms of HIV

Some people get flu-like symptoms within a month after they have been infected. These symptoms often go away within a week to a month. A person can have HIV for many years before feeling ill.

As the disease progresses, both women and men may experience yeast infections on the tongue (thrush), and women may develop severe vaginal yeast infections or pelvic inflammatory disease. Shingles is often seen early on, often before someone is diagnosed with HIV.

 Symptoms of AIDS

  • A fever that won’t go away
  • Sweating while you sleep
  • Feeling tired all the time (not from stress or lack of sleep)
  • Feeling sick all the time
  • Losing weight
  • Swollen glands (neck, groin, or underarms)
  • Oral thrush

 Other infections affiliated with AIDS

People with AIDS are extremely vulnerable to infection, called AIDS-defining illnesses, and often exhibit the following conditions:

  • Kaposi’s sarcoma, a skin tumour that looks like dark or purple blotches on the skin or in the mouth
  • Mental changes and headaches caused by fungal infections or tumours in the brain and spinal cord
  • Shortness of breath and difficulty breathing because of infections of the lungs
  • Dementia
  • Severe malnutrition
  • Chronic diarrhea

 

 

 Treatment of HIV

Today, there are a variety of treatments that, when used in combination can significantly slow down and in some cases stop altogether, the progression of HIV infection.

After HIV infection is confirmed, your doctor will start you on a drug regimen consisting of several drugs; combinations of different types of anti-HIV drugs sometimes are called HAART, for highly-active antiretroviral therapy (HIV is a kind of virus called a retrovirus).

Taking HAART therapy is very manageable yet isn’t necessarily easy. These drugs must be taken at the right time, every single day. Also, a range of side effects may occur, including: diarrhoea, nausea, rash, vivid dreams, or abnormal distribution of body fat. And, especially if medications are taken incorrectly or inconsistently, the virus can mutate, or change, into a strain resistant to treatment. The good news is that there are now several HIV medications that are only taken once a day. If there is resistant virus, however, these may not work and other medication options must be used.

If your disease has progressed to AIDS, your treatment may also include drugs to combat and prevent certain infections.Your doctor can monitor how well your HIV treatment is working by measuring the amount of HIV in your blood (also called the viral load.) The goal of treatment is to get the viral load undetectable on labs tests; ideally less than 20 copies. This does not mean the virus is gone or cured, it means the medication is working and must be continued.

 Prevention of HIV/AIDS

The best way to protect yourself from HIV is to avoid activities that put you at risk. There’s no way to tell by looking at someone if he or she has HIV. Always protect yourself.

  • Use latex condoms (rubbers) whenever you have any type of sex (vaginal, anal, or oral).
  • Don’t use condoms made from animal products.
  • Use water-based lubricants. Oil-based lubricants can weaken condoms.
  • Never share needles to take drugs.
  • Avoid getting drunk or high. People who are drunk or high may be less likely to protect themselves.

You can help prolong your life by taking good care of yourself and developing a good relationship with an experienced doctor specialising in HIV and AIDS. Also, be consistent about taking your HIV medications as prescribed and getting regular lab work to catch any problems early.

 

Sexually Transmitted Diseases (STDs)

Sexually transmitted diseases (STDs), or sexually transmitted infections (STIs), are generally acquired by sexual contact. The organisms that cause sexually transmitted diseases may pass from person to person in blood, semen, or vaginal and other bodily fluids.

Some such infections can also be transmitted non-sexually, such as from mother to infant during pregnancy or childbirth, or through blood transfusions or shared needles.

It’s possible to contract sexually transmitted diseases from people who seem perfectly healthy — people who, in fact, aren’t even aware of being infected. Many STDs cause no symptoms in some people, which is one of the reasons experts prefer the term “sexually transmitted infections” to “sexually transmitted diseases.”

 Symptoms

Sexually transmitted infections (STIs) have a range of signs and symptoms. That’s why they may go unnoticed until complications occur or a partner is diagnosed. Signs and symptoms that might indicate an STI include:

  • Sores or bumps on the private parts or in the oral or rectal area
  • Painful or burning urination
  • Discharge from the man-hood
  • Vaginal discharge
  • Unusual vaginal bleeding
  • Sore, swollen lymph nodes, particularly in the groin but sometimes more widespread
  • Lower abdominal pain
  • Rash over the trunk, hands or feet

Signs and symptoms may appear a few days to years after exposure, depending on the organism. They may resolve in a few weeks, even without treatment, but progression with later complications — or recurrence — sometimes occurs.

 Causes of STIs

Sexually transmitted infections can be caused by:

  • Bacteria (gonorrhea, syphilis, chlamydia)
  • Parasites (trichomoniasis)
  • Viruses (human papillomavirus, private part herpes, HIV)

 

Sexual activity plays a role in spreading many other infectious agents, although it’s possible to be infected without sexual contact. Examples include the hepatitis A, B and C viruses, shigella, cryptosporidium and Giardia lamblia.

 Complication of STIs

Possible complications include:

  • Sores or bumps anywhere on the body
  • Recurrent private part sores
  • Generalised skin rash
  • Pain during intercourse
  • Scrotal pain, redness and swelling
  • Pelvic pain
  • Groin abscess
  • Eye inflammation
  • Arthritis
  • Pelvic inflammatory disease
  • Infertility
  • Cervical cancer
  • Other cancers, including HIV-associated lymphoma and HPV-associated rectal and anal cancers
  • Opportunistic infections occurring in advanced HIV
  • Maternal-foetal transmission, which causes severe birth defects

 

Treatments and drugs

STIs caused by bacteria are generally easier to treat. Viral infections can be managed but not always cured. If you’re pregnant and have an STI, prompt treatment can prevent or reduce the risk of infection of your baby. Treatment usually consists of one of the following, depending on the infection.

  • Antibiotics. Antibiotics, often in a single dose, can cure many sexually transmitted bacterial and parasitic infections, including gonorrhoea, syphilis, chlamydia and trichomoniasis. Typically, you’ll be treated for gonorrhoea and chlamydia at the same time because the two infections often appear together.Once you start antibiotic treatment, it’s crucial to follow through. If you don’t think you’ll be able to take medication as prescribed, tell your doctor. A shorter, simpler treatment regimen may be available. In addition, it’s important to abstain from s*x until you’ve completed treatment and any sores have healed.
  • Antiviral drugs. You’ll have fewer herpes recurrences if you take daily suppressive therapy with a prescription antiviral drug, but you can still give your partner herpes at any time.Antiviral drugs can keep HIV infection in check for many years, although the virus persists and can still be transmitted. The sooner you start treatment, the more effective it is. Once you start treatment — if you take your medications exactly as directed — it’s possible to lower your virus count to nearly undetectable levels.

 

Partner notification and preventive treatment

If tests show that you have an STI, your sex partners — including your current partners and any other partners you’ve had over the last three months to one year — need to be informed so that they can get tested and treated if infected. Official, confidential partner notification effectively limits the spread of STIs, particularly syphilis and HIV. The practice also steers those at risk toward appropriate counselling and treatment. And since you can contract some STIs more than once, partner notification reduces your risk of getting re-infected.

  • Prevention

Don’t drink alcohol excessively or use drugs. If you’re under the influence, you’re more likely to take sexual risks.

  • Avoid anonymous, casual sex. Don’t look for sex partners online or in bars or other pickup places. Not knowing your sex partner well increases your risk of possible exposure to an STI.
  • Communicate. Before any serious sexual contact, communicate with your partner about practicing safer sex. Reach an explicit agreement about what activities will and won’t be OK.
  • Abstain. The most effective way to avoid STIs is to abstain from sex.
  • Stay with one uninfected partner. Another reliable way of avoiding STIs is to stay in a long-term mutually monogamous relationship with a partner who isn’t infected.
  • Get vaccinated. Getting vaccinated early, before sexual exposure, is also effective in preventing certain types of STIs.

 

Report compiled by TemitopeObayendo with additional information from:

Nigeria Bulletin, WebMD Medical Reference and Planned Parenthood Organisation

 

 

Chain drugstores: Strategic tool for business expansion

0

(By Pharm. Steve Okoronkwo)

 Nigeria’s healthcare system is undergoing rapid changes. The pharmaceutical industry is equally transforming to conform to these changes. According to John Strong (2011), the changing nature of pharmaceuticals, innovations in products and services and rising competition from new entrants and channels have prompted fundamental rethinking on strategy.

Pharmacy is a hybrid profession. It is a unique profession that shares almost, in equal proportions, the characteristics of a profession and a business. Little wonder, Denzin and Metlin (1968), say that Pharmacy has been identified as an occupation that may struggle to reconcile what has been argued to be the disparate aim of commercial profitability and professional altruism; while Lord Wilberforce in the Dickson’s case (1968) described Pharmacy as a trading profession.

The ownership and operating structures of retail pharmacy vary from one country to another. The United States is the most liberal, with pharmacists being employed by retail chain drug stores. In Canada, pharmacists own drug stores and it appears there are no restrictions on the number of establishments. Also, the organisational form this ownership takes is quite liberal. Europe operates a free market approach in which ownership can be separated from operations.

In Nigeria, the regulation guiding the ownership and operation of retail pharmacies is everything but liberal. Ownership and operation of retail drugstores in Nigeria is the exclusive preserve of the pharmacists. Although one can say that there has been some slight shift from this uncompromising stance in recent times, the justification for this rather rigid approach to ownership of retail pharmacies is however based on the constraints to the regulatory oversight by the government due to lack of enforcement staff, adequate finance, or the regulatory and judicial framework that exists in developed countries (Strong,2011).

Understanding chain drugstores

Retail pharmacies or drugstores have traditionally been run as independent pharmacies. An independent pharmacy is a retail drugstore that is not directly affiliated with any chain of pharmacies and is not owned or operated by a publicly traded company. Independent pharmacies are pharmacist-owned, privately-held businesses in varying practice settings. They include single-store operations, multiple-store locations and supermarket pharmacy operation.

Traditionally, retailing is local in nature and requires the knowledge of the needs and habits of a specific community. Community pharmacists took the advantage of regulatory and operational standards that were generally accompanied by restriction on ownership, entry and competition and established in various localities. With economic growth and advancement in medicine, pharmacies were able to take advantage of this environment and build profitable enclaves with limited competition. Pharmacies competed mostly on location, convenience and by claiming to provide better quality in practice.

However, with rising standards of living around the world, cost and productivity have become secondary concerns. Also, with globalisation of popular culture and development in technology, independent pharmacies which have held their own over the past decades are being driven out of business with the proliferation of chain drug stores. Another factor driving chain store retailing is the fact that some leading retailers are approaching saturation in their dominant market.

Chain drugstore is a group of retail outlets owned by one firm, with outlets nationwide or worldwide. Before being considered a chain, stores must meet the following conditions.

  1. The business or company must operate a number of local retail establishments, usually not less than four, in different geographical locations.
  2. The stores must have similar architecture.

III.  The design and layout of the stores must be similar.

  1. The stores must have the same choice of products.
  2. The stores must have a central head office/management.

In Nigeria, only few pharmacies can conveniently meet these criteria. We have ready examples such as Healthplus and Medplusin Lagos and, perhaps, Paxs Pharmacy in Onitsha.

Chain drugstores and business expansion

While chain stores can be viewed by many as the inevitable result of market forces, it is as well a competitive strategic tool that can be employed in retail business to drive expansion. Strategy is a choice on how to compete; competitive advantage drives from immediate fast-thinking responsiveness to market changes- which is what chain drugstore model represents.

Three generic strategies have been identified in the marketplace (Porter, 1980). These are:

  1. Focused (niche) strategy: This strategy targets a specific market intensively- usually a limited but highly profitable market with high entry barriers. Most retail drugstores or pharmacies in Nigeria adopt this strategy. It is common to find many community pharmacies providing pharmaceutical care services within a particular locality. These retail or community pharmacies make much profit from consultations, even when sales may be low. However, the major limitation of this mainstream approach is that the pharmacy, as well as the practice, is built around the pharmacist-owner. The pharmacy can hardly survive without the owner because patients’ and customers’ patronage and loyalty is to the particular pharmacist and not the pharmacy.Another drawback is that success in a particular location cannot guarantee success in sister outlets,since the pharmacist can only practice in a place at any particular time, and the pharmacy or drugstore does not enjoy any brand loyalty. Finally, market liberalisation and economic growth have transformed retailing from being a profit-driver to a traffic-driver. Hence, as appealing as creating a niche in practice by practicing pharmaceutical care is, focus strategy isunlikely to lead to market expansion because it does not take a population-outlook to marketing.
  1. Overall cost-leadership strategy: This involves offering products or services at the lowest cost. Emphasis may not usually be on quality. This strategy is a very difficult one to operate because success requires volume. Cost-leadership players are usually very few in every country. In Nigeria, Boluke Pharmacy in Lagos is a well-known example of a cost-leader.
  1. Differentiation strategy: Differentiation entails competing on the basis of value added to customers (quality, service, differentiation). This strategy requires creative flair, research capability and strong marketing. Research has shown that patients and customers choose their pharmacymost often because of location/convenience and brand/chain. It is only about 20 percent of the customers that report lowest price as the reason for shopping most often at a particular pharmacy (Strong, 2011).

While pharmacists in Nigeria may have done well in location selection and competitive pricing, majority have paid little or no attention to the concept of chain drugstores and branding. It is very important to note that knowledge/trust is not a primary driver of shopping behaviour in pharmacies/drugstores. However, the trust and reputation which pharmacies enjoy generally as compared to other retail stores is because of the nature of pharmacy as a profession.

Given the obvious limitation of focus and cost leadership strategies, community pharmacies in responding to new market demands are adopting the chain-storepharmacy model as a differentiation tool to create and deliver value to customers as well as convert payments to profit. Market expansion is the natural and probable result of chain drugstores because of its inherent ability to attract the following market advantages:

 i. Large network of channels

Chain drugstores aremodels of community pharmacy practice that can enable pharmacists extend their public health services to rural communities. This large network of stores can as well be seen as a means of delivering pharmaceutical services on a population basis as against the individualised approach in addressing the problem of preventing illness.It is also very important to mention that chain stores are heavily reliant on information technology for management. The focus on technology has shifted from automation as used in most single store operations to internal system integration.

ii. Economies of scale

Chain drugstores can order merchandise in much larger quantities than stand-alone retailers,making it possible for chain stores to offer greater selection of products at lower prices than independent competitors who do not have the same supply advantage. Product sourcing in chain stores isalso more centrally coordinated and chain retailers have sufficient volume to commission manufacturing which has removed the cost of middlemen in the distribution channel from manufacturer to the retailer.

iii.  Brand familiarity/equity

Chain store has the same architectural design and store layout that help build its brand and enable customers to identify with the particular store. Branding is a major differentiation tool by chain drug stores. Without branding, competition will be solely on price. Branding enables companies to actively influence the demand side of the equation by encouraging customers to base their purchase decision on factors other than price. Marketing is a battle of perceptions and chain stores create impressionable brands which enrich our lives.

Chain Drugstores and Promotion of Public health

Public health function is by stratification. The micro level is from the perspective of a health professional whose primary role is not in public health but who is performing some public health functions; while the macro level derives from the perspective of a health professional whose primary role is public health (Johnson, 2008). The pharmacist’s role in public health has mostly been at the micro level.

The lack of awareness of the role of pharmacists in public health can be attributed to the niche strategy which they mostly adopt in practice. This unfortunate position of pharmacists is clearly evident in the United States where pharmacists are not defined as health care providers under the state and federal laws.

Brazier(2001) captures the situation of pharmacists in public health succinctly thus: The pharmacist’s work reaches out to the entire community. The impact of his or her practice affects us all, but when pharmacists do their job properly we barely even notice its importance. Gallup polls have shown pharmacist as highly trusted professionals and thatPharmacy,as a hybrid profession is greatly admired, though pharmacists are the least appreciated in terms of their contribution to public health.

Chain drugstores/pharmacies are opening new vistas to the perception of pharmacists as public health providers. Pharmacists’ role in public health is about the delivery of pharmaceutical services on a population basis as against the nicheapproach in health promotion. In the United States, the National Association of Chain Drug Stores fills over 2.7 billion prescriptions annually, which is more than 72 percent of annual prescriptions in the United States. The overall economic impact of all retail stores with pharmacies transcends their over USD 1 trillion in annual sales.

Associates, inc. on behalf of the Cape Cod Commission

Johnson, W.C.N (2008): The Pharmacist in Public Health: A Regional Perspective. West African Journal of Pharmacy. Vol. 21 No1

American Society of Health- System Pharmacists. ASHP Statement on the role of health-system pharmacists in public health. Am J Health-Syst Pharm. 2008, 65: 462-7

42 U.S.Css1395 (2011)

Brazier, M (2005): Forward in Appelle, G and Wingfield, J. Dale and Applbe’s Pharmacy Law and ethics. London Pharmaceutical Press. Eight edition

NACDS (2013): Statement of The National Association of Chain drug Stores for U.S. House of Representatives Energy and Commerce Committee. Subcommittee on Health.Hearing on “Examining Public Health Legislation to Help Local Communities” November 20, 2013, 2:00 p.m 2123 Rayburn House Office building. www.nacds.org

Preamble to the Constitution of the World Health Organization as adopted by the International Health Conference, New York, 19-22 June, 1046; signed on 22 July 1946 by the representatives of 61 States (Official Records of the World Health Organization, no. 2, p. 100) and entered into force on 7 April 1948

Ernst, ME, Bergus, GR, Sorofman, BA: Patients’ acceptance of traditional and non-traditional immunization providers. J. Am Pharm Assoc (Wash) 2001; 41: 53-9

Meyerson at al (2013): achieving Pharmacy- Based Public health: A call for Public Health engagement. Public Health Reports /May-June 2013/ vol.28

Teece, D.J (2009): Business Models, Business Strategy and Innovation. Long Range Planning 43 (2010) 172-194.http://www.elsevier.com/locate/lrp

 

Contact: steveokoronkwo@yahoo.com

E-commerce in pharmaceutical business: An overview

3

E-commerce in pharmaceutical business

There is no doubt that the Internet is changing the way we conduct business. The very nature of the web has made it possible for companies to interact and exchange information with each other and with their customers real-time in a seamless and efficient manner. Companies are using the Internet in a variety of ways to enhance their business performance by providing product and service information to customers; negotiating prices and contracts; placing, receiving and tracking orders; filling and delivering orders; paying and receiving payment.

The purchasing, selling, and exchanging of goods and services over the Internet is referred to as e-commerce. E-commerce can be broken into four main categories: Business-to-Business (B2B), Business-to-Customers (B2C), Customer-to-Business (C2B), and Customer-to-Customer (C2C), which are, in essence, various segments along the ecommerce value chain.

The “Click-and-Jump” character of web surfing has caused several changes in customer and vendor behaviour. For example, a shopper can easily navigate from one “storefront”to the other in a blink of an eye, making his/her comparative shopping easier. This before could have been impossible when considering the physical distance between the different retail stores.

Online product information allows a much faster time to market as a new product can be “introduced” as soon as its first unit is available. Providing online product and other information to customers allows flexibility on price, product portfolio and promotions. The Internet makes information located at a central source (the vendor’s web server) available to anyone with Internet access, so that a change in price, product portfolio or promotions only requires one database entry.

The pharmaceutical sector also is equally being increasingly influenced by the Internet. Online drug-stores are attracting attention to pharmaceutical companies as they continue to shape the future of drug purchasing and have created new relationships between patients/customers,retail/wholesale pharmacies and drug companies. Especially with the recent advocacy of cashless economy by the Nigerian central bank, e-payments and e-transactions are already taking roots in Nigeria, and some pharmaceutical businesses are already exploiting the opportunity and enjoying the benefits therein.

Many studies have shown that businesses are driven to gain competitive advantage by innovative technology. However, to enjoy the gains of e-commerce, it is important that the business model/strategy in operation is considered – how e-commerce would optimize the business strategy, the potential cost and revenue impact etc – all have to be considered.

 Revenue opportunities of e-commerce

E-commerce allows companies to boost revenues by direct sales to customers. Manufacturers and wholesalers/distributors that do not have direct contact with customers in traditional retail channels can use the Internet to shrink the supply chain by bypassing retailers and selling directly to customers.

Furthermore, the iniquitousness of the Internet permits access at any time from any place interms of order placement to online drug stores. Customers that are often busy at work and, thus, not be able to place orders during regular business hours can place orders at night when most physical retail stores are closed.

Another benefit of e-commerce is how it annihilates almost completely the factor of geographical location. For example, customers in Abuja can visit the online store of a wholesale pharmacy located in Lagos, go through the product catalogue and price list, put orders and make payments in real time.

E-commerce can also speedup revenue collection. When one considers the amount of time and effort taken in processing payments by cheques which usually takes up to 48 hours, online payments either by bank wire transfer or credit/debit cards which is processed instantaneously becomes much more appealing.

Cost impact of e-business

A firm considering integrating ecommerce into its business model should think about the cost impact on business processes. In other words, will the adoption of ecommerce result in a reduce cost in processing and fulfilling orders placed by customers? Will it reduce facility and transportation cost significantly and minimise wastages in the supply chain cycle?

For a firm whose business reach covers a large geographical area, e-commerce will enable it to centralise facilities because online sales allow the separation of order placement and order fulfillment. Site costs may decrease as direct customer-manufacturer contact and geographical centralization eliminates or reduces the number retail sites or warehouses.

E-commerce can also decrease processing cost as it increases the amount of customer participation. For example, customers purchasing online do all the work of selecting the product, placing an order, and paying.

Many e-businesses can also centralise inventories because they do not have to carry inventory close to the customer. This geographical centralisation reduces required inventory levels because of increased economies of scale in the supply and reduced aggregated variability in the demand. A major advantage of e-business is that, by separating ordering from fulfillment, increased flexibility in operations is gained to implement postponement.

Sanofi, PAN renew fight against pneumonia

1

– Celebrate World Pneumonia Day 2014

 

L-R: Dr Fifen Inousa, medical director, Sanofi; Dr Ekanem Ekure, consultant paediatrician, LUTH; and Prof. Adebiyi Olowu, president, Paediatric Association of Nigeria ( PAN), during the press parley held at Protea Hotel, Ikeja, Lagos, recently

 

Sanofi, a leading multinational pharmaceutical company, and the Paediatric Association of Nigeria (PAN), have restated their commitment to tackling pneumonia among children in the country.

The two organisations made the pledge during a media parley organised to mark the World Pneumonia Day (WPD) 2014, held at Protea Hotel, Ikeja, Lagos, recently. The theme of WPD 2014 was “Universal Access to Pneumonia Prevention and Care.”

Speaking at the press parley, Dr Fifen Inousa, medical director of Sanofi Nigeria and Ghana, announced a paediatric initiative, tagged, “Healthy Children, Happy Children”, which he said was being implemented in partnership with PAN.

Dr Inousa stressed that paediatrics was a priority for Africa because one child out of four in the world is in Africa and 50 per cent of the worldwide infant mortality occurs in Africa, adding that the Sanofi Paediatric Initiative was a crucial reinforcement of the company’s commitment to child health care.

Inousa stated that preventing pneumonia in Africa was a challenge Sanofi wanted to share in partnership with PAN and the Federal Ministry of Health.

According to Sanofi’s head of public affairs, Nigeria and Ghana, Oladimeji Agbolade, the initiative relies on three commitments, namely, development of medicines and vaccines by taking into account epidemiological profiles of countries; training and communication for healthcare professionals; and the deployment of information and educational activities for the general public, as well as follow-up tools for children.

Also speaking at the press parley, Prof. Adebiyi Olowu, president of PAN, urged the government to ensure that all children in the country had access to not only proper pneumonia care but free health care at all levels of government.

He specifically urged the federal government to ensure the availability of the Pneumococcus Conjugate Vaccine (PVC) by December as it had promised, bemoaning the repeated change of dates of introduction of the PVC.

Agbolade further noted that the rolling out of the vaccine was crucial to efforts aimed at ensuring that Nigeria exits the league of nations of high child mortality, adding that countries that are not as endowed as Nigeria like Ghana, Rwanda, Ethiopia, were already using the PVC.

 

 

 

Leadership competencies in the health care industry

0

Organisations are experiencing changes and health care organisations are not left out-health reforms, changes in technology, government policy and consumers’ expectations are transforming relationships among actors and impacting on operations in critical ways in the industry. These staggering twists, added with a sagging economy, poor Research &Development budgets and lacklustre sales pipelines are issues today’s leader must grapple with.

The pharmaceutical industry represents a major sub-sector of the health care industry. In a study conducted by the Centre for Creative Leadership, about a thousand leaders were evaluated and out of the major sixteen leadership competencies, respondents say there are eight top critical leadership competencies important in the pharmaceutical market.

 The traditional 16 critical leadership competencies include:

  1. Strategic perspective – Understands the viewpoint of higher management and effectively analyses                         complex problems.
  2. Having a quick study – Quickly masters new technical and business knowledge.
  3. Decisiveness – Prefers quick and approximate actions in many management situations.
  4. Change management – Uses effective strategies to facilitate organisational change initiatives and                  to overcome resistance to change.
  5. Leading employees – Attracts, motivates and develops employees.
  6. Confronting problem employees – Acts decisively and with fairness when dealing with problem                         employees.
  7. Participative management – Involves others, listens and builds commitment.
  8. Building collaborative relationships – Builds productive working relationships with co-                 workers and external parties.
  9. Compassion and sensitivity – Shows genuine interest in others and sensitivity to employee                         needs.
  10. Putting people at ease -Displays warmth and a good sense of humour.
  11. Respect for differences – Values people of different backgrounds, cultures, or demographics.
  12. Taking initiative – Takes charge and capitalises on opportunities.
  13. Composure – Demonstrates self-control in difficult situations.
  14. Balance between personal and work life – Balances work priorities with personal life.
  15. Self-awareness – Has an accurate picture of strengths and weaknesses and is willing to             improve.
  16. Career management – Uses effective career- management tactics, including mentoring,             professional relationships and feedback channels.

Common leadership derailment factors

Across culture and times, there have been five common leadership derailment factors that have been found to be fairly consistent.

  1. Problems with interpersonal relationship – Ineffective at developing good working relationships with others.
  2. Difficulty building and leading a team – Exhibits problems when attempting to select, develop and motivate a team.
  3. Difficulty changing or adapting – Shows resistance to change and to learning and developing from mistakes.
  4. Failure to meet business objectives – Finds it difficult to follow up on promises and complete a job.
  5. Too narrow a functional orientation – Lacks the depth needed to manage outside of current function.

Critical leadership requirements in the pharmaceutical sector

The following are the 8 critical leadership requirements essential to success in the pharmaceutical industry:

  1. Leaders must build collaborative relationships. People, they say, are more important than things. A leader should be able to establish a productive working relationship with co-workers and other external parties. He must ensure that his team builds cordiality while pursuing the common goal. The effective leader places value on the welfare of his team and sees their personal satisfaction as key to growing performance.
  2. Leaders must have a strategic perspective. According to the Forbes magazine, strategic leadership begins with understanding the complex relationships between an organisation and its environment. Today’s leader needs to be able to understand the organisation’s vision, the workings of top management officers and also be critical in dealing with issues. He must see beyond his nose and effectively harness informal relationships with top officers to effect some desired changes. He must anticipate and be prepared in his mind.
  3. Leaders must take initiative.It seems to be that the definition of a leader is one who takes initiative. He should take charge and must be alert to capitalise on opportunities.Harland Cleveland’s quote adds credence to the need for leaders to take prompt initiatives –”The leader must always lean forward on pushing the invisible.”
  4. Leaders must allow for participative management. The effective leader calls for meetings regularly in order to get others involved and to listen to them.This builds confidence in the team and enhances trust.
  5. Leaders must be able to manage change. Change management, most times, determines whether a pharmaceutical or any organisation stays afloat or sinks.They are expected to use effective strategies to facilitate organisational change.They must adapt, control and effect change.
  6. Leaders must lead their employees. An effective leader has a presence he has built over time from hardwork,discipline and professionalism.He or she attracts,motivates and develops employees.
  7. Leaders must be decisive. Today’s leader is expected to not hesitate in the face of situations but take quick and approximate actions in management matters.
  8. The effective leader must be a quick learner. He must develop strong listening skills to study new business and to acquire technical knowledge from team members and across competitors.

In light of these expected competencies, the study conducted by the CCL showed that leaders in the pharmaceutical industry struggle in some areas. The major derailment factors are as listed above in order of prevalence.

Major Derailment Factors

Too narrow functional orientation

Failure to meet business objectives

Difficulty building a team

Difficulty changing or adapting

Problems with interpersonal relationships

Narrow functional orientation

The study showed that the greatest potential derailment factor for pharma executives is “having too narrow a functional orientation.” This is most noticeable when the leader has risen up the ranks through sales, research, or some other functional “silo.” This leader may struggle when asked to take on a more general leadership role.

Often times, there is organisational pressure to keep top functional performers focused on their areas of expertise and these top performers may themselves prefer to remain in their functional comfort zones. To fulfil the promise of a leader’s potential, it is critical to have developmental assignments that broaden experience.

Organisations can help leaders avoid this by offering and encouraging “zigzag” career paths that feature lateral plus vertical movement. Allowing future leaders move to different areas within the organisation can help them develop a broader management perspective and learn how to build relationships with different people in different ways.

There is need therefore for organisations to invest in leadership development.

 

Our focus on leadership development

Our experience at the Pharmanews Centre for Health Care Management Development also confirms these observations and has informed our focus on health care management development as a critical step in advancing the quality of health care service provision in Nigeria. Therefore, we have focused on the following critical areas for intervention:

 

  • Fostering of system understanding

Here, we seek to help leaders and emerging leaders understand the different aspects of the health care industry – global best practices, financing structures and quality management processes. We understand that good leadersmust understand the global, regional and national environment within which their organisations. This provides the depth required to be able to engage others in achieving the organisational objectives. A good macro-economic perspective would help leaders develop interventions that maximises the best of their resources within the limits of their environment.

  • Development of collaborative partnerships

Characteristics of a manager who is effective at building collaborative relationships include:

  • Ability to relate with all kinds of people
  • Ability to treat people fairly
  • Gains support and trust of peers, higher management and customers
  • Uses good timing when negotiating with others
  • Can settle problems internally and externally

We have found these skillset to constitute essential components of the clinical leadership framework. To achieve organisational renewal, today’s leader must be able to enhance collaborative relationships, hold regular meetings, and develop performance standards and feedback processes for managers. They should learn to assign responsibilities, applaud staffers and reward hard work.

 

Business financing structures

Nigerian health financing system has been characterised by low government investment, extensive out-of-pocket payments, limited insurance coverage and low donor funding. Thus, achieving effective and successful healthcare financing system has been a major challenge in Nigeria.

Health care leaders need to understand the challenges, the National Health Insurance Scheme, global financing structures, the macroeconomic outlay of the Nigerian economies and the emerging opportunities. These are essential for both private, public and public–private organisations.

 Organisational development

In a Business Leader survey, four areas in particular where there are signiûcantopportunities for improvement in most organisations include: talent, culture, alignment, and engagement. These areas constitute our major areas of intervention.

  1. Talent – Leaders urgently need support in areas related to talent, including developing current and future leadership capacity, as well as attracting and retaining top talents.
  2. Culture – There is also an urgent need for support in effectively addressing organizational culture during organisational realignments, industry consolidations and the formation of private – public partnerships.
  3. Alignment – Another high priority area requiring more effective support is alignment. Successful ûrms must align and execute business strategies in ways that meet their ûnancial goals and are consistent with their core values. Moreover, strategies, people, systems and processes must be aligned organization-wide to enhance productivity and proûtability.
  4. Engagement – Finally, business executives and leaders need support to engage their workforce. An organisation can best achieve its business results when its workforce is engaged and committed to achieving its goals and objectives. An organisational leader must be able to clarify and communicate succinctly the purpose and mission of the organisation to inspire and engage the workforce.

 

Below is a summary of our services:

  • Scheduled and on-demand training at Pharmanews training facilities
  • On-site training at clients’ premises
  • Executive management training for health care administrators
  • Advanced care workshops (sponsored training for health institutions and professional groups)

 Reference

  • Wirtenberg et al, (2007). The Future of Organisational Development: Enabling Sustainable Business Performance Through People. Organisational Development Journal, Special Edition: Best Global Practices in Internal OD, Summer 2007, Volume 25: Number 2.
  • Leslie et al, (2014). The Leadership Challenge in the Pharmaceutical Sector What Critical Capabilities are Missing in Leadership Talent and How Can they be Developed? Center for Creative Leadership.

 

 

Community pharmacy in Nigeria must reflect global trends – Bukky George

0

Community pharmacy practice worldwide is being transformed in line with global trends, requiring practitioners in Nigeria to catch up with the pace of advancement in order to bring about overall improvement and better outcomes, Pharm. (Mrs) Bukky George, CEO, HealthPlus Pharmacy, has said.

Pharm. George, who spoke during a session at the 87th Annual National Conference of the Pharmaceuitcal Society of Nigeria (PSN), held in Uyo, Akwa Ibom State, recently, urged practitioners to benchmark community pharmacy practice in Nigeria with that of developed countries and be determined to embrace best practices.

Delivering a paper titled, “Transforming Community Pharmacy Practice for Better Outcomes”, Pharm. George tasked community pharmacists in Nigeria to raise the bar in order to achieve excellence in healthcare delivery.

Noting the vital role of of community pharmacists, the HealthPlus boss emphasised that community pharmacists form part of the frontline in the battle for better health and wellbeing because they are easily accessible, adding that some pharmacies are open for 24 hours.

Pharmacists, she said, are always readily available to give sound professional advice and to help to deal with everyday health concerns and problems.

She further added that pharmacies provide convenient and less formal environment for those who cannot easily access or do not choose to access other kinds of health service.

Explaining further on how to transform community pharmacy for better outcomes in Nigeria, Pharm. George,stated that there was no need searching for clues, as practitioners can easily adopt best practices from the United Kingdom (UK), United States of America (USA), and other developed countries.

The HealthPlus CEO also advocated for improvement in the training of pharmacists, adding that all stages of pharmacy training need to be revamped in line with global best practices while ensuring local relevance.

She also urged pharmacy regulatory agencies, pharmacy associations and key leaders in community pharmacy to engage with government and highlight the value of community pharmacy and their role in healthcare delivery to the public.

Pharm. George equally advised community pharmacists to consistently strive to improve their business knowledge and skills by reading books and magazines on entrepreneurship, management, strategy execution, leadership, and the likes.

While stressing the importance of collaboration among members of the healthcare team, Pharm. George also tasked government on proper implementation of the National Health Insurance Scheme (NHIS), to ensure that roles are clearly defined and that all members of the healthcare team are equitably remunerated.

 

 

General Manager needed at Pharmanews Limited

3
job Vacancy
General manager needed at Pharmanews limited

Pharmanews Limited requires the services of a General manager.
Job Title: General Manager

Location: Lagos

Job Description

  •  Direct internal operations to achieve targeted results
  • Develop operation policies and ensure their adequate execution
  • Supervise activities in compliance with company policies and professional regulations.
  • Oversee the interests and welfare of employees

 

Qualifications

  • Minimum of Bachelors in Pharmaceutical Sciences.
  • A post graduate qualification would be an advantage (MBA).
  • Excellent written and verbal communication skills, including technical writing skills.
  • Understanding of business processes.
  • Computer literacy
  • Managerial experience

Age: 30-40 years

Remuneration: Attractive

Application Closing Date: 15th December, 2014
Method of Application
Interested candidates should send their CVs and application letters to: jobs@pharmanewsonline.com before 15th December, 2014

Only shortlisted candidates will be contacted.

Don seeks overhaul of pharmacy school curriculum

1

  A lecturer in the department of Pharmacology and Toxicology, University of Benin (UNIBEN), Pharm (Prof.) Ray I.Ozolua has called for holistic change in the curriculum of pharmacy schools across the country, stressing that this would positively affect the entire pharmaceutical profession.

Prof. Ozolua, who was one of the speakers at the 87th Annual National Conference of the Pharmaceutical Society of Nigeria (PSN), held in Uyo, Akwa-Ibom State, explored the topic, “Academic pharmacy practice: Time for change.”

Ozolua opined that the focus of pharmacy schools should always be on the relevance of a topic or subject to contemporary practice and research, rather than emphasising old and irrelevant issues.

“The world must not leave us behind, as many health professions have stepped up their game. Pharmaceutical medicine and herbal medicine are being introduced into the curricular of some schools of medicine. Therefore our type of Pharm.D should be a good blend of industrial, clinical practice and research,” he said.

He further asserted that a robust curriculum for pharmacy schools would be beneficial to national development as it would result in self-sufficiency and export of pharmaceutical products, including herbal products to other countries, while providing sound clinical basis for interpreting drug actions.

Prof. Ozolua also emphasised the need for improved teaching methodology, noting that lack of inspiration from some lecturers, low mental capacity, poor dress sense and lack of self-confidence were part of the challenges that must be surmounted for progress to be made.

“Absence of quality lecturing which ranges from dictating lecture notes without explanation, poor background preparation, failure to deploy ICTs and poor mentoringshould also change,” he urged, adding that “the change we are talking about cannot be achieved in academics if teaching methodology is not improved. Time for dictating lectures is over; time for telling students to ‘read up every topic’ is over; time for bullying students over minor acts of misdemeanour is over.”

The don, who defined pharmacists as professionals and group of persons with common background in training and who possess requisite skills that no other group possesses, however, lamented that pharmacists do not often defend their professionand colleagues.

“Pharmacists are expected to act as a vector, in one accord, in one direction, with a common focus and unrelenting force until the common goal is achieved. This is the main threat to our claim of professionalism,” he observed.

Recalling how Pharmacy started in Nigeria when diploma pharmacists were trained at the Yaba College of Technology, Lagos, up to 1962 when it started as a degree programme at the University of Ife, now Obafemi Awolowo University (OAU), Ife, Prof. Ozolua stated that the main thrust of pharmaceutical care is that pharmacists accept responsibilities for assisting patients get the best out of their medication, adding that, sadly, the current nature of pharmaceutical education in Nigeria is neither clinical nor industrial.

 

Alembic Pharmaceuticals Ltd’s Moments with the Innovation Express

1



“It has been a wonderful experience for us.The Innovation express has given us a glimpse of latest technology updates in the field. I compliment SAP for this great initiative” says Mitanshu Shah, Vice President- Finance Alembic Pharmaceuticals
For more information on how SAP can help you transform your business visit ~ http://theinnovationexpress.com/

source

How to manage diabetes mellitus

15

The rising incidence of diabetes mellitus (commonly called diabetes) in Nigeria has been a source of concern to health experts. Medicinal specialists ascribe the surge to poor way of life of individuals and consequently advised that individuals regularly assess their wellbeing through restorative examination.

“These days in our general public, particularly in the urban groups, most individuals rely on fast food,” Babatope Kolawole, a consultant doctor in Obafemi Awolowo University, Ile-Ife, said. “Most individuals work out their pancreas. They take dairy milk, consume a lot of greasy nourishment, unreasonable oil use, which incline individuals to diabetes and other serious infections.”

At a recent workshop on Strategies for Improving Diabetes Care in Nigeria, held in Ibadan, experts expressed shock that the level of attention given to the malady was very low, necessitating the joint efforts among stakeholders in the health sector to devise ways of curbing the trend.

 What really is diabetes?

Diabetes mellitus is a group of metabolic diseases characterised by high blood sugar (glucose) levels that result from defects in insulin secretion, or its action, or both. Diabetes was first identified as a disease associated with “sweet urine,” and excessive muscle loss in the ancient world. Elevated levels of blood glucose (hyperglycaemia) lead to spillage of glucose into the urine, hence the term “sweet urine”.

Normally, blood glucose levels are tightly controlled by insulin, a hormone produced by the pancreas. Insulin lowers the blood glucose level. When the blood glucose elevates (for example, after eating food), insulin is released from the pancreas to normalize the glucose level. In patients with diabetes, the absence or insufficient production of insulin causes hyperglycaemia.

Diabetes is a chronic medical condition, meaning that, although it can be controlled, it lasts a lifetime.

According to Prof. Alebiosu Olutayo, coordinator of Journalists Action Against Diabetes (JAAD), no fewer than three million Nigerians are living with diabetestoday.

“Many people are living with the condition unaware of the seriousness of the disease and its consequences as those diagnosed are often poorly managed due to lack of resources or because the health care professionals who care for them have poor knowledge about diabetes and how to provide good care,” he said.

He warned that with the rate at which diabetes is spreading, it might overtake tuberculosis, malaria, HIV/AIDS, and other terminal diseases by the year 2030, if adequate attention is not paid toward the provision of health education to the masses.

 

How serious is diabetes?

Over time, diabetes can lead to blindness, kidney failure, and nerve damage. These types of damage are the result of damage to small vessels, referred to as microvascular disease. Diabetes is also an important factor in accelerating the hardening and narrowing of the arteries (atherosclerosis), leading to strokes, coronary heart disease, and other large blood vessel diseases. This is referred to as macrovascular disease.

From an economic perspective, the total annual cost of diabetes in 2011 was estimated to be 174 billion dollars in the United States alone. This included 116 billion in direct medical costs (healthcare costs) for people with diabetes and another 58 billion in other costs due to disability, premature death, or work loss. Medical expenses for people with diabetes ate over two times higher than those for people who do not have diabetes. Globally, the statistics are staggering.

What causes diabetes?

Insufficient production of insulin (either absolutely or relative to the body’s needs), production of defective insulin (which is uncommon), or the inability of cells to use insulin properly and efficiently leads to hyperglycaemia and diabetes. This latter condition affects mostly the cells of muscle and fat tissues, and results in a condition known as insulin resistance. This is the primary problem in type 2 diabetes.

The absolute lack of insulin, usually secondary to a destructive process affecting the insulin-producing beta cells in the pancreas, is the main disorder in type 1 diabetes. In type 2 diabetes, there also is a steady decline of beta cells that adds to the process of elevated blood sugars. Essentially, if someone is resistant to insulin, the body can, to some degree, increase production of insulin and overcome the level of resistance. After time, if production decreases and insulin cannot be released as vigorously, hyperglycaemia develops.

Glucose is a simple sugar found in food. Glucose is an essential nutrient that provides energy for the proper functioning of the body cells. Carbohydrates are broken down in the small intestine and the glucose in digested food is then absorbed by the intestinal cells into the bloodstream, and is carried by the bloodstream to all the cells in the body where it is utilized. However, glucose cannot enter the cells alone and needs insulin to aid in its transport into the cells. Without insulin, the cells become starved of glucose energy despite the presence of abundant glucose in the bloodstream. In certain types of diabetes, the cells’ inability to utilize glucose gives rise to the ironic situation of “starvation in the midst of plenty”. The abundant, unutilized glucose is wastefully excreted in the urine.

Insulin is a hormone that is produced by specialized cells (beta cells) of the pancreas. (The pancreas is a deep-seated organ in the abdomen located behind the stomach). In addition to helping glucose enter the cells, insulin is also important in tightly regulating the level of glucose in the blood. After a meal, the blood glucose level rises. In response to the increased glucose level, the pancreas normally releases more insulin into the bloodstream to help glucose enter the cells and lower blood glucose levels after a meal. When the blood glucose levels are lowered, the insulin release from the pancreas is turned down. It is important to note that even in the fasting state there is a low steady release of insulin than fluctuates a bit and helps to maintain a steady blood sugar level during fasting. In normal individuals, such a regulatory system helps to keep blood glucose levels in a tightly controlled range. As outlined above, in patients with diabetes, the insulin is either absent, relatively insufficient for the body’s needs, or not used properly by the body. All of these factors cause elevated levels of blood glucose (hyperglycemia).

What are the different types of diabetes?

There are two major types of diabetes, called type 1 and type 2. Type 1 diabetes was also formerly called insulin dependent diabetes mellitus (IDDM), or juvenile onset diabetes mellitus. In type 1 diabetes, the pancreas undergoes an autoimmune attack by the body itself, and is rendered incapable of making insulin. Abnormal antibodies have been found in the majority of patients with type 1 diabetes. Antibodies are proteins in the blood that are part of the body’s immune system. The patient with type 1 diabetes must rely on insulin medication for survival.

In autoimmune diseases, such as type 1 diabetes, the immune system mistakenly manufactures antibodies and inflammatory cells that are directed against and cause damage to patients’ own body tissues. In persons with type 1 diabetes, the beta cells of the pancreas, which are responsible for insulin production, are attacked by the misdirected immune system. It is believed that the tendency to develop abnormal antibodies in type 1 diabetes is, in part, genetically inherited, though the details are not fully understood.

Exposure to certain viral infections (mumps and Coxsackie viruses) or other environmental toxins may serve to trigger abnormal antibody responses that cause damage to the pancreas cells where insulin is made. Some of the antibodies seen in type 1 diabetes include anti-islet cell antibodies, anti-insulin antibodies and anti-glutamic decarboxylase antibodies. These antibodies can be detected in the majority of patients, and may help determine which individuals are at risk for developing type 1 diabetes.

Type 2 diabetes was also previously referred to as non-insulin dependent diabetes mellitus (NIDDM), or adult onset diabetes mellitus (AODM). In type 2 diabetes, patients can still produce insulin, but do so relatively inadequately for their body’s needs, particularly in the face of insulin resistance as discussed above. In many cases this actually means the pancreas produces larger than normal quantities of insulin. A major feature of type 2 diabetes is a lack of sensitivity to insulin by the cells of the body (particularly fat and muscle cells).

In addition to the problems with an increase in insulin resistance, the release of insulin by the pancreas may also be defective and suboptimal. In fact, there is a known steady decline in beta cell production of insulin in type 2 diabetes that contributes to worsening glucose control. (This is a major factor for many patients with type 2 diabetes who ultimately require insulin therapy.) Finally, the liver in these patients continues to produce glucose through a process called gluconeogenesis despite elevated glucose levels. The control of gluconeogenesis becomes compromised.

While it is said that type 2 diabetes occurs mostly in individuals over 30 years old and the incidence increases with age, we are seeing an alarming number patients with type 2 diabetes who are barely in their teen years. Most of these cases are a direct result of poor eating habits, higher body weight, and lack of exercise.

Regarding age, data shows that for each decade after 40 years of age regardless of weight there is an increase in incidence of diabetes. The prevalence of diabetes in persons 65 years of age and older is around 27%. Type 2 diabetes is also more common in certain ethnic groups. Compared with a 7% prevalence in non-Hispanic Caucasians, the prevalence in Asian Americans is estimated to be 8%, in Hispanics 12%, in blacks around 13%, and in certain Native American communities 20% to 50%. Finally, diabetes occurs much more frequently in women with a prior history of diabetes that develops during pregnancy (gestational diabetes).

Diabetes can occur temporarily during pregnancy, and reports suggest that it occurs in 2% to 10% of all pregnancies. Significant hormonal changes during pregnancy can lead to blood sugar elevation in genetically predisposed individuals. Blood sugar elevation during pregnancy is called gestational diabetes. Gestational diabetes usually resolves once the baby is born. However, 35% to 60% of women with gestational diabetes will eventually develop type 2 diabetes over the next 10 to 20 years, especially in those who require insulin during pregnancy and those who remain overweight after their delivery. Patients with gestational diabetes are usually asked to undergo an oral glucose tolerance test about six weeks after giving birth to determine if their diabetes has persisted beyond the pregnancy, or if any evidence (such as impaired glucose tolerance) is present that may be a clue to the patient’s future risk for developing diabetes.

“Secondary” diabetes refers to elevated blood sugar levels from another medical condition. Secondary diabetes may develop when the pancreatic tissue responsible for the production of insulin is destroyed by disease, such as chronic pancreatitis (inflammation of the pancreas by toxins like excessive alcohol), trauma, or surgical removal of the pancreas.

Diabetes can also result from other hormonal disturbances, such as excessive growth hormone production (acromegaly) and Cushing’s syndrome. In acromegaly, a pituitary gland tumor at the base of the brain causes excessive production of growth hormone, leading to hyperglycemia. In Cushing’s syndrome, the adrenal glands produce an excess of cortisol, which promotes blood sugar elevation.

In addition, certain medications may worsen diabetes control, or “unmask” latent diabetes. This is seen most commonly when steroid medications (such as prednisone) are taken and also with medications used in the treatment of HIV infection (AIDS).

What are diabetes symptoms?

The early symptoms of untreated diabetes are related to elevated blood sugar levels, and loss of glucose in the urine. High amounts of glucose in the urine can cause increased urine output and lead to dehydration. Dehydration causes increased thirst and water consumption.

The inability of insulin to perform normally has effects on protein, fat and carbohydrate metabolism. Insulin is an anabolic hormone, that is, one that encourages storage of fat and protein.

A relative or absolute insulin deficiency eventually leads to weight loss despite an increase in appetite.Some untreated diabetes patients also complain of fatigue, nausea and vomiting.   Patients with diabetes are prone to developing infections of the bladder, skin, and vaginal areas.Fluctuations in blood glucose levels can lead to blurred vision. Extremely elevated glucose levels can lead to lethargy and coma.

 How is diabetes diagnosed?

The fasting blood glucose (sugar) test is the preferred way to diagnose diabetes. It is easy to perform and convenient. After the person has fasted overnight (at least 8 hours), a single sample of blood is drawn and sent to the laboratory for analysis. This can also be done accurately in a doctor’s office using a glucose meter.

Normal fasting plasma glucose levels are less than 100 milligrams per deciliter (mg/dl).

Fasting plasma glucose levels of more than 126 mg/dl on two or more tests on different days indicate diabetes.

A random blood glucose test can also be used to diagnose diabetes. A blood glucose level of 200 mg/dl or higher indicates diabetes.

When fasting blood glucose stays above 100mg/dl, but in the range of 100-126mg/dl, this is known as impaired fasting glucose (IFG). While patients with IFG do not have the diagnosis of diabetes, this condition carries with it its own risks and concerns, and is addressed elsewhere.

 The oral glucose tolerance test

Though not routinely used anymore, the oral glucose tolerance test (OGTT) is a gold standard for making the diagnosis of type 2 diabetes. It is still commonly used for diagnosing gestational diabetes and in conditions of pre-diabetes, such as polycystic ovary syndrome. With an oral glucose tolerance test, the person fasts overnight (at least eight but not more than 16 hours). Then first, the fasting plasma glucose is tested. After this test, the person receives 75 grams of glucose. There are several methods employed by obstetricians to do this test, but the one described here is standard. Usually, the glucose is in a sweet-tasting liquid that the person drinks. Blood samples are taken at specific intervals to measure the blood glucose.

 For the test to give reliable results:

*     The person must be in good health (not have any other illnesses, not even a cold)

*     The person should be normally active (not lying down, for example, as an inpatient in a hospital), and

*     The person should not be taking medicines that could affect the blood glucose.

*     The morning of the test, the person should not smoke or drink coffee.

The classic oral glucose tolerance test measures blood glucose levels five times over a period of three hours. Some physicians simply get a baseline blood sample followed by a sample two hours after drinking the glucose solution. In a person without diabetes, the glucose levels rise and then fall quickly. In someone with diabetes, glucose levels rise higher than normal and fail to come back down as fast.

People with glucose levels between normal and diabetic have impaired glucose tolerance (IGT). People with impaired glucose tolerance do not have diabetes, but are at high risk for progressing to diabetes. Each year, 1% to 5% of people whose test results show impaired glucose tolerance actually eventually develop diabetes. Weight loss and exercise may help people with impaired glucose tolerance return their glucose levels to normal. In addition, some physicians advocate the use of medications, such as metformin (Glucophage), to help prevent/delay the onset of overt diabetes.

Research has shown that impaired glucose tolerance itself may be a risk factor for the development of heart disease. In the medical community, most physicians are now understanding that impaired glucose tolerance is nor simply a precursor of diabetes, but is its own clinical disease entity that requires treatment and monitoring.

Glucose tolerance tests may lead to one of the following diagnoses:

Normal response: A person is said to have a normal response when the 2-hour glucose level is less than 140 mg/dl, and all values between 0 and 2 hours are less than 200 mg/dl.

Impaired glucose tolerance: A person is said to have impaired glucose tolerance when the fasting plasma glucose is less than 126 mg/dl and the 2-hour glucose level is between 140 and 199 mg/dl.

   Diabetes: A person has diabetes when two diagnostic tests done on different days show that the blood glucose level is high.

   Gestational diabetes: A pregnant woman has gestational diabetes when she has any two of the following:, a fasting plasma glucose of 92 mg/dl or more, a 1-hour glucose level of 180 mg/dl or more, or a 2-hour glucose level of 153 mg/dl, or more.

What are the chronic complications of diabetes?

These diabetes complications are related to blood vessel diseases and are generally classified into small vessel disease, such as those involving the eyes, kidneys and nerves (microvascular disease), and large vessel disease involving the heart and blood vessels (macrovascular disease). Diabetes accelerates hardening of the arteries (atherosclerosis) of the larger blood vessels, leading to coronary heart disease (angina or heart attack), strokes, and pain in the lower extremities because of lack of blood supply (claudication).

Eye Complications

The major eye complication of diabetes is called diabetic retinopathy. Diabetic retinopathy occurs in patients who have had diabetes for at least five years. Diseased small blood vessels in the back of the eye cause the leakage of protein and blood in the retina. Disease in these blood vessels also causes the formation of small aneurysms (microaneurysms), and new but brittle blood vessels (neovascularization). Spontaneous bleeding from the new and brittle blood vessels can lead to retinal scarring and retinal detachment, thus impairing vision.

To treat diabetic retinopathy a laser is used to destroy and prevent the recurrence of the development of these small aneurysms and brittle blood vessels. Approximately 50% of patients with diabetes will develop some degree of diabetic retinopathy after 10 years of diabetes, and 80% of diabetics have retinopathy after 15 years of the disease. Poor control of blood sugar and blood pressure further aggravates eye disease in diabetes.

Cataracts and glaucoma are also more common among diabetics. It is also important to note that since the lens of the eye lets water through, if blood sugar concentrations vary a lot, the lens of the eye will shrink and swell with fluid accordingly. As a result, blurry vision is very common in poorly controlled diabetes. Patients are usually discouraged from getting a new eyeglass prescription until their blood sugar is controlled. This allows for a more accurate assessment of what kind of glasses prescription is required.

 Kidney damage

Kidney damage from diabetes is called diabetic nephropathy. The onset of kidney disease and its progression is extremely variable. Initially, diseased small blood vessels in the kidneys cause the leakage of protein in the urine. Later on, the kidneys lose their ability to cleanse and filter blood. The accumulation of toxic waste products in the blood leads to the need for dialysis. Dialysis involves using a machine that serves the function of the kidney by filtering and cleaning the blood. In patients who do not want to undergo chronic dialysis, kidney transplantation can be considered.

The progression of nephropathy in patients can be significantly slowed by controlling high blood pressure, and by aggressively treating high blood sugar levels. Angiotensin converting enzyme inhibitors (ACE inhibitors) or angiotensin receptor blockers (ARBs) used in treating high blood pressure may also benefit kidney disease in diabetic patients.

Nerve damage

Nerve damage from diabetes is called diabetic neuropathy and is also caused by disease of small blood vessels. In essence, the blood flow to the nerves is limited, leaving the nerves without blood flow, and they get damaged or die as a result (a term known as ischemia). Symptoms of diabetic nerve damage include numbness, burning, and aching of the feet and lower extremities. When the nerve disease causes a complete loss of sensation in the feet, patients may not be aware of injuries to the feet, and fail to properly protect them. Shoes or other protection should be worn as much as possible. Seemingly minor skin injuries should be attended to promptly to avoid serious infections. Because of poor blood circulation, diabetic foot injuries may not heal. Sometimes, minor foot injuries can lead to serious infection, ulcers, and even gangrene, necessitating surgical amputation of toes, feet, and other infected parts.

Diabetic nerve damage can affect the nerves that are important for penile erection, causing erectile dysfunction (ED, impotence). Erectile dysfunction can also be caused by poor blood flow to the penis from diabetic blood vessel disease.

Diabetic neuropathy can also affect nerves to the stomach and intestines, causing nausea, weight loss, diarrhea, and other symptoms of gastroparesis (delayed emptying of food contents from the stomach into the intestines, due to ineffective contraction of the stomach muscles).

What can be done to slow diabetes complications?

Findings from the Diabetes Control and Complications Trial (DCCT) and the United Kingdom Prospective Diabetes Study (UKPDS) have clearly shown that aggressive and intensive control of elevated levels of blood sugar in patients with type 1 and type 2 diabetes decreases the complications of nephropathy, neuropathy, retinopathy, and may reduce the occurrence and severity of large blood vessel diseases. Aggressive control with intensive therapy means achieving fasting glucose levels between 70-120 mg/dl; glucose levels of less than 160 mg/dl after meals; and a near normal hemoglobinA1c levels (see below).

How is diabetes treated?

The major goal in treating diabetes is to minimize any elevation of blood sugar (glucose) without causing abnormally low levels of blood sugar. Type 1 diabetes is treated with insulin, exercise, and a diabetic diet. Type 2 diabetes is treated first with weight reduction, a diabetic diet, and exercise. When these measures fail to control the elevated blood sugars, oral medications are used. If oral medications are still insufficient, treatment with insulin is considered.

Medications for type 2 diabetes

WARNING: All the information below applies to patients who are not pregnant or breastfeeding. At present the only recommended way of controlling diabetes in women who are pregnant or breastfeeding is by diet, exercise and insulin therapy. You should speak with your doctor if you are taking these medications and are considering becoming pregnant or if you have become pregnant while taking these medications.

Based on what is known, medications for type 2 diabetes are designed to:

* increase the insulin output by the pancreas,

*   decrease the amount of glucose released from the liver,

*   increase the sensitivity (response) of cells to insulin,

*   decrease the absorption of carbohydrates from the intestine, and

*   slow emptying of the stomach to delay the presentation of carbohydrates for digestion and absorption in the small intestine.

When selecting therapy for type 2 diabetes, consideration should be given to:

*the magnitude of change in blood sugar control that each medication will provide;

* other coexisting medical conditions (high blood pressure, high cholesterol, etc.);

*adverse effects of the therapy;

*contraindications to therapy;

*issues that may affect compliance (timing of medication, frequency of dosing); and

*   cost to the patient and the health care system.

It is important to remember that if a drug can provide more than one benefit (lower blood sugar and have a beneficial effect on cholesterol, for example), it should be preferred. It’s also important to bear in mind that the cost of drug therapy is relatively small compared to the cost of managing the long-term complications associated with poorly controlled diabetes.

Patients with diabetes should never forget the importance of diet and exercise. The control of diabetes starts with a healthy lifestyle regardless of what medications are being used.

To this end, Alebiosu urged the government to give priority attention to the treatment of the silent killer-disease as being done to others.

He deposed that as part of its own efforts towards the control of the disease, his organisation through a health project would distribute enlightenment materials in form of posters and stickers to major markets, schools, motor parks and all available gatherings during its awareness campaigns nationwide.

Report compiled by Adebayo Folorunsho-Francis with additional reports from medicinenet.com/diabetes_treament and American Diabetes Association

 

 

How often do you need a mirror?

0

During the civil war (1967-1970) I worked as a pharmacist in the Biafran Army, under a medical doctor who was the Commanding Officer (CO) of the hospital unit. My CO was heavily bearded. I was bearded, too, but I did not allow my beard to outgrow his, being my boss. That was how careful I was not to permit anything to cause misunderstanding between us.

However, despite my efforts to maintain a cordial relationship, a misunderstanding occurred between us and he had to order for my transfer to another hospital unit. Luckily for me, the CO of the new unit was my schoolmate, although much senior to me. We related very well and I worked cordially with him until the war ended.

I remember my former bearded CO for one thing. He liked using chewing stick to clean his teeth. Nothing is wrong with that, actually; but my concern was that after chewing the stick he allowed some white bits of the stick to rest on his heavy black beard. On two different occasions, I had to help him remove the particles. I did so because such a thing could happen to me also. Anybody with a beard is always careful when eating to avoid food particles or streak of soup falling on it.

Apparently, my boss was not used to using, mirror to check his face in the mornings before leaving the house. That was why I had to often step in to help him. He should have observed the error himself, if he had used a mirror.

The use of mirror is common, especially among females. Many of them carry small mirrors in their handbags to check their faces when they apply and reapply their cosmetics. Mirrors of various sizes are usually provided in restrooms, offices, cars, hotel rooms, shops and other public places for people to check and correct or adjust themselves, if necessary.

We rely on the mirror because it shows us our true state. Your mirror can never deceive you. It presents a replica of anything and gives you true reflection. You see yourself exactly as you are. If you look into the mirror and see that the knot of your tie is one- sided, it is truly one-sided. If your lipstick is heavy in the mirror, it is indeed heavy.

A mirror does not distort any image. Someone can tell you that you need a haircut but that is merely his opinion. Your own opinion should be determined by the mirror when you look into it.

The Bible describes the Word of God as a mirror. James 1:22-24 says, “Be ye doers of the word, and not hears only, deceiving yourselves. For if anyone is a hearer of the word and not a doer, he is like a man who looks intently at his natural face in a mirror. For he looks at himself and goes away and at once forgets what he was like.”

God’s mirror gives you a true reflection of yourself. The closer you are to the mirror, the clearer you see yourself. Psalm 119:9 asks a pertinent question and then provides the answer: How can a young man keep his way pure? By guarding it according to your word.

You use the divine mirror to examine and evaluate yourself. This mirror reflects the thoughts of your heart and the condition of your soul. Do not depend on what people tell you about your moral or spiritual state. People’s opinion can distort, enlarge or diminish what you are on the inside because people can only see your outward appearance. You need the Word of God to check and reveal your spiritual state.

No right-thinking person looks into the mirror, notices a speck on his face, and does not quickly remove it. But many receive the Word of God, without taking necessary actions. If you do so, you are ignoring valuable counsels that could preserve your life and secure your destiny. You must not be only a hearer but also a doer of God’s Word.

2 Timothy 3:16 says, All scripture is given by inspiration of God, and is profitable for doctrine, for reproof, for correction, for instruction in righteousness. Just as you use the mirror to check and correct your physical body, so also must you use the spiritual mirror to check the condition of your soul. The spiritual mirror is the only instrument that tells you exactly the type of person you are and your true state before God, regardless of what people think of you.

Most of us use the mirror to make sure we are looking good before getting out of the house in the morning. We should also daily endeavour to check our lives in God’s mirror, the Word of God. I believe we will greatly enhance our physical, as well as spiritual conditions, if we use the two mirrors every time.

 

 

 

 

 

 

 

 

 

Why I don’t attend PSN conferences – Pharm. Adebutu

2

In this interview with Adebayo Folorunsho-Francis, Pharm. (Chief) Timothy Adebutu, a retired principal pharmacist, formerly in charge of the Lagos State Health Management Board (LSHMB) and current manager of his premises – Gem Pharmacy – reveals how he became a pioneer of LSHMB, how his wife’s untimely death cut short his dream of leaving the civil service, as well as his grievances against the Pharmaceutical Society of Nigeria (PSN). Excerpts:

 Tell us a bit about yourself, especially your early days

I was born on 24January, 1932, and attended St James Anglican School, Iperu, Remo, Ogun State, from 1938 to 1945. I proceeded to the Baptist Academy, Lagos (1947–1952) for further studies,after which I enrolled at the Pharmacy School, Yaba, where I qualified as a pharmacist.

 How about your work experience?

I had the privilege of sitting the London Matriculation Examination and passed. Not long after that, I joined Customs & Excise, Lagos. After working for close to a year, I was granted permission to write Cambridge Examination in December. Due to my passion for teaching, I was transferred to the education department in the civil service (Federal Ministry of Health) from 1957 to 1976.

Were you affected by the sudden change?

Well, as a senior pharmacist I was in charge of the health management board. I was made to retain the same position under the Lagos State Government (Lagos State Health Management Board) from 1976 to 1980. Until I retired in 1980, I was the principal pharmacist in charge of the board.

Do you have any regret spending your entire career in civil service?

I am not sure. You see, I planned to retire early in 1960. The reason was because, back then, it was quite attractive to work as a private practitioner than in civil service. Unfortunately, my wife’s death ended that dream forever.

 How did that happen?

Well, I got married to her in November 1959. She was then a London-trained nurse. Those days, nurses were being trained at the UCH (it was not yet owned by University of Ibadan). My wife was among the second set of nurses to be trained there before travelling to London for another one-year course. On her return, she became a nursing tutor in a school opposite Island Maternity, which was still under construction. That was the situation, until I lost her in 1960 when she died in the labour room, struggling to deliver our first child. That incident cut short my dream of moving out which further kept me in the civil service for another 20 years with little opportunity except to retire on pension.

 How do you feel as a pioneer of the modern-day Lagos State Health Management Board?

What else can I say other than “We did our best”? You see, the Lagos State Health Management Board (LSHMB) was actually created in 1972 by the Lagos Ministry of Health. All existing hospitals were drafted under its management and people like me were thrown into the system without proper training or a guideline on how to make the system work. Nevertheless, rather than complain, we poured our vexation into coming up with a grand structure. The health system was systematically organised and became a model of sort. So good was it that other states in Nigeria found it appealing and started adopting it. In fact, it is the same model that is still in use. I can confidently say that was the legacy we (pioneers) left behind. Interestingly, Massey Street was about the only maternity hospital we had in Lagos before the transformation.

 Looking back, can you confidently say studying Pharmacy was a good decision for you?

At that time, it didn’t really matter because I was just after the admission. I could have studied anything. Initially, I thought of studying marine engineering but changed my mind. So the idea of studying Pharmacy just came to me naturally. Besides it was one course where you are expected to finish everything the same day – examination, interview and offer of admission. It was also open to sponsorship.

What was the profession like in your day compared to today’s practice?

Of course, you cannot expect everything to be the same. The School of Pharmacy I attended was a remnant of the Yaba College. In that same Yaba environ, there was a medical school. Back then, when you entered a laboratory, you would see each student in full lab kit. Also it used to be one student to one microscope and other equipment. It is much different from what I have been seeing around today.

I think commerce has taken over the pharmacy profession. I remember in our time, only few hands were on ground and they were quite effective. We were respected because of how disciplined we were. Now, indiscipline has taken over. Although I want to agree that every profession has a black sheep, but among pharmacy practitioners, the act of indiscipline is gross.

Prior to the Nigerian Civil War, there was nothing like ethnic rift and what have you. I could be posted to Sokoto or anywhere. As government students (on scholarship), we were expected to serve the federal government for five years; otherwise you might have to refund the bond you took. Once you started working as a pharmacist, you were automatically required to register with the PSN to show you were qualified. Even Koreans who worked in the country had dual qualification. That should tell you how serious being a pharmacist was back in those days.

What has changed?

We are in a confused state, especially pharmaceutical companies. Everybody just does what he likes. When the expatriates and the multinationals were here, everybody knew how much he was expected to pay for a particular medicine. This is because all the drugs were standardised. We don’t have that professional class anymore. It has been wiped out completely. What we have today is political class. People are just after power. That is why it is quite hard to create a business today and expect to make profit.

What is your view about pharmacists in politics?

That would be ideal if we were in a regulated profession. We need to carefully look at those pharmacists moving into politics. Have they passed through the right channels such as hospital, community, academia or industrial pharmacy? If not, what do they want to contribute there? Politics is a cult. They bring you in and give you their rules and regulations. Tell me, what are you going there to influence? Please prove me wrong if you can – do we have a comprehensive health institution that is based on partnership in this country that succeeded? Only Eko Corp really stood the test of time.

Look at even Juli Plc. Ordinarily, it ought to be a public liability company. However, it is still being run as if it is private. Unfortunately, it has to in order to avoid collapse. I cannot really blame people for most of the things you see in society today. The incursion of the military in Nigerian administration added to our woe. It has not only worsened things but also succeeded in dragging us backward

How best do you think the issue of fake drugs and counterfeit medicine can be curbed?

Pharmacists sold off this profession. They are proving too big to manage it well. We don’t value our profession. What we only know how to do well is to employ labourers, assistant this, assistant that… to help us do something we can do ourselves. The same way we sold this country to the military to manage is the same manner we have traded off pharmacy practice.

The simple truth is that once you give somebody your responsibility, they would hijack it from you. What we call fake drugs is a source of livelihood to those practising it. To them, it is business. In other countries, there are strict laws guarding against counterfeiting. But here, there is laxity. Most of these pharmacists, customs officers and law enforcers know most of these people (counterfeiters) and their activities – right from inspection to delivery stage. However it is a long battle that can be won only when we are sincere to ourselves.

Were you given some sort of recognition for your selfless service?

I believe you know how civil service operates. There is nothing like special reward. My only joy lies in the fact that we pioneered the model of the modern-day Lagos State Health Management Board which is also used in others of the federation. You will agree with me that it is not easy to select few hands and throw them into a system to go and work wonders. We had no training, no prior experience of how to make it work. But we thank God that it all turned out well.

I recall vividly that Jay-Kay (Pharm. Jimi Agbaje) was just coming in as an intern when I was planning for my retirement in 1978. A fine gentleman he turned out to be. Anyway, I quietly retired in 1980.

Did you get any special recognition or award from PSN?

If you read about Pharm. Albert Brown (former registrar of the Pharmacists Board of Nigeria) biography, you will understand how long it took him before he was made a PSN Fellow. Well, that is a story for another day. If there is any honour I cherish more, it has to be the Nigerian Institute of Management which I joined in 1983 as an associate member. I later became a full member in 1997. Owing to my commitment, I soon became a Fellow in 2011.

How often do you attend the annual PSN national conferences?

What will I be doing there when I don’t get PSN’s invitation? Look, I am still a licensed pharmacist, but whenever it is time for renewal, you will be struggling to get it done. Only people who know you would offer to help. In other professions, like Law, this is not so. Barristers will always grant you grace and special recognition. Even in the Nigerian Institute of Management, I was made a Fellow and we are consulted from time-to-time for counsel. But the PSN is different.

What else does it take to get recognised as a Fellow? Have we suddenly forgotten how the PCN came into being? Was it not through the help of Prince Juli (Adelusi-Adeluyi)? It is as if we are not proud to have ourselves as colleagues. So sad.That was why I asked how I would attend PSN conferences when I have not been extended an invitation. If esteemed bodies like NIM can honour me with invitation for major events, what stops the PSN? It is that bad.

 How will you describe pharmacists working in civil service?

Again, you need to read about (Albert) Brown’s biography, you will know that the civil service doesn’t give any recognition to pharmacists. Only women still prefer working in the ministry. The reason is obvious – it affords them the luxury of working and raising a family at the same time. Notwithstanding, to gain experience, I think the civil service is still the best place to go. That is one of the benefits. In fact, the house I am staying was built with the housing loan I got from the ministry. I don’t know how many private companies can do that.

If you were not to be a pharmacist, what other profession would you have opted for?

I would have definitely turned out to be a teacher. I love the teaching profession to the extreme.

 Is there a particular age that an active pharmacist should retire?

It is only death that can separate a practitioner from his profession. Being in a profession does not necessarily mean that you are making millions from it. It is just the joy of doing something.

As an elder in the pharmacy profession, what is your advice to young pharmacists?

Well, I don’t know what to say. I have just observed children of these days (mine inclusive) don’t want to study Pharmacy anymore. Anyway, my only advice has always been “Do the right thing at all times”. Since I have limited time, everything I do now is on short-term basis.

 

WHO prequalification and pharmaceutical innovation

0

In 2005, the African Union (AU) assembly, comprising 55 African ministers of health, adopted a roadmap towards universal access to prevention, treatment and care. The AU policy position is “to pursue, with the support of our partners, the local production of generic medicines on the continent and to making full use of flexibilities within the Trade and Related Aspects of Intellectual Property Rights (TRIPS) and DOHA Declaration on TRIPS and Public Health.”

This decision by the health ministers is in the right direction and offers many advantages, which include foreign exchange savings, job creation, facilitation of technology transfer, prospects of developing cheaper raw materials, increased supply sufficiency and stimulation of export markets. This is besides the national pride and self-esteem that is very much needed in developing countries.

A 2008 International Finance Corporation (IFC) report showed that 70 per cent of Sub Saharan Africa’s estimated $1billion in annual pharmaceutical production is domiciled in South Africa; with Nigeria, Kenya and Ghana contributing only 20 per cent. Six years after, we believe this data is about to change, especially with three more pharmaceutical firms – May &Baker Plc., Chi Pharmaceuticals and Evans Plc. – achieving WHO prequalification status, bringing to four, the number of Nigerian firms accorded the status. Swipha attained the prestigious qualification some months earlier.

At the moment, WHO prequalification is critical to sustainable local productivity in Africa, given the low consumer and institutional purchasing power in the continent, especially for endemic diseases like malaria and HIV/AIDS, for which international funding has become the lifeblood. WHO prequalification is necessary for firms to be able to access these funds, for the local production of the necessary medicines.

While we applaud these achievements, it must be emphasised that, to achieve sustainable development in pharmaceutical innovation, much more efforts would be needed, particularly in the areas of research and development, adequate regulatory frameworks and funding structures. With the projected increase in chronic disease burden and rising infectious disease burden in Nigeria, there is a great need for increased funding of health care systems and research for health in a way that favours indigenous capacity development. Our R & D institutions are in dire need of domestic funding besides the usual international funding. In the pharmaceutical industry, adequate research – industry collaboration are critical for sustaining competitiveness.

At present, Nigeria unlike South Africa which invests 0.9 per cent of her GDP in R&D, invests less than 0.3 per cent. This focus on knowledge building is important as only South Africa possesses the capacity for development of Active Pharmaceutical Ingredients in Sub Saharan Africa. A situation where the greater majority of pharmaceutical research is sponsored by foreign organisations is simply not acceptable and amounts to rent seeking and explains why the few pharmaceutical research endeavours in academic institutions are not aligned with national priorities as “he that pays the piper dictates the tune”.

Nigeria must realise that our often repeated cry of “we don’t have enough resources” is a consequence of not having invested in research and development. “Lack” must not be allowed to hinder progress.

Also, there is an urgent need for a regional policy – especially for drug regulations. We recommend that Nigeria pursue the 2009 recommendation by NEPAD for dug registration efforts to be domiciled with regional economic communities, which, in the case of Nigeria, is ECOWAS. This will help minimise duplication of efforts and yield greater reach for pharmaceutical firms that have attained the WHO prequalification status. With such structures, medications manufactured and registered in Nigeria could easily be sold in every other West African nation and vice versa thereby increasing the competitiveness of the region.

Other crucial areas of focus include: development of human resources, knowledge management expertise and a focus on interdisciplinary interventions. While Africa bears 25 per cent of the world’s disease burden, it has only 1.3 per cent of the health care force, due to the brain drain syndrome. This focus is important because, to achieve quality access to care, we need professionals in our health care facilities. Also, to remain globally competitive, massive levels of skillset and technology transfers must be achieved.

May & Baker gets WHO GMP certification

0

Nigeria’s foremost pharmaceutical company, May & Baker Nigeria Plc, has joined the league of pharmaceutical companies whose manufacturing operations are certified by the World Health Organisation (WHO). The company recently earned the WHO GMP Certificate for its manufacturing facility in Ota, Ogun state, known as the Pharma Centre.

Breaking the news at a press conference on October 13, 2014, Prof. Onyebuchi Chukwu, minister of health congratulated May & Baker along with two other pharmaceutical firms for making the country proud.

The award of the Certificate coincided with the company’s celebration of 70 years of doing business in Nigeria, the first pharmaceutical company so established in the country.

The WHO is the arm of the United Nations that regulates healthcare practice worldwide on the application of international best practice. Its Certificate of Good Manufacturing Practice (GMP) is issued to companies that meet its standards and apply to it for certification. The WHO GMP Certificate will enable the company to offer its products for the pre-qualification process of the WHO and subsequently position for the sales of her products to every market in the world.

It opens the door for foreign countries, donors and agencies to procure the company’s drugs for various health intervention programmes worldwide.

Every year, hordes of patients in resource-limited countries around the world receive life-saving drugs procured through international agencies such as World Health Organisation (WHO), United Nations Children Fund (UNICEF), United Nations Population Fund (UNFPA), UNITAID and the Global Fund to Fight AIDS, TB and Malaria.

While WHO prequalification certification of Medicines Programme ensures that selected drugs supplied by the aforementioned agencies meet international standards of quality, safety and efficacy, the World Health Organisation and the Global Fund, on their part, spends close to N20 billion each year to purchase medicines for malaria, TB and AIDS intervention programmes in Nigeria from countries like Pakistan, India and Brazil because no pharmaceutical industry in Nigeria is pre-qualified.

Hitherto, the country’s pharmaceutical companies were not in a position to partake in international tenders for drugs against the three pandemics that require WHO prequalification. Health experts identify this as a major challenge on the local supply of medicines, especially anti-malarial, anti-retroviral (ARVs) and anti-tuberculosis agents.

That notwithstanding, the good news is that top Nigerian pharma giants such as May and Baker and others have now joined other global firms in producing medicines that conform with WHO-current Good Manufacturing Practice (WHO-cGMP) standards, a condition for WHO pre-qualification.

Chairman of May & Baker, Lt-Gen. Theophilus Danjuma (rtd) disclosed that following the policy of future based investments projected by the management, the company saw the need for global best practice and competitiveness.

“That was why we embarked on a long term project to seek international accreditation for the manufacturing processes of the company. The first step was to build a factory that would meet the standards of the World Health Organisation (WHO) in Good Manufacturing Practice (GMP) and other ramifications.

“That factory was completed and commissioned in 2011. Now, we are on the verge of obtaining WHO GMP certification for this facility and Prequalification for our products,” he said.

Danjuma strongly believed that above all, May & Baker’s quest for global best practice would further open a floodgate of interests in the Nigerian pharmaceutical manufacturing industry.

The chairman also commended the efforts of government through the Federal Ministry of Health and the National Agency for Food and Drugs Administration and Control, (NAFDAC), which he declared as assisting growth in the pharmaceutical industry.

This hope was fulfilled less than two weeks later.

His optimism was equally shared by the managing director, Pharm. Nnamdi Okafor who said the company has transformed into a global player through the years.

“I can confirm to you that the company has, in the past eight years, been rejuvenated, renewing itself with huge investments in two world class factories, research & development, human capital development and technology / process optimisation,” he said.

He summed it up by reiterating that with the aforementioned initiatives, May & Baker Nigeria is good to go!

In Africa, only South Africa, Morocco, Uganda and Nigeria have WHO GMP certified companies.

It would be recalled that May & Baker Nigeria Plc commemorated her 70th anniversary at Muson Centre, Onikan, Lagos on September 11, 2014 with several pharmacists, government functionaries and relevant stakeholders in the health sector in attendance.

As part of the 70th anniversary celebrations, the pharmaceutical giant donated sickbays to three primary schools in a national project of corporate social responsibility.

According to the company’s managing director, “It is our hope that these facilities will assist the management of the schools and those around them to provide emergency and primary healthcare to the young ones while in school.”

Each sick bay is fully air conditioned and equipped to the standard of a clinic with beds, medical instruments, drugs, recovery motifs and television sets to enable the children feel less of their pains while receiving attention.

The pioneer beneficiary schools were Central Primary School, Ikeja; United African Methodist Primary School, Eleja and St Agnes Primary School, Sabo-Yaba, Lagos.

On September 9, senior officials of May & Baker also made a visit to four charity homes in Lagos and Ogun States with products and other gifts for the inmates.

The company was founded on September 4, 1944 as Nigeria’s first pharmaceutical company and began local manufacturing of pharmaceuticals in 1976. In 2002 the company became 100 per cent owned by Nigerians with the complete buyout of the foreign partners who had decided to divest.

 

May & Baker facility in Ota
The WHO-certified May & Baker Pharma Centre in Ota

 

 

 

ACPN joins Global Handwashing campaign

0

Global Handwashing Day, celebrated every 15 October, is a worldwide campaign to sensitise and mobilise people around the world to wash their hands with soap. This year’s edition, with the theme, “Choose Handwashing, Choose Health,” is essentially meant to raise awareness about handwashing as a key approach to prevention of diseases.

According to a press release by the Association of Community Pharmacists of Nigeria (ACPN), signed by its national chairman, Pharm. (Alh) Olufemi Ismail Adebayo, handwashing is a choice that everyone can make many times a day.

“When people choose to wash their hands with soap, especially after using the restroom and before touching food, they are choosing to create a healthier environment, not only for themselves but for people around them,” it said.

The statement further urged people to imbibe handwashing, not only on Global Handwashing Day but every day.

It noted that handwashing focuses on children because research has shown that children are the segment of the society that are energetic, enthusiastic, and open to new ideas, adding that they are powerful agents of change for behavioural shift like handwashing with soap in their communities.

The ACPN national chairman however disclosed that the association, as a key stakeholder in healthcare delivery, had been marking the event with visits to primary and secondary schools, with practical demonstration of proper handwashing with soap under running water, since 2011.

“We believe that a vast change in hand washing behaviour is critical to meeting the Millennium Developmental Goals (MDGs) of reducing mortality of children under 5 years by two third by year 2015.Handwashing with soap under running water still remains the cheapest and most effective way to prevent Ebola, diarrhea, typhoid and respiratory diseases,” he said.

Enterprising Nigeria: The role of bishops

0

In his book, The Business Angel as a Missionary, Prof. Pat Utomi gave details on his “evangelical” stewardship in the Nigerian business terrain; his efforts at promoting social good through entrepreneurship and management education. In the book, he made it clear that contrary to the pervasive drive for material acquisition which underlies most capitalist pursuits, his big, audacious goals were driven more by an altruistic commitment to social welfare rather than personal enrichment. His commitment and those of many like him have yielded Africa’s premier management learning organisation – the Pan African University.

I have, in previous essays, noted that his life has in many ways engendered my own commitment to the development of men and women in the marketplace, whose primary motivations are driven more from long–term social good, rather than the immediate bottom line.It is a path that I have, in my own little journey so far, found to be very educating with numerous challenges. It is easy to understand why this path is not appealing to many; hence the aim of this article is not to disparage those to whom it would be an anomaly but to embolden those to whom such has earlier occurred.

Recently, in a speech to a group of NYSC members who had just arrived the city of Lagos to undertake the mandatory one year service to motherland, I had cause to share with them my reflections on similar chains of thoughts which I seek to describe and expand below.

 Solving Nigeria’s biggest problem

Our unemployment statistics is no longer news.We know the figures.What I believe we are too quick to miss are the implications of the status quo and our current disposition. For one, more than 70 per cent of our population are young people who naturally constitute the greater bulk of the unemployment data. Of this population, employers believe that a lot of them are not employable.

Our problem is more of a human capital problem than anything else. By human capital I refer to human capital management and development.In spite of our peculiar challenges, a lot of organisations in Nigeria would do a thousand times better if their leaders had a more capable followership.

According to a study by an indigenous consultancy firm, Conceptual Strategy Limited, the following constitute the critical skill-set required by employers in the global marketplace.

 

  1. Business communication skillsEmployers know there is a big problem when they have to write every letter and review every corporate communication from their organisations. When the CEO has to draft every concept note himself, the centre is not exactly holding. This skill-set includes achieving structure in thinking and writing; knowledge of Basic Englishand the ability to write concept notes, proposals and project/business plans.

 

  1. Analytical skillsSeeing the big picture is essential here.The ability to put two and two together is not necessarily an inherent trait; it is a product of consistent use of the analytical part of our brains. The “cram and pour” education system in Nigeria has succeeded in dulling the greater majority of her products; students no longer read to understand. Analysis is impossible when understanding is lacking.
  1. Strategic thinking, problem solving and value creationThis is a product of the interplay between technical, conceptual and analytical skills. In Nigeria, the greater majority of employees have just the technical skills – i.e., sufficient skill-set to get the designated job done (as written in the job description). The problem with this is that, in a knowledge economy, the job description is not constant, it is a moving target.
  1. Office toolsThis, essentially, is the ability to use MS-Word, MS-Excel, MS-PowerPoint, MS-Access and MS-Outlook.

 

  1. Leadership and organisational skillsOrganisations are as big as the number of good leaders they have and not in the size of their captain-leader. An organisation with ten good middle level leaders and an average captain-leader will always outperform one with one very good captain- leader but mediocre middle level leadership.

The international dimension

From the above, it is evident that we do not have sufficient human capacity for our present challenges. The situation looks even grimmer when we consider the effects of global competition. It is not just that we are losing our best brains to Europe and North America; our import-driven economy is helping sustain a culture of consumerism that does not encourage the development of the enumerated skill-set.

A case study of the Nigerian pharmaceutical industry points out the obvious – greater than 90 per cent of our workforces are salesmen.Not that there is anything wrong with sales, but we are made of more.Even the Pharmacy curriculum did not fathom that the demand for our skills would be so skewed in the sales direction. Also, there is always the threat of foreign competition when our manufacturing sector is non-competitive.

 The challenge

The challenge therefore is to expedite human capacity development andcreate a demand for such development in such a way that could be self-sustaining with the government providing the necessary catalysts for favouring the forward direction of such a chemical reaction.It is a challenge that only business leaders – bishops – can make happen.

 The role of bishops

A bishop, by definition, is an overseer, a leader. Bishops play critical roles in religious settings, in academic settings and in political arenas. In this context, however, I wish to limit the definition of bishops to that of business leaders. To me, the role of business leaders in the development of societies is one of the most crucial roles in any society, particularly in capitalist societies like ours.

Business leaders play the following functions:

  • They win and administer the contracts that comprise the majority of the government’s budget.
  • They administer the pooled resources of the society – the insurance, pension funds and savings of the public and the government in banks are all managed by bishops.
  • They manage the resources of the government, e.g. oil wells, firms, etc.
  • They employ the greater majority of the society directly or indirectly.
  • They directly and indirectly influence the quality and quantity of the food on the table of the society in the form of wages and salary.
  • They influence the election of the personnel into government positions.
  • They are lobbied by government to bring in investment and drive economic growth.
  • They lead efforts in the creation of new products and services and determine the level ofindustrialisation of the nation.
  • They are great leaders and are often paid premiums for administering the funds of the nation.

 

The role of bishops in the society is a noble one.They are critical to the advancement of the public good and their focus on profit maximisation or national development would make or mar any civilization. Their commitment to reversing the human capital trends in Nigeria is going to be the critical factor in our quest for national renewal and survival.

Business leaders are more equipped to engage the ruling elite than the mass of the population put together.They are articulate enough to fashion win-win situations for advancing the cause of the Nigerian nation and, much more than labour, they are in the best position to make governments move in a particular direction.

In essence, the problems of the Nigerian polity as it is presently constituted are mainly because business leaders do not know that they are the ones that will change things and partly because of pervasive selfishness.

In the pharmaceutical industry, if we keep waiting for the day the Nigerian government will form the Nigeria Pharmaceutical Export Promotion Council, for example, we might wait forever. A cohesive strategic thrust between business leaders in the pharmaceutical industry will achieve a lot more than any single government intervention, much more when such government interventions are at the impulse of business leaders.

This, however, is not to say that our business leaders are not thinking and acting in this light. I know they are; what is being canvassed is the nobility and urgency of our task.

A particular biblical reference in 1 Timothy 3:1 reads, “He that desires the office of a bishop desires a noble task.” I have found that passage particularly enlightening as it emphasises the power of a noble desire.The rest of the passage outlines the characteristics of a bishop, which, essentially, is that he should be someone able and worthy of influence; the individual should be able to build up the people under his headship so that they can attain to greater heights. This deliberate commitment to capacity development is pretty scarce.

I suggest that firms develop internship positions that are focused on giving management experience to personnel that desire to gain such at the pay they can afford. From my experience, I know that there are many young people who know that such exposure is their only passport to demonstrating their unique contributions to national development.

The bishopric of some of Nigerian business leaders is such that doesn’t bring the level of guts required to take Nigeria out of her current quagmire.It is as if we are all in it for ourselves. As shown above in the roles of bishops, the effects are far-reaching.

Capitalism, as it is presently defined – the maximisation of shareholder’s wealth – is often tilted to the wealth part rather than the shareholder part. We often forget that, as long as we maintain our market share, the growth of the society will reflect in the growth of our private economies.

In Nigeria, the greatest shareholder is the society, whose collective wealth bishops are directly and indirectly supervising.Their actions and inactions would, to a large extent, determine the nature of the nation at the end of the day.We saw such in the banking industry – a few greedy individuals, by their actions, squandered the collective commonwealth of some of us.

 Noble is not necessarily easy

Now, nobility is not necessarily easy, at least in Africa. The path to industrialisation for Nigeria would mean going against global expectations; it would mean renegotiating the terms of our partnerships and suffering the punishments that would come from our “late enlightenment”.Yet it is the only path we can take to escape being the perpetual recipients of global pity parties as is presently witnessed by our siblings in Liberia and Sierra Leone. To do that we must tell ourselves the truth – that our biggest asset is our people and that to be a bishop is much more than a survival engagement or a wealth club – it is a noble calling that reckons with God and man.

Ebola: NANNM mourns slain nurses

0

Members of the National Association of Nigerian Nurses and Midwives (NANNM), Lagos branch, recently took to the streets to mourn their colleagues who lost their lives in the line of duty to the Ebola Virus Disease (EVD).

The nurses, who were clad in black, commenced the candlelight procession from Agidingbi down to the Ministry of Information, Alausa, Ikeja, chanting different dirges, as well as the nursing anthem.

Speaking in an exclusive interview with Pharmanews, NANNM Chairperson, Mrs Olatunde Olushola, explained the essence of the candlelight procession, describing it as the association’s way of mourning its Ebola-slain members, as well as sensitising the government and the public on the need to recognise and compensate the family members of the dead nurses.

“Government and the public have not been mentioning the nurses that died in the line of duty, while caring for Ebola patients. We are all equal before God; so, both the nurses and the doctors that lost their lives due to EVD deserve the same recognition. Moreover, nurses are the first and last contact patients meet in the hospital. And after Nigeria has been declared Ebola-free, nurses will still continue to talk about the disease as well as enlightening patients on it,” she stressed.

Olushola further emphasised the need for government to lead by example, by appreciating nurses, in order to correct the widespread notion that nurses are nobody in the health care team.

“Our government should not wait until nursing will be relegated to the background, as it is often said to us that nurses are nobody in the health sector; it is as if they are ants before the government. If the government believes that there is equality in what we called life, then they should do what is right.”

A sorrowful Olushola, who identified the late nurses as Justina Echelonu and Ukor Evelyn, both staff of First Consultants Hospital, Obalende, said this was the first time in her tenure that the association would lose two nurses to an epidemic in quick succession.

She also faulted the one-sided clamour for the immortalisation of Dr Stella Adadevoh, describing it as an aberration.

“I want to believe that even if it is a health attendant or a security man that died in the course of treating Patrick Sawyer, I think they should be compensated. For government to be mentioning Adadevoh alone, is an aberration. It shows how little the government t appreciates the nursing profession,” she said.

Also speaking on the event, NANNM Secretary, Mr Otaro Daniel, urged the government to console bereaved relatives by shouldering major responsibilities left by the deceased nurses, as well as putting machineries in place to prevent such occurrences in the future.

Comrade Akintunde Ibironke, NANNM’s state auditor II, also expressed her sympathy for the bereaved, urging them to take solace in the Almighty God.

“But at the same time, we still want the government to do one or two things for us. We want to immortalise our nurses; we want the government to recognise the pains that the family members are going through in terms of what they are doing for Dr Adadevoh, and they should do for them too,” she noted.

Ibiroke further added that “as regards our hazard allowance, though we cannot measure money with life, at the same time, we expect the government to revisit our hazard allowance so that we are sure of taking something home that measures up to the type of services we are rendering. We have a lot of nurses working in IDH and they are being exposed to these diseases every blessed day. Again, we need protectives to guard against these infectious diseases which should be supplied at regular interval.”

Addressing the nurses at the government secretariat, Lagos State Commissioner for Health, Dr Jide Idris, said the government was making adequate provision to reward every one that suffered in one way or the other in curtailing the Ebola disease.

He explained that Governor Babatunde Fashola had invited and met with the survivors of all the deceased health workers and not just the doctors, adding that “while some turned up, some did not come. However, we have agreed to support the hospital, by asking them to show us the way in which we can support them.”

He assured that the government would not discriminate in its compensatory efforts.

“I also want to join you in commiserating with the families of the bereaved. I also pray that we don’t see something like this in the future,” the commissioner said.

 

How nutrition, detoxification prevent prostate cancer, by Prof. Ashiru

0

In this exclusive online interview with Temitope Obayendo, Professor Oladapo A. Ashiru, a consultant reproductive endocrinologist at the Mart-Life Detox Clinic, Lagos, disclosed causes of prostatic cancer, and more interestingly, how the rich components of human diets, exercise and reduction of inflammation and oxidation process in the body can prevent the development of prostate cancer. Excerpts:

As a human anatomy expert, could you explain the likely causes of prostate enlargement?

Prostatic enlargement is due to the Androgen deficiency of the adult male. Basically, some hormone imbalance, principally DHEA in men.

What is the population of Nigerian men with prostate enlargement?

According to Dr. Abia Nzelu, coordinator, National Cancer Prevention Programme (NCPP), prostate cancer kills 14 men in Nigeria every day.

What are the symptoms to indicate the onset of benign prostatic hyperplasia (BPH)?

Symptoms may include urinary problems such as frequent urination, inability to urinate, difficulty starting or stopping the urinary stream, dribbling, pain, blood or semen in urine. Other symptoms, like frequent pains in the lower back, hips or thighs, could be noticed, including pain on ejaculation.

 

When does prostate enlargement become cancerous?

If left untreated, the benign prostatic hyperplasia becomes malignant after some years.

What are the available preventive and treatment options for prostate cancer?

Studies have shown that lifestyle, especially nutrition and exercise, has significant influence in prevention and treatment of prostate cancer. Inflammation and oxidation of body cells are natural processes that contribute to the development and progression of prostate cancer. However, environmental toxins and carcinogens also play a major role in developing cancer of the prostate.

Excess weight has been associated with rapidly progressive prostate cancer, which is a severe form. Therefore, incorporating good nutrition, exercise and detoxification (body cleansing) reduces inflammation and oxidation process in the body. At Martlife Detox Clinic, in collaboration with Viva Mayr Centre (Austria), we teach and practise a holistic approach to prevent and manage prostate cancer. Our focus is to maintain optimum health by conducting advanced diagnostic tests, detoxification programmes, health education, nutrition and exercise.

Nutrition can influence cancer prevention and treatment; therefore we encourage eating of foods rich in anti-inflammatory and anti-oxidant substances, such as colourful fruits, ocean-caught fish, flaxseed oil, vegetables, whole grain and spices. Also, you can increase the protective anti-inflammatory components of your diet by cooking properly. Therefore, a diet rich in anti-oxidants, low in pro-inflammatory and carcinogenic substance can make a difference in prostate cancer prevention and treatment.

Orthomolecular supplements help in prevention and treatment of prostate cancer; they include vitamins, carotenoids, and mineral supplements like selenium, folic acid, calcium, magnesium and zinc.  Vitamins are essential in preventing and treating prostate cancer. They include vitamin C, B3, and vitamin E, which is an anti-oxidant that decreases concentration of free radicals that can lead to cancer. Lycopene is a naturally occurring chemical that gives fruits and vegetables a red colour. It is one of the numbers of pigments called carotenoids. Lycopenes is found in tomato, watermelons, pink grapefruits, apricots and pink guavas. Lycopene is a powerful anti-oxidant that may help protect cells from damage. Studies have revealed that lycopene supplements help in preventing prostate cancer.

Magnesium plays an essential role in DNA repair, cell differentiation and proliferation, apoptosis and angiogenesis. Magnesium deficiency is also linked to inflammatory response and oxidative stress; therefore this can alter multiple pathways to cause cancer. Research carried out by the National Cancer Institute found out that higher blood magnesium levels are associated with a lower risk of prostate cancer.  Calcium has been identified to reduce the risk for prostate cancer, especially in black men and lowers the risk for high grade cancer among all men.  Co-enzyme Q10, also called ubiquinone, has been reported to have anticancer properties, as well as folic acid.  Selenium is a mineral supplement, a trace element that is important in prevention of cancer.  Zinc is noted to shrink enlarged prostate glands and is helpful in the prevention and treatment of prostate cancer.

Detoxification is also very helpful. It is the process of cleansing the body from accumulated toxins. These toxins could be derived from the environment or the food we consume daily. Mart-Life Detox Clinic is fully equipped with advanced technology and trained professionals to deliver expert detoxification process which is the core element of any treatment. Emphasis is placed on rest, strict cleansing of the digestive system, and removal of heavy metals by foot hydrolysis detox.

Regular exercise is essential in preventing prostate cancer. This enables one lose excess weight, which is a risk factor for this disease. It helps in reducing the inflammatory and oxidative processes that assist in carcinogenesis.

How best can prostate cancer be managed?

The management of prostate cancer has different treatment options, which depend on the stage of the cancer. These include: watchful waiting, surgery, radiation, hormone therapy or chemotherapy. The choice of treatment depends on the age of the patient and doctor’s recommendation, but most people advocate watchful waiting.

Mart-Life Detox Clinic has successfully managed prostate cancer patients with our Mayr medical practice, which is based on principles of rest; cleansing; re-education of eating habits; nutrition; orthomolecular supplements to hinder the inflammatory and oxidative processes in carcinogenesis; exercise; meditation; and self-discovery.

There is also hormonal treatment, which involves the use of LHRH antagonist like Lupron depot hormones to decrease the size of the prostatic enlargement. The same hormone, Lupron or zoladec, is used in the female to reduce fibroid size.

A recent surgery research has revealed that one in three men treated with surgery or radiation will have cancer return. However, the choice of surgery should be ONLY as a last resort.

 

 

 

Atueyi bags PEFON Fellowship

0

Managing Director of Pharmanews Limited, Sir (Pharm.) Ifeanyi Atueyi, was among 22 distinguished personalities recently made Fellows of the Professional Excellence Foundation of Nigeria (PEFON).

PEFON, which has Prince Julius Adelusi-Adeluyi, managing director of Juli Plc as chairman, board of trustees, aims to identify Nigerian professionals, home and abroad, who have excelled in their chosen fields.

The induction ceremony, graced by several captains of industries and other professionals, took place at Hotel Victoria Palace on 27 September, 2014.

Dignitaries at the occasion include Sir (Dr) Oladipupo Bailey, founder of the foundation; Chief Badru Olaogun, oath administrator; Engr Also Abdullahi, director (steel development), Ministry of Mines & Steel Development; Mr.Dozie Atueyi, executive director of Pharmanews, representing the managing director; Kunle Aderinokun, associate editor in THISDAY newspaper and Olufemi Okeleye, PEFON secretary

In his welcome address, Bailey declared that PEFON was practically the only Foundation that aims to bring distinguished professionals from all walks of life under the same umbrella.

He stressed that, aside giving special recognition to those who have excelled in their chosen careers, the body’s objectives also include raising scholarship funds to assist young ones become professionally qualified, as well as identifying those who, though are not professionals, have established conglomerates that have employed a large number of professionals.

“We strive to celebrate people like Pa Akintola Williams who is about to celebrate his 95thbirthday,” he said.” He is one of those celebrated professionals we like to recognise.”

Explaining more about the purpose of the Foundation, Bailey said, “Today, we have many graduates roaming the streets; some riding okada with good grades. These are some of the people we hope to engage and solve this shortage of manpower in Nigeria. By so doing, we will be building the right leaders for this country.”

Sharing Bailey’s optimism, Adelusi-Adeluyi remarked that there was nothing as grand as an idea whose time had come.

He said, “In Nigeria today, I make bold to say that about 0.05 per cent of the 170 million people are the ones who really run things in this country. Majority are mostly onlookers. Therefore it became imperative to repromote character formation.”

The former minister of health however lamented that good people were not often celebrated in the country.

“It is only when one dies, you hear statements like ‘You are the best president Nigeria never had.’ This is one area PEFON hopes to change. How can we do this? As professionals representing every facet of life, we will continue to grow steadily. By the time we reach about 100 members, we will then gradually start exerting our influence. That is why I congratulate you all, especially our new inductees,” he emphasised.

The induction of Atueyi has increased the number of pharmacy professionals with PEFON Fellowship.

Others include Dr (Mrs) Stella Okoli, chairman, Emzor Pharmaceuticals; Prince Julius Adelusi-Adeluyi, managing director of JuliPlc; Dr Michael Oyebanjo Paul, chairman, Mopson Pharmaceutical Limited; Dr Nelson Uwaga, former PSN president and incumbent president of the Nigerian Institute of Management (NIM); and Pharm. Olumide Akintayo, PSN national president.

Why we organised Sir Atueyi competition – PANS president

20

In recognition of his contributions to pharmacy profession and continued support to pharmacy schools in the country, the recently launched National Essay and Debate Competition has been named after Pharm. (Sir) Ifeanyi Atueyi, managing director of Pharmanews Limited.

The maiden edition of the event, organised under the aegis of the Pharmaceutical Association of Nigerian Students (PANS) in partnership with Faculty of Pharmacy, University of Benin (UNIBEN), was held at the Old Lecture Theatre, Faculty of Pharmacy, UNIBEN, Edo State.

The competition, which witnessed a huge turnout of pharmacy students, was slated for participants from the University of Benin (host); OlabisiOnabanjo University, Ago-Iwoye, Ogun State; and Igbinedion University, Okada, Edo State. However,the representative of Igbinedion University arrived late and, therefore, could not participate in the debate.

Explaining the rationale behind the honour accorded the Pharmanews boss, Samuel Lena, president, PANS UNIBEN, explained that it was the association’s way of appreciating Sir Ifeanyi Atueyi for his contributions to the progress of pharmacy profession in Nigeria and beyond.

Lena further hinted that the competition was already working on modalities to ensure the annual event rotated across pharmacy schools in the country, even though the idea originated from UNIBEN.

“We want it to move across all institutions where Pharmacy is being studied because Sir Ifeanyi Atueyi himself is a man for all,” he remarked.

The actual debate contest, which centred on two topics, “Our Worst Fear, Government or The People?” and “Resolving the Problem of Militancy in Nigeria: Is Amnesty the Way Forward?”, saw Ganiyat Atinuke Alaraba of OlabisiOnabanjo University, Ago-Iwoye emerging the best speaker.

Beaming with smiles, Alaraba disclosed that the competition had boosted her self-confidence, adding that Pharm. Ifeanyi Atueyi had always been a source of inspiration to her.

“I am always proud of him because the first time I heard that the publisher of Pharmanews is a pharmacist, I was surprised. Aside the uniqueness of the journal and its popularity, Pharm. Atueyi continually gives people like me hope that Pharmacy is not all about what you learnt in school but a vision born out of passion,” she said.

Speaking in the same vein, Toyosi Odusanya, a 500-level student of Olabisi Onabanjo University, whose school came second in the debate, described Sir Atueyi as a versatile motivator and mentor.

“Even though I have never had the opportunity to meet him in person, the Pharmanews journal and several of his books have been quite motivational to me. It got me thinking that if someone who graduated as a pharmacist can do well in the world of journalism, the sky is the starting point for people like us who still see him as a mentor,” he noted.

Odusanya further suggested that for future editions of the competition, the judges should be picked from other institutions other than the host school to add more credibility to the event.

Shortly before the debate winners were announced, a list of the top ten winners of the essay writing competition was read out.

According to the organisers, a total of 50 entries were submitted by Pharmacy students from the 15 participating schools. Two of the 10 winners were announced joint winners after clinching first position. They were Onuwabagbe Lisa, University of Benin with 36.5 points and Igodo Uzo also from the University of Benin with 36.5. Others were Agboola Samuel Olakunle from the University of Ibadan, second position, with 35.5 points; Robo, University of Benin, third position, with 35 points.

While presenting the prizes to the winners, Mr Adebayo Folorunso-Francis, who represented Sir Ifeanyi Atueyi at the event, commended the organisers of the competition for a job well done, adding that aside developing the students academically, the competition would also foster unity among pharmacy schools across the nation.

The sums of N60,000 and N40,000, courtesy of Greenlife Pharmaceuticals, were presented to the winner and runner-up of the debate competition respectively, while winners of the essay writing competition were equally rewarded.

Other dignitaries at the event include Dr Patrick Igbinaduwa, senior lecturer, Department of Pharmaceutical Chemistry, University of Benin; and Pharm. Ayo Akinsola, sales manager, Institutions, Shalina Healthcare Nigeria Limited.

Why Pharmacy in Nigeria needs total change, by CPFN president

0

With recent advancements in pharmacy practice globally, the National President of the Christian Pharmacists Fellowship of Nigeria (CPFN), Pharm. (Sir) Ike Onyechi, has called for a comprehensive reform of pharmacy practice in Nigeria, in order for practitioners to compete favourably in the global arena. Speaking to Pharmanews in an exclusive interview, the managing director of Alpha Pharmacy and current winner of the Ikeja Golf Club Eid-el-Kabir Kitty tournament, also discusses the activities of CPFN and the need for a more progressive PSN in the nearest future. Excerpts:

Thinking of PSN at 87, can it be said that Pharmacy has positively affected the nation so far?

Yes, I can say that Pharmacy is evolving, growing and getting better by the day. We wouldn’t forget that we started as dispensers of drugs so many years back, and from a diplomate course, Pharmacy has evolved into a professional course, awarding degrees. We now have West African Post graduate College of Pharmacists (WAPCP), which is now interfacing the public to meet their needs. Also from about three pharmacy schools during our school days in the 1970s, now we have 19 pharmacy schools. So it’s a great improvement compared to the beginning, because it was only OAU that was offering Pharmacy as a course before UNN, ABU, UNIBEN, UNILAG and other universities joined in.

The quality of learning has also improved along the line, and we are hoping to get better. In practice, Pharmacy has also changed from drug-focused to patient-oriented. There is so much enlightenment on pharmaceutical care, and this has resulted in the creation of counselling space in most pharmacies. However, there is still room for improvement.

 The theme of the 87th PSN conference is “Transforming Pharmacy Practice for Better Outcomes”. From your experience and interactions, which areas of the profession need to be changed?

The needed change should be total and holistic. While I admitted in your previous question that we are getting better, it’s on a relative term. During FIP conferences, we normally observe the level of discussions from participants from Australia, UK, France, USA, and others, and we have discovered that the level of their contributions is usually far from where we are. So we need to retool and change the process before we can think of better outcomes.

For better outcomes, the tools will change, and the curriculum needs to change. The way and manner in which lecturers teach students, as well as the quality of facilities used, need massive upgrading for better outcomes. We need to change from the admission policy, to teaching and facilities.

We need also to look into manufacturing areas for change options, remunerations to pharmacists at all levels of their work, need to be improved. Whether you are lecturing, community-based or hospital-based, the entry points into pharmacy have increased, so should the reward be increased. The community pharmacists will have to upgrade from small shops to bigger pharmacies, with available areas for counselling. Also, the aesthetics of pharmacies need to be upgraded in order to compete with global standard. Pharmacies should devote enough space for wellness products, for instance, Alpha Pharmacy in Enugu has specially created a section for wellness equipment like Bicycles, Tennis Boards, Golf Kits, Lawn Tennis rackets and Boards, thread mills, and so on.

CPFN was in Uyo last month for its conference, in preparation for the 87th PSN conference. Were there divine instructions received for the leadership of the profession?

Yes, though not a direct “thus says the Lord”, we had a very good outing and a fulfilled session. We had a lot of interactions on the theme, “Fulfilling Your Purpose”. Pharmacists were reminded of their purpose as co-workers with God to preserve the health integrity of men. Also as labourers in the vineyard of God, we were admonished to take our work more seriously, with more humility, dedication and commitment, with the goal of improving the quality of life of the average man. Pharmacists also need to find ways of serving God within the profession, by demonstrating more compassion towards patients and giving free drugs to the less-privileged.

As the national president of CPFN, what are your plans to check the unethical attitudes of some Christian pharmacists who keep three jobs at a time, as well as defraud companies?

You can only say that many of them are Christians; but in the real sense of it, they are unbelievers. This is happening, not because they are pharmacists, but due to the morally depraved society we find ourselves. And this is why CPFN has been praying for an improved and healthy society – a society that will work with less greed, where there is less grabbing, and so on.

There are also many nominal Christians, who could be as high as 80 per cent, in some congregations. Thus the society needs a holistic change from leadership to followership, from top to bottom. If you get to Europe, many of them are not Christians, but have high moral standard. This calls for intercessory activity on the part of all Christians, and that is part of our obligations at CPFN.

As the Christian umbrella of PSN, what roles has CPFN played in the faceoff between medical doctors and other health workers in the country?

CPFN, in each of our outings, has always prayed for peace. According to the Holy Writs in Hebrew 12:14, “Pursue peace with all men and holiness, without which no one shall see God.” To pursue means to make efforts to be at peace with all men. This is the guiding principle of Christian pharmacists, to be at peace with all men, doctors or non-doctors. We are not regulators. Government representatives are already wading into the issue, but our God can do more.

What is CPFN’s vision for PSN in the next five years?

In the next five years, we would like the PSN to have resolved all its internal acrimonies. We want to see a more mature PSN that will have this guiding principle of finding peace with all and sundry, with a more peaceful coexistence within its ranks and files, with other associations and health workers.

Mega LifeSciences launches Prostacare to curb prostate enlargement

4

Mega LifeSciences Nigeria Limited, a research based pharmaceutical multinational, has launched prostacare into the Nigerian market for the treatment of benign prostatic hyperplasia (BPH) symptoms in men.

Unveiling the drug at the Lagos office of the company on 8 October, 2014, the Product Manager, Pharm. Ifeanyi Offor emphasised the importance of Prostacare to every man, noting that one in every four normal Nigerian men from the age of 40 has the likelihood of developing BPH.

He described BPH as a disease of the prostate gland, characterised by benign enlargement of the prostate tissues causing difficulties in urination.

Quoting a report released by WHO in 2012, which placed the average life expectancy of Nigerian men at 53, Offor said more Nigerian men would be living with BPH symptoms.

He further explained that though BPH is not always a life threatening condition, it has tremendous negative impact on the quality of life of the patient.

Offor further noted that while some individuals consider the cost of treating BPH as prohibitive, the desease, if not detected and treated in good time, could lead to other complications such as severe urinary tract infections; bladder disease and obstruction of urinary tubules; and sexual dysfunction or acute urinary retention.

“Early detection is key to successful treatment”, he stressed.

Explaining the uniqueness of the newly launched product, the product manager said Prostacare is the only officially registered Saw palmetto brand with NAFDAC approval in Nigeria, and it contains lipophylic extract of Saw palmetto 320mg per capsule.

He noted that Saw palmetto is the most popular, effective and safe phytomedicinal agent used in the treatment of BPH since the late 19th Century.

On the usage of Prostacare, Offor said the drug “inhibits the action of a male hormone called dihydroxytestosterone (DHT) in the prostate tissue. Scientists believe that the action of DHT in the prostrate is responsible for prostate enlargement. Some conventional BPH drugs like Finasteride and Dutasteride also work this way. Also, Prostacare has been reported to relax the muscles of the prostate and bladder, helping to ease the flow of urine. For effective treatment, one capsule should be taken daily after meal with sufficient water, as relief in symptoms is seen after two weeks of continuous use,”

Describing the manufacturing practices of the company, Offor stated that Prostacare is manufactured in Thailand by Mega LifeSciences Public Company Limited and marketed and distributed in Nigeria by Mega LifeSciences Nigeria Limited, adding that Mega LifeSciences has two state-of-the-art manufacturing facilities in Thailand and Australia which are WHO approved manufacturing facilities.

On the safety of Prostacare, Offor said, “Prostacare is quite safe and highly tolerable. Prostacare does not have the significant side-effect of erectile dysfunction, delayed ejaculation or anorgasmia and cardiovascular side effects found in the conventional BPH drugs. Rarely, mild stomach disturbances like nausea can occur. No serious drug-drug interactions have been reported with Prostacare”, he assured.

He however advised patients to confirm from their pharmacist whenever in doubt of any medication.

While admitting the possibilities of patients confusing the disease for other infections, Offor advised community pharmacists, who are often the first port of call in the community for most health complaints, to be careful in handling such cases and make appropriate referrals since early detection is very crucial in the management.

“In severe lower urinary tract symptoms with much enlarged prostate volume, surgical intervention is recommended. The commonest surgical procedure is Transurethral Resection of the Prostate (TURP), where a surgical instrument is used to remove part of the prostate tissues. Studies have shown that 5 to 10 per cent of the patients undergoing TURP have erectile dysfunction and about 10 per cent of the men will have the procedure repeated after five years”, he said.

Also speaking with Pharmanews in an exclusive chat on BPH, Dr Rufus Ojewole, a consultant urologist at the Lagos University Teaching Hospital (LUTH), stated that the most important factor in the development of BPH is age.

“In men, prostate gland begins to increase in size in the fifth decade of life and continues to increase in size with increasing age. BPH is rare before middle age and very common after that. In fact, it is the most common clinical condition in ageing men,” he noted.

Ojewole, who said there was no specific data on the exact burden of prostate enlargement in Nigeria due to the paucity of community-based studies on clinical entity, however rated the prevalence of the condition very high in the country, according to hospital based studies.

On the symptoms of prostate enlargement, the urologist said this could manifest in two ways: asymptomatic and symptomatic. He defined asymptomatic BPH as an enlarged prostate without clinical manifestation or symptom, which could be called histological BPH. Digital Rectal Examination (DRE) and Ultrasound (US) imaging of the prostate gland usually detect this. It therefore means that someone may have an enlarged prostate and yet, no symptoms.

He added, on the other hand, that “when symptomatic, benign prostatic enlargement commonly manifests with various difficulties in passing urine, which nowadays is termed Lower Urinary Tract Symptoms (LUTS). LUTS is sub-divided into irritative (storage), obstructive (voiding) and post-void symptoms.

“Irritative symptoms are urinary frequency, nocturia, urgency and urge incontinence. Voiding symptoms consists of hesitancy, weak stream, straining and intermittency while post-void symptoms consist of feeling of incomplete bladder emptying and terminal dribbling.

“These symptoms may progressively worsen over time and culminate in episodes of acute or chronic urinary retentions, which are painful and painless inability to pass urine respectively. Other symptoms are haematuria, weak erection and symptoms suggestive of urinary tract infections like fever and supra-pubic pain”, he elucidated.

Ojewole also stated that some symptoms may occur due to complications of the disease, usually from lack of treatment or delayed/inadequate treatment. He listed these to include: facial puffiness; leg swelling; hiccups and vomiting, as seen in patients who develop renal failure from the obstruction caused by the prostatic enlargement. Others are loin pain, hernias and painful swollen testicles from infection (Epididymo-orchitis).

The urologist however emphasised that benign prostatic enlargement does not lead to prostate cancer, noting that prostate cancer may co-exist with BPH. Thus, he recommends thorough evaluation of enlarged prostates by urologists, who will utilise various tools, including Prostate Specific Antigen (PSA), DRE and Transrectal Ultrasound (TRUS), to arrive at accurate diagnosis.

He added, on a gloomy note, that as long as aging is inevitable, prostate enlargement is not preventable because it comes along with age advancement in men.

He therefore urged men to visit their caregivers, preferably urologists, for prostate check, noting that this will afford them the opportunity of early treatment of BPH and, more importantly, allow early detection with potential cure.

“As a matter of fact, all men should see a urologist annually from the age of 50years for prostate check whether symptomatic or not,” he counselled.

 

Akure national conference will be great – ACPN chairman

0

harm Olufemi Ismail Adebayo

As community pharmacists in the country look forward to the next national conference of the Association of Community Pharmacists of Nigeria (ACPN), holding in Akure, Ondo State, next year, National Chairman of the association, Pharm. (Alh) Olufemi Ismail Adebayo, has assured members of a more improved conference. Speaking in an exclusive interview with Pharmanews in his office, the pragmatic leader also revealed some of the achievements, as well as challenges of his administration, as he prepares to hand over to the next leadership at the forthcoming conference. Excerpts:

Tell us some of your achievements and challenges since you became the national chairman of ACPN.

Regarding our achievements, we have been able to bring ACPN into limelight through our various activities.We are now more visible, as we have been able to advertise the pharmacy emblem which is our symbol as community pharmacists to the people through various journals, educating them on the need to purchase their drugs from only registered pharmacists.And I am happy that the campaign is yielding good fruits as people are now enlightened and informed.

Secondly, we have been able to create a database for the association.It is already established and we have successfully signed a Memorandum of Understanding (MoU) with Globacom at the last national conference in Ilorin, Kwara State.

We have also been able to work cordially with our parent body, the Pharmaceutical Society of Nigeria (PSN). Presently,our parent body is an active member of JOHESU, which is a body for all healthcare professionals in the country. We are also on the lookout for a more befitting national secretariat for the association and, hopefully, something will happen soon.

The major challenge that I faced when I assumed office was the issue of finance, because funding an association that is non-governmental like this is always a challenge.But I want to appreciate my members for the trust they had and still have in me, especially when we increasedour capitation by hundred percent. The capitation had been the same for more than seven to eight years, since around 2006, without consideration for increase in the cost of living and even cost of travelling around and outside the country, which, as a national chairman, I cannot do without. So I appreciate them for bearing with us on the increment of our capitation and I am assuring them that I will not renege on my promise that the money will be judiciously used and that their welfare will be paramount in our hearts.

We also appreciate the efforts of the various companies that have always been there for us during our national conferences and major events – not only pharmaceutical but also telecom companies.If not for them, maybe we would have been running the association at a loss.

What positive changes should community pharmacists in the country expect at the next national conference in Akure?

We’ve always believed at the ACPN national office that every conference should come with a difference and, coincidentally, the next conference will be my last conference as the national chairman of ACPN.So we promise that there is going to be innovations, new ideas and better improvements on the last conference in Ilorin.

It has been our practice that, as soon we are through with a certain conference, we reappraise the event, and we try, as much as possible, to improve on it.So I promise my members that this is going to be a conference with a difference. And, being an election year, we want members to turn out enmasse to elect a good and pragmatic leader of their choice. Every vote counts; and we promise that the election will be free and fair.

We have taken note of the challengeswe had at the last conference, even though it was an improvement on the 2013 edition in Calabar. And we promise that we are still going to have more improvements.

 What grey areas in the profession do you think stakeholders at the conference need to address?

The grey area that I want us to focus on is the issue of unity among pharmacists. We have technical groups, which involve the community pharmacists, the hospital and administrative pharmacists, the industrial pharmacists and pharmacists in academia.We should all live as one big family because we all have our various roles to play.If any of the technical groupshas a problem, it should be shared by all because we belong to the same profession.

Also, the National Drug Distribution Guidelines is one programme that, if well implemented, will solve the problem of fake and counterfeit drugs in the country. All pharmacists should support it and ensure it is well implemented so that it will benefit the professionals, as well as the general populace.

What is your general view of the current state of the healthcare sector?

We are happy that the society is now aware that there are other professionals, aside medical doctors, in the healthcare sector.I believe healthcare should involve team work, because everybody has his or her own role to play, and the focus should be the patient.Until this is done, we will still witness a lot of wrangling and unnecessary rivalry.

 

Why pharmacists can no longer hide behind counter – Pharm. Lawal

1

Pharm Lawal

In this recent interview with Pharmanews, Managing Director and Superintendent Pharmacist of Victory Drugs, Festac Town, Lagos ,Pharm. Folasade Olufunke Lawal bares her mind on the happenings in the pharmaceutical industry and why she thinks pharmacy practice has progressed over the years. Excerpts:

 

How long have you been in the practice and how did it all begin?

Victory Drugs was established on 6 May, 1989 out of passion for a practice that would please God and be maximally beneficial to mankind, a patient-focused healthcare delivery. I graduated from the University of Ife (now Obafemi Awolowo University) in 1985 with a Bachelor of Pharmacy degree. I later got a master’s degree in Clinical Pharmacy in 2006 from the University of Lagos.

While in secondary school, my strength was in the sciences, with Mathematics being my best subject. I was caught between studying Mathematics and a medical sciencescourse. My closeness to my maternal grandfather, a herbal medicine practitioner, drew me closer to the medical sciences than to Mathematics. However, the thought of working in a hospital as a medical doctor was unappealing. In our day, pharmacy profession was very unpopular -so little was heard or known of pharmacists. However, I got to know more about Pharmacy through my secondary school classmate and close friend, Remi Oladeji.

I had my internship training at a community pharmacy and did my National Youth Service programme at a government hospital. Thereafter, I worked in a private hospital for one year. In none of these places was I able to express my passion the way I wanted to. So I took the bull by the horn and started my own retail pharmacy with about N7,500, for furniture and stock, and by God’s grace, we have evolved, over the years, to a standard retail pharmacy. The journey was tough but the Lord was, and is still on our side.

Tell us about some of the challenges you have faced in your practice and how they were tackled

Having practised as a community pharmacist in Victory Drugs for over25 years, challenges faced by me and my teamhave been enormous, but I will briefly enumerate the major ones.

Lack of adequate and regular supply of electricity is number one and, to overcome this, we have had to get generator sets and inverters. This, of course, results in very high running costs which cannot be passed on to clients.

Insecurity is another challenge that is limiting ouractivities and time of operation. What we have done is to employ the services of security companies. Of course, that is also additional cost. We have also had our fair share of the inter-professional rivalries rampant in our practice setting, but God has helped us to surmount this by teaching us to put ourselves in the shoes of others, see things more objectively and carefully pursuing peaceful ways of resolving conflicts whenever they arise. We have high regards for other healthcare professionals and see them as partners-in-progress; so we go out of our way to make friends with them in the best interest of our clients. We obey the biblical injunction that, as much as it lies within us, we should live peaceably with all men.

Another professional challenge borders on poor differentiation of roles by the various healthcare professionals. It is easier for a camel to pass through the eye of a needle than to get prescriptions from private hospitals, while it is also common that prescription drugs are dispensed without appropriate prescription or any prescription at all in community pharmacies. We all have our share of the blame for this unethical practice, with the government probably having the largest share.

Moreover, ours is a peculiar country where healthcare is often paid for, out-of-pocket, by people who would rather pay for “product” than “service”. Most services rendered in community pharmacies are not remunerated, and most patients are also not willing to pay reasonable hospital bills without accompanying medications. This has contributed in no small measure to the sub-optimal healthcare service being rendered in the country, making ethical practice rather difficult. It is a big and difficult challenge.

What we have done is to build a healthcare team around healthcare professionals who share our “Health for all”vision, using the principles of pharmaceutical care. When we pick up health challenges that need input of other healthcare professionals, we refer appropriately and politely ask for feedback which, more often than not, we get. By this, there is continuum of care, communication gap is avoided and the patient gets the best at minimal cost.

There is also the challenge of poor access of patients to information on their health and medication, thereby limiting or compromising our input into their care or management. For instance, patient Xmight have seen a healthcare professional who diagnosed malaria and gave him drugs without disclosing to him the name of the drugs. The patient could then visit us a few days later with same complaint, with test results still showing malaria but patient can’t tell what drug he took. It becomes herculean to choose the right medication because, apart from the risk of overtreatment, we also stand the risk of failure to treat in the event that we give him the same drug he just took that failed to cure the malaria. This is a case too many. We have tried to solve this by coming up with Medical Diary,which empowers patients, through documentation, to track their medical records and benefit from continuum of care or intervention from various healthcare professionals instead of the disjointed healthcare which exposes them to mismanagement.

How do you see pharmacy profession today compared to when you started?

Pharmacy profession, when I started, was more drug-focused than patient-focused. It was very unpopular to have pharmacists intervene in disease-prevention or the likes. Pharmacists hid behind counters and were not to be seen. Most people did not know what Pharmacy was. There were very few pharmacists and the few were hidden, not accessible. Perhaps, then, only the academic pharmacists were recognised in terms of their contribution to national development. I think there were only about five schools of Pharmacy in the country then.

Thank God,Pharmacy today has metamorphosed from drug-focused to patient/client-focused, with pharmaceutical care getting more entrenched in the country. Pharmacists now play leading roles in preventive healthcare, which is the strength of any healthy society. Today, the pharmacist is very visible and easily accessible. In fact, the community pharmacy today is the first port of call by the public and is thus an indispensable resource for preventive health.

 What do you think government can do to improve the standard of pharmacy profession in Nigeria?

Government’s role in improving the standard of pharmacy profession in Nigeria is critical to national development. The higher the standard of pharmacy practice, the lesser the morbidity and mortality indices of the country and the healthier the nation. And the healthier the nation, the wealthier it gets.

The Nigerian government can improve the standard of pharmacy profession by sanitising the chaotic drug distribution which, as I mentioned earlier, has already been embraced by the government. Also, they should be empowering pharmacists to optimise their potentials by reviewing the statutory hindrances mentioned above with a view to promoting access to healthcare.

There should also be adoption of national guidelines on disease prevention and management, with the roles of each healthcare professional group clearly defined and measures put in place to enforce compliance.

Other suggestions include ensuring that national prescription and dispensing policy is adhered to; strengthening the health insurance scheme and allowing equal opportunities for all healthcare professionals to practise through adequate remuneration and adoption of pay-for-service; empowering community pharmacies through provision of easy-to-access loans with very low interest rates and provision of basic amenities like uninterrupted supply of electricity; making it attractive for community pharmacies to be set-up in rural areas; compelling all private establishments where drugs are handled to have pharmacists in their employ, either full-time or part-time as the case may be; and upholding the law that states that only pharmacists can own retail pharmacy outlets in Nigeria.

 What are the most common health conditions that bring patients in this area to your pharmacy, and why is this so?

They are largely preventable diseases like malaria, typhoid fever and infections generally. Also gaining grounds are non-communicable diseases like hypertension, which accounts for the highest visits, diabetes and dyslipidemia.

These are pointers to not-good-enough health prevention strategies in the community and the country at large. For cases like malaria, apart from the mosquito-breeding environment, it seems like malaria is generally over-treated.Many people are not willing to be tested before treatment largely because of the cost to them. They have to pay to be treated and if, positive, will now pay for their medication.So they prefer to just buy antimalarial drugs. This is another area we need the government to invest in or cover with functional health insurance. To be effective, community pharmacists should be remunerated to carry out rapid malaria tests on people who ask to buy antimalarial drugs off prescription or who come with symptoms suggestive of malaria.

We need, as a country, to focus or expend more energy on effective preventive health strategies, thereby optimising pharmacists’ intervention.

 Many people have canvassed for stiffer penalties to be meted out to drug counterfeiters. Do you support the motion?

If it will act as deterrent, why not?But I think the government needs to empower indigenous manufacturers to produce safe effective medicines at affordable costs. This will deter drug counterfeiters. With the current move by the government to sanitise drug distribution, I believe the population of counterfeiters will naturally reduce.

 Finally, what’s your advice to pharmacists in Nigeria?

Dearly beloved pharmacist, the train of pharmacy best practices is moving.If you are not yet on board, please come on board and let us continue to fight the good fight of pharmacy best practices, armed with the biblical injunction that “godliness with contentment is great gain”.

The dividends of pharmacy best practices are great and should not be seen in terms of money alone. We shall all have our share if we do not get weary in doing good. The God who has called us to this noble profession is more than able to uphold us and make us fulfilled in Him. As men of honour, we join hands for pharmacy best practices – no compromise!

WWCVL rewards trade partners …As Emzor, GSK, Novartis emerge highest pharma producers in Nigeria

0

In appreciation of their unwavering loyalty over the years, no fewer than 78 trade partners were given awards and special recognition at the recent World Wide Commercial Ventures Limited (WWCVL) Partners Reward Function.

The colourful occasion which took place at Intercontinental Hotel, Victoria Island, Lagos, on 9 October, had several distributors, pharmacy owners, as well as the company’s top management staff, regional managers and sales representatives, in attendance.

The awards which came in three different categories – Platinum, Gold and Silver – attracted rounds of applause from the teeming audience.

While delivering a presentation, WWCVL’s head of special business unit, Mr Sanjay Upadhyaya, noted that a pharmaceutical distribution outfit like WWCVL couldn’t have made so much progress without the commitment and utmost loyalty of its partners.

He disclosed that the company was indeed pleased to be associated with every partner and distributor represented at the event.

“It has been said that a woman’s loyalty is tested when her man has nothing. On the other hand, a man’s loyalty is tested when he has everything. This is why we are appreciating your commitment today,” he stated.

Also speaking, WWCVL’s superintendent pharmacist, Pharm. Lucky Ubokor, declared that WWCVL, a subsidiary of Eco Health Limited since inception in Nigeria, was in partnership with over 16 multinational companies, maintaining 10 strategic distribution hubs scattered across the six geo-political zones as well as servicing 144 wholesalers and depots nationwide.

The superintendent pharmacist also reiterated that, aside having 450 staff across the country, the company’s new facility was recently commissioned by Dr Paul Orhii, the director-general of National Agency for Food Drug Administration and Control (NAFDAC).

While presenting the keynote address, another head of the company’s special business unit, Mr Santosh Kumar, announced that Nigeria’s pharma industry was worth N203 billion, which would have doubled up by 2018.

Using BMI (Business Monitor International) research report, Kumar assured that the challenge of counterfeiting in the pharma industry had drastically reduced.

“Counterfeiting of products which was about 40 per cent in 2005 reduced by 30 per cent in 2010 and in 2014, it has been estimated to be around 20 per cent. This is an indication of better regulations and distribution practice,” he disclosed.

Kumar also attributed the noticeable reduction to the sustained efforts and campaigns of NAFDAC.

Appraising the rapid development in the industry, Kumar declared that Emzor Pharmaceuticals had become the number one company in Nigeria, in terms of products output; followed closely by the likes of GlaxoSmithKline, Novartis, May & Baker and Hovid respectively.

Among the eminent personalities who graced the event were Pharm. Ike Onyechi, managing director of Alpha Pharmacy; Pharm. Kunle Ara, managing director of Kunle Ara Pharmacy, Ibadan; Mr. Anant Narayan, managing director of WWCVL and Pharm. Lucky Ubokor, regulatory manager.

Others were Pharm. Yemi Olalere, WWCVL’s director; Mr. S. Kannan, head of finance and the duo of Messrs. Santosh Kumar and Sanjay Upadhyaya (heads, special business unit).

World Wide Commercial Ventures Limited (WWCVL) is a licensed vendor to all major healthcare providers in Nigeria. It has also been described as a one-stop solution for warehousing, pharma marketing, supply chain, leads, delivery and sales, regulatory and port clearance, transportation logistics and inventory management.

 

Pharm Ike Onyechi, managing director of Alpha Pharmacy (middle) receiving an award from Mr. Santosh Kumar, WWCVL’s head of special business unit and Mr. S. Kannan, finance head
Pharm Ike Onyechi, managing director of Alpha Pharmacy (middle) receiving an award from Mr. Santosh Kumar, WWCVL’s head of special business unit and Mr. S. Kannan, finance head

Pharmanews releases 2015 Training Programme

1

2015 progmxx.

In line with our core objectives at Pharmanews to educate and contribute to the capacity development of health care professionals, we are pleased to notify the general public of our health care management curriculum for the year 2015. (Click to download programme)

The 2015 training programme is focused on developing leadership and management capacity of health care personnel in West Africa. We believe that this focus is necessary to equip participants with the necessary skill-set and attitude required to engage a changing global health care industry.

The 2015 programme includes:

  1. Three international workshop in Dubai, South Africa (new), and Ghana. Our international programmes offer exciting opportunities for learning, networking and tourism. They are designed to expose participants to international best practices.
  2. Two clinical leadership and organisational change management workshops in Lagos, Nigeria.
  3. One health care entrepreneurship workshop
  4. Two academic service workshops for Pharmacy Technicians and Pharmacy support workforce.

All of our scheduled workshops are available for sponsorship. Clients can also demand for specific clinical leadership, leadership or academic service workshops for their firm or specific health care organisation.

For workshop bookings and enquiries, contact:

Cyril Mbata                                  – 0706 812 9728

Nelson Okwonna                        – 0803 956 9184

Elizabeth Amuneke                     – 0805 723 5128

 

 Please click here to download the PDF copy of the 2015 Training Programme

 

PIPAN to become clearing house for pharma industry policies – Dr Adeagbo

0

In this interview with Pharmanews, Dr Wale Adeagbo, the executive director of Pharmaceutical Industry Practitioners’ Association of Nigeria (PIPAN), with over 15 years’ experience in corporate strategy across the public, private and voluntary sectors, speaks on the objectives of PIPAN and why he thinks members of the association can be unified, despite their diverse views. Excerpts:

 What prompted your decision to take up the position of executive director?

I have some background in health policy and health governance, plus an academic interest in corporate strategy and social economics. I acted as a policy adviser to a minister in the UK and chaired some health networks in Europe, including the Non-Executive Directors’ Network of the UK NHS Alliance, and the Alliance of Community Oriented Primary Care Organisations, Netherlands (under the aegis of the European Forum for Primary Care).

Taking up this position with PIPAN is a privilege for me. I believe I was chosen for the role as I have a good understanding of the strategic purpose and intent of the organisation and I fully subscribe to the vision and innovative thinking of the founding agencies of PIPAN, especially that of the leadership of the associations that midwifed PIPAN.

Tell us about PIPAN. What are the objectives of the association?

PIPAN was established by NAIP and the following pharmaceutical trade associations: Pharmaceutical Manufacturing Group of the Manufacturing Association of Nigeria (PMG-MAN); Indian Pharmaceutical Manufacturers & Importers of Nigeria (IPMIN); Association of Pharmaceutical Importers of Nigeria (APIN); and the Nigerian Representatives of Overseas Pharmaceutical Manufacturers (NIROPHARM).

The objectives of PIPAN are targeted at common industry issues shared by the founding agencies. They include: better knowledge of employees and operatives by carrying out background checks to reduce loss to the industry; developing standardised, professionalised and accredited qualifications for sales reps and some associated roles in the industry; sharing of market /business intelligence that can inform and influence business development; and enabling coordinated approach to policy and practice – at national and international arenas.

You have taken up the task of harnessing an association comprising all practitioners in the pharmaceutical industry in Nigeria. Considering how diverse the practitioners are and their various business interests, which sometimes make them competitors, how optimistic are you that PIPAN members can speak with one voice on issues?

I am optimistic about the attainment of unified views and voices in the industry, despite the varied slants of the players. For starters, the establishment of PIPAN emerged through considerable thought processes, engagements and consultations with all key stakeholders; so the objectives and identified tasks are the common issues that challenge the industry. And all the trade associations recognise that these issues will be better tackled if hosted within a shared institutional tent.

Also, the leadership of each agency constitutes the governing board of PIPAN; so there is equal stake in terms of its strategic directions and activities. The governance structure of PIPAN also creates a space for policy and practice debate – which we have called the Governing Council. This will host all stakeholders in discussing common issues and arrive at agreed and consensual solutions to identified issues. The future is in collaboration, not competition, and the industry is well aware of this; hence the establishment of PIPAN is to future-proof the industry’s aspirations.

Since you took over as the executive director, what challenges have you encountered at PIPAN and how have you tackled them?

Noting that the establishment of PIPAN is an institutional solution to current and potential challenges facing the pharma industry, there is the need to constantly remind ourselves of the need for PIPAN and the necessity of all stakeholder agencies/associations to continue to support the organisation. The good news is that the leadership of all the leading agencies – NIROPHARM, APIN, NAIP, PMGMAN, IPMIN – are totally committed to this initiative and they see the challenges that PIPAN confronts as their challenges.

Where do you hope to see PIPAN in the next five to ten years?

I pray that, well before then, PIPAN would have achieved and will be sustaining its core functions. These will entail hosting of a detailed repository of data about sales force and marketing activities in the Nigerian pharma industry, so that we know what we sell/distribute, where we sell/distribute to, what we import, and what we manufacture – all this is to enable us ascertain how we can improve the health and well-being of Nigerians, while publicising the trends and developments of the industry.

By then, PIPAN would have birthed a full-fledged academy that will ensure the capacity development of the industry and provide certified and accredited courses for the field workers and associated employees. Working in partnership with mainstream associations, PIPAN would have become the clearing house of and for industry policy – at the national and international arenas.

Our vision is to reposition PMG-MAN – Okey Akpa

0

Okey Akpa

In this exclusive interview with our reporter, Adebayo Oladejo, the recently appointed chairman of the Pharmaceutical Manufacturers Group of the Manufacturers Association of Nigeria (PMG-MAN), Pharm. Okey Akpa, speaks on the challenges facing pharmaceutical manufacturers in the country and his plans for the group. Excerpts:

What prompted your decision to serve as PMG-MAN chairman?

My decision to serve the group is coming from the point of view that everyone of us wants to contribute his or her own quota to create a better industry and, by extension, a better healthcare system for Nigerians.So it is simply to serve and contribute my quota to the development of the industry and nothing beyond that.

 You are succeeding a chairman that has been extoled as an achiever. What are your plans to further take the association to higher level?

PMG-MAN has been blessed with very good leaders from inception.The immediate past chairman, Chief Bunmi Olaopa, was one of them, and before him were Mr Joe Odumodu, Mr Emma Ebere, Dr (Mrs) Stella Okoli and Mazi   Sam Ohuabunwa.So you can see that it is a very strong leadership team that we have had and my intention, by the special grace of God, is to continue with the good work of these people over the years and obviously to execute projects which will take the industry to the next level.

Already a lot of good things are happening the World Health Organisation pre-qualification and others.So this leadership team,of which, by God’s grace, I am the chairman will endeavour to consolidate on all the great achievements of our past leaders and also look at new opportunities in the Industry for positioning the industry at the global level and creating a vibrant pharmaceutical sector.Those are the things that occupy our minds at the moment and making PMG-MAN an organisation that is well respected within government circle, the healthcare circle, within Africa and internationally.

 A major challenge facing pharmaceutical manufacturing in Nigeria is the problem of fake drugs. How can this challenge be tackled?

Fake drug, as a phenomenon, is a global challenge and not only localised to Nigeria – though it occurs in all the countries at different proportions. Besides, if you look at it closely, you would realise that a lot has happened by way of improvement, because there was a time in Nigeria that made-in-Nigeria drugs were seen to be predominantly fake. This is no more so, and that shows that something good is happening.

In this regard, I will like to recognise the efforts of NAFDAC. Other professional bodies have also contributed and, of course, the manufacturers as well are eager to produce quality medicines.So there is an avalanche of quality medicines in the country that people can access and afford.This is important because, in the absence of quality medicines that are made in Nigeria, fake drugs will become a lot more available because people cannot do without using medicine.So,one of the ways that PMG-MAN is trying to contribute is to make sure that quality made-in-Nigeria pharmaceutical products are available, accessible and affordable.That, on its own, is a major pillar of fighting against fake drugs, as it makes fake drug business less attractive.So, we are winning the war.

 

You talked about affordability of drugs in the country.It is generally believed that drugs are more expensive in Nigeria, what can you say about this?

That’s people’s perception because the word “expensive” is relative. But when several factors are considered, you will discover that it’s just mere perception.

 

As one of the stakeholders in the pharmaceutical profession, what grey areas do you think the stakeholders at the November PSN conference should specifically address?

If you look at the theme of the conference, “Transforming Pharmacy Practice for Better Outcomes”, which centres on focusing on how to improve the practice of Pharmacy, you will see that the theme is apt and one must give the president of the PSN and other organisers kudos for packaging the conference in this way.

If you follow the programme for the conference, there is going to be a lot of sessions to discuss how to improve the practice of Pharmacy and there is going to be lots of brainstorming sessions and panel discussions. I think it’s the right thing to do because Pharmacy is a profession that takes care of people; so it must continue to evolve and find relevance in meeting the needs of people.

 So, how would you assess the contribution of conferences to the development of the profession?

Sincerely, conferences are very important as they bring all pharmacists in the country together.Considering the fact that Pharmacy has different dimensions of practice – the industry, community practice, pharmacists in academia, the hospital pharmacists, the researchers, and even pharmaceutical journalism – conferences bring all the professionals together and we share ideas and review all that is happening around us.And it has been so far so good.

 It has been discovered that over 70 per cent of our drugs are imported.How do you think government can improve local manufacturing of drugs in the country?

One of the key points of the National Drug Policy of the country is an objective to produce 70 per cent of the drugs to be used in the country locally, and it is the desire of PMG-MAN that government should help Nigerian pharmaceutical manufacturers to achieve this or even surpass it.

One of the means of supporting them is for government agencies and parastatals to patronise Nigerian manufacturers and pharmaceutical products., Secondly,the industry needs appropriate protection because many of the drugs we are using in Nigeria are imported, which should not to be so because we have the capacity to produce most of these products locally. So,government must develop the political will to do the right thing and discourage the importation of items that we can manufacture locally.That, on its own, is a very strong way to encourage local manufacturing

Also,we must look at the general infrastructure which affects not only pharmaceutical but every manufacturing effort in Nigeria. The more government improves the infrastructural base, the better.Look at what is happening with electricity.

Funding is another challenge.It is the wish of Nigerian manufacturers that government looks at making funds for development of pharmaceutical manufacturing available to the industry.Of course, we are not asking for free money but money that can be accessed at a competitive rate and that will make investment in the industry to be possible. As soon as these things are put in place, the industry will grow better.

 What is your view about current happenings in the health sector?

The provision of health to any society is a team effort, and the health sector should be more of teamwork. Any disharmony is against the principle of teamwork and it is my desire and prayer that all the different stakeholders in the sector will realise this and come together and work as team.

 

South Jersey Healthcare’s IoT solution

0



South Jersey Healthcare wanted to improve patient care by providing critical data to medical professionals across multiple campuses. To improve efficiency, South Jersey Healthcare replaced manual medication-distribution processes with an automated dispensing system from Omnicell that runs on Microsoft technologies. Because the solution shares information across multiple applications and devices, medical staff have better visibility into patient care and more control of their workflow. By using the automated solution, the pharmacy has cut delivery time for patient medication from two hours to 18 minutes. In addition, South Jersey Healthcare can more easily meet electronic health-record regulatory requirements, improve inventory control and simplify IT management.

source

WHO officially declares Nigeria free from Ebola

2

After a 42-day period without new cases of Ebola in the country, the World Health Organisation (WHO) has declared Nigeria Ebola free. According to a WHO representative, Rui Gama Vaz who addressed a press conference in Abuja on Monday, he said “Nigeria is now free of Ebola”.

According to a report from Aljazeera, Vaz said: “The virus is gone for now. The outbreak in Nigeria has been defeated. This is a spectacular success story that shows to the world that Ebola can be contained”.

The pronouncement by the world’s apex health institution was a welcome development in the country, as the average Nigerian is relieved of the phobia of contracting the disease in his environment. However, health officials want people to celebrate but to remain cautious, as Nigeria borders is open to all and sundry.

Nigeria becomes the second country in West Africa to be declared Ebola free in the past week. On Friday, the UN health agency declared Senegal free of Ebola after it passed the 42 day landmark.

“WHO officially declares the Ebola outbreak in Senegal over and commends the country on its diligence to end the transmission of the virus,” the WHO said.

In all, eight people died out of 20 confirmed cases in Nigeria’s biggest city, Lagos, and the oil hub of Port Harcourt, while nearly 900 people were monitored for signs of the disease.

More than 4,500 people have died and nearly 10,000 have been infected with the haemorrhagic fever, most of them in West Africa, since the start of the year.

 

How superintendent pharmacists can improve pharmacy practice in Nigeria

1
Pharm Lolu Ojo 1
Pharm. (Dr ) Lolu Ojo

 

 

 

 

 

 

 

That the Nigerian pharmaceutical market is in a messy state is not news to many in the industry or even the customer. The problems and challenges facing the industry are known to many of us. They have been identified, analysed and endlessly discussed at various forums and yet we sit in the same cesspool of failure to perform at the highest professional level. What’s even more shocking is the failure of stakeholders to find and implement solutions to the problems. And so, the malaise persists.

But all is not lost. There are solutions that we can begin to implement now and they begin with the superintendent pharmacist, the one key player that can take a leadership role in resolving some of the challenges we face today. In subsequent articles, I will address other segments and players in the industry and offer some practical steps we need to take as an industry to avert further disaster. For now, though, we must evaluate the role of the superintendent pharmacist in both creating and getting us out of the current embarrassing situation.

Superintendent pharmacists occupy a unique role in the practice of Pharmacy in our society. In a normal environment, they anchor the industry, serve as principal officers responsible for maintaining the integrity of the system and, where necessary, act as agents of change. In that last capacity, they are sorely lacking in Nigeria today and I would like to call on them to step up to this role. In doing so, they can move the industry forward and help reverse some of the damages that years of neglect have done to the pharmaceutical market.

A superintendent is “a person who manages or superintends an organisation or activity.” A direct extrapolation of this definition will make the superintendent pharmacist the overseer, administrator, manager, supervisor or controller of the organisation that he presides over. By law, he is the legal “face” of the pharmaceutical outlet, premise or factory. He is the representative of the Pharmacist Council of Nigeria (PCN) and without him the pharmaceutical organisation will not be registered.

The superintendent pharmacist is the protector of the public interest, ensuring that there is a balance between the profit-making goals of the enterprise and the discharge of ethical responsibilities expected of a pharmaceutical business.

The failure of superintendent pharmacists to play their part has contributed in no small measure to the mess that we are currently in. We would have been able to eliminate or, at least, control the battery of unethical practices that currently pervade the entire system.

How did we get to this level where more than 90 per cent of commercial activities in Pharmacy are out of control? If you are a superintendent pharmacist, you bear part of the blame for this malaise. Many superintendent pharmacists like the title and the financial compensation associated with the position but often fail to discharge the corresponding duties. The failures are stunning: abdication of responsibilities demonstrated in the popular but nefarious “Register and Go” activities, and shocking lack of appreciation of the enormous responsibility associated with the superintendent pharmacist’s office.

Over the years, the pharmaceutical regulatory authority has also been permissive and complicating its oversight of the profession: registration is “static”(occurring once a year) and there are no institutionalised procedures in place to interface with the organisation and the superintendent pharmacist, apart from sporadic inspections, usually following pressure from other pharmacists.

The superintendent pharmacist can help change the face and practice of Pharmacy for good in Nigeria. The duties associated with the position entail more than premises and product registration. Everything involving pharmaceutical products should start and end with the superintendent pharmacist, including raw materials procurement, manufacturing, quality control, distribution, sales and dispensing of drugs.

We must, therefore, do everything possible to empower the superintendent pharmacist. They must be sufficiently equipped to discharge the responsibilities attached to the post; this goes beyond the possession of a Bachelor of Pharmacy degree. They must also be held accountable for their performance. Furthermore, the industry needsto organise regular workshops for all pharmacists who have chosen to work as superintendent pharmacists.

In 2012, the Association of Industrial Pharmacists of Nigeria (NAIP) organised a special workshop for superintendent pharmacists as part of its 15th Annual Conference. The workshop was attended by more than 250 superintendent pharmacists and the PCN, led by the then acting Registrar, Pharm (Mrs) Gloria Abumere, FPSN. At the end of the workshop, a standard operating procedure (SOP) for superintendent pharmacists was produced and sent to the PCN for action. Regrettably, nothing has been done to give effect to the SOP, which we consider a good tool for the superintendent pharmacists.

I am reproducing the SOP with this article, with the hope that the relevant authorities in PCN and PSN will make use of it as appropriate.

God bless Pharmacy in Nigeria.

 Draft Procedure to Operate as a Superintendent Pharmacist in the Pharmaceutical Industry

 Purpose:

This document prescribes the conduct of a Superintendent Pharmacist in the Pharmaceutical Industry with the objective of ensuring a compliance with the code of ethics guiding the practice of Pharmacy as regulated by the relevant authorities.

 Scope:

This procedure is applicable to all Pharmaceutical Industries as regulated by the relevant authorities.

Responsibility:

It is the responsibility of the Superintendent Pharmacist and the relevant authorities with the cooperation of the top management of Pharmaceutical Industries to ensure the implementation of this standard operating procedure.

Procedure:

To operate as a Superintendent Pharmacist, the following attributes and standard are expected:

  1. He/she should be knowledgeable, skilled, licensed by and responsible to the Pharmacists Council of Nigeria.
  2. He/she should have the overall professional control of a set standard of planning, implementing and executing the approved Pharmaceutical Policies of a premise in accordance with Act. P17 LFN, 2004.
  3. He/she should set standards and policies for the pharmaceutical aspect of the business.
  4. He/she should ensure that all Legal, Professional and Regulatory requirements in relation to pharmaceutical aspect of the business are complied with.
  5. He/she should ensure that there are appropriate policies setting on the number of staff and their required experience.
  6. He/she should respond appropriately to any system failures or concerns that may arise.
  7. He/she should ensure that all professional activities undertaken within the premises are adequately covered by professional indemnity.
  8. He/she should ensure the registration and annual licensure of the premises and also of all Pharmacists working in the organization.
  9. He/she should set standards and policies for the pharmaceutical aspect of the business.
  10. He/she should be professionally accountable for the day to day level of practice.
  11. He/she should be responsible for the over-all quality assurance of the establishment, according to Section 4(3) of the PCN Act.
  12. He/she should be sufficiently positioned:
  13. to supervise the Production and Quality Control Managers or at least have a dotted line relationship with the key officers in accordance with Section 4(4) of the PCN Act.
  14. To review the Sales marketing practices of the company and bring them in line with ethical practices.
  15. He/she should ensure that every agreement pertaining to the pharmaceutical aspect, entered into by his company is done according to professional ethics and within the ambits of the law.
  16. He/she should ensure that starting materials are purchased following due process in line with specified standards.
  17. He/she should ensure that all processes and procedures that are necessary for compliance to the principles of good manufacturing practice are properly carried out by qualified personnel on a timely basis.
  18. He/she should approve all working document before implementation by production and quality assurance/control department.
  19. He/she should approve all test results before release for use or sale.
  20. Where the business is IMPORTATION only:
  21. He/she should be aware and approve the source(s) of supply.
  22. He/she should approve the product for sales after receipt into the warehouse.
  23. He/she should order periodic testing of the products to ensure that they are safe for public consumption.
  24. In all cases, He/she should review, at a regular interval(monthly), the sales procedures in the company, confirm that customers are fit and proper person or companies licensed to handle drugs.
  25. A written report of the exercise in (s) above should be kept in the company record for PCN inspection.
  26. He/she should be personally involved in all decision making that may impact on products.
  27. He/she should liaise with regulatory agencies as the sole responsible officer of the facility.
  28. He/she should ensure that standards of practice are up to date, understood and followed by both management and staff of the facility.
  29. He/she should ensure proper documentation by institutionalizing a culture of accurate, up to date and accessible record keeping, with controls where necessary.
  30. He/she should make sure clear lines of accountability exist and that a retrieval or recall process is in place in case of product failure.
  31. He/she will be held RESPOSNSIBLE and ACCOUNTABLE for any unethical practices that may take place in the procurement, production, marketing, Sales and distribution of the products in the company.

 References for Implementation:

  1. Laws of the Federation of Nigeria, Pharmacists Council of Nigeria Act (1992 No. 91)
  2. Pharmacists Council of Nigeria Act (1992 No. 91). Registration of PharmaceuticalPremises Regulations, 2005
  3. Pharmacists Council of Nigeria Act (1992 No. 91). Inspection, Location and Structureof Pharmaceutical Premises Regulation 2005
  4. Code of Ethics for Pharmacists in Nigeria.
  5. Membership of Association of Industrial Pharmacists(AIPN).
  6. A testimonial of compliance to be obtained from AIPN before PCN is approached for registration.

References for Continual Improvement:

  1. A forum or an Association of Superintendent Pharmacists within the ambit of AIPN is imperative to encourage interactions, sharing of experiences, counselling, personal development and networking.
  2. At least 3 years post qualification experience or 1 year post NYSC exposure is necessary before a registered Pharmacist becomes a Superintendent Pharmacist or handles importation of drugs.

iii.  The Pharmacists Council of Nigeria should develop computer software that would detect multiple full time employments of Pharmacists.

 

 

Future of Pharmacy is in specialisation – Sir Echezona

2
Sir Echezona
Sir Echezona

 

 

 

 

 

 

 

In this in-depth interview with Adebayo Folorunsho-Francis, Pharm. (Sir) Gilbert Umeadi Echezona, Fellow of the Pharmaceutical Society of Nigeria and former director of pharmaceutical services in Anambra State from 1997 to 2007, recalls several significant events in the growth of Pharmacy in Nigeria, as well as offering practical suggestions on advancing the profession and strengthening its umbrella association, the Pharmaceutical Society of Nigeria. Excerpts:

Tell us a little about your background

My early life was shaped by my maternal uncle who was a teacher with the Catholic Mission. I started my early education in 1954 in Sobe, a town about 12 miles from Auchi in present day Edo State (Mid-West Nigeria). For my secondary education, I attended the famous College of Immaculate Conception, Enugu, from 1962 to 1966.

My educational pursuit was disrupted by the civil war (1967-1970). During the war, like most young men at the time, I joined the militia and,later, the Biafra Organisation of Freedom Fighters(BOFF) from 1968-1970. At the end of the war, I was offered admission to the University of Nigeria, Nsukka (UNN), to read Pharmacy. I obtained bachelor’s degree in Pharmacy in 1975.

I started my pharmacy career as an intern pharmacist at the University of Nigeria Teaching Hospital, Enugu (1975-1976). I did my one year mandatory National Youth Service Corps programme in Yelwa Yauri, Sokoto State, from 1976 to 1977. In August 1977, I joined the Anambra State Civil Service as Pharmacist Grade 1. I also served Anambra State in various capacities, holding different positions and retired in 2007,after 30 years of meritorious service.

How would you describe your career in government?

Without exaggerating, my career in government was exciting and fulfilling. As a young pharmacist, I had a lot of exposure in the service, such as attending a store management course in Ghana for three weeks, and appointment as instructor and head of department at the College of Health Technology, Oji-River, an institution that trains middle-level manpower. I will tell you some other major posts I held in the course of our discussion.

Why did you decide to study Pharmacy?

At the end of my secondary education in 1966, I wanted to study Geology. However, my contact with a herbal ‘doctor’ in the course of military assignment during the civil war changed that. At UNN, where I attended, the introductory lectures in Pharmacognosy reassured me that I did not make a mistake. In the university, other students had high regard for pharmacy students.

Three months after graduation, as intern pharmacists, we were granted car loans for cars of our choice. The house officers received more money. We did not understand and were too excited to probe.

Did you eventually discover the reason?

Yes.The reason became clear when I finally took up a permanent appointment with the government. I discovered, to my utter disappointment, that pharmacists were discriminated against in the civil service. The conditions of service for pharmacists were very poor. Pharmacists were not included in policy-making committees in the hospital hierarchy. They were denied promotions and stagnated. Many of my contemporaries became disillusioned and left for the private sector. Those of us who were patient stayed and, by the grace of God, broke through the man-made bottlenecks and made it to the top.

Even in the private sector, it is the same story. Quacksand charlatans have taken over the profession. In spite of all these, I still believe I made the right choice. Today, a lot has changed. We now have pharmacists in top political positions as governors, ministers, legislators, ambassadors, commissioners, etc. I believe the future is still very bright for pharmacists and Pharmacy. I have nothing to regret.

 Tell us about your work experience

I worked first as a hospital pharmacist, then as an administrative pharmacist. As a Grade 1 pharmacist, I served under a senior pharmacist for three years before being postedto head a hospital pharmacy. In those days, one was not allowed to function unsupervised until one had had five years’ post qualification experience, the internship and NYSC periods inclusive.

What was the profession like in your day compared to today’s practice?

As at then, safe and good quality drugs were available in adequate quantities. The out-of-stock syndrome was non-existent. Patients received all the medicines in their prescriptions and at no cost to them.The drug distribution/supply chain was reliable and coordinated. Fake counterfeit medicines did not exist. There was paucity in the number of pharmacists employed to function in government hospitals, arising from discrimination in recruiting pharmacists. Consequently, non-pharmacists (pharmacy technicians and pharmacy assistants) were used to cover pharmaceutical duties in some hospitals.

Job satisfaction was equally lacking. Pharmacists in government served under poor work environment, poor remuneration package, not being included in decision-making committees in the hospital hierarchy, career stagnation, and limitation of professional privileges.

Tell us more about controversial issues that characterised your time

Discrimination against the profession was not limited to pharmacists in state service. It permeated the specialist and teaching hospitals and even the army. It was not until 1980 that the Federal Chief Pharmacist was upgraded to Director of Pharmaceutical Services, GL 16. My classmate who joined the Nigerian Air Force had to leave because he was started on GL 07.

During our time, pharmacists in government service were denied the right to private practice. We did not have the opportunity of coordinated continuing education programmes in Pharmacy,as is the case today.

Perhaps one can say some of the controversiesback then included poor working conditions for pharmacists in the public service; reluctance of most state governments, teaching and specialist hospitals to accept newly qualified pharmacists for internship training, leading to a great number of them roaming the streets for placement; and dominance of doctors as heads of hospitals at all levels.

Others included cheap substitution in hospitals for pharmacists using sub-professional health personnel; open drug markets and circulation of fake, counterfeit and substandard medicines; practising doctors keeping drug stores and dispensaries,in defiance of extant drug laws; and protest from the Nigerian Medical Association (NMA) against the appointment of a pharmacist as Minister of Health in 1993, the very first pharmacist to be so appointed.

There was also the proliferation of patent and proprietary medicine vendors in the cities and the complete lack of political will by government to curb the situation. Then came thepoisoned paracetamol syrup episode in which about 109 Nigerian children died. This dealt a devastating blow on the image of pharmacists.We had not fully recovered from the shock when the tragic death of Miss Cynthia Osokogu was reported,leading to the arrest of a young pharmacist, who is currently standing trial for murder.

In your opinion, what are the main challenges facing pharmacy practice in Nigeria and how can they be surmounted?

The pharmacy profession has a multitude of challenges to contend with. Many of the challenges have been there over the years. For instance, our laws in pharmacy practice are unwieldy and are not supportive of theprofession. There are manyoverlaps, leading to conflicts and faulty implementation. This problem can be overcome if the PSN is given the statutory function of formulation of policies and execution of laws governing the practice of Pharmacy.

Another challenge is absence of professional recognition. Pharmacists in government are engaged under poor conditions of service. The number employed is usually grossly inadequate,leading to cheap substitution with sub-professional health personnel to render pharmaceutical functions in hospitals. They are poorly remunerated and not promoted as and when due, leading to stagnation and frustration. Pharmacists in hospitals are not involved in decision making committees of the hospitals.

Pharmacy also has the issue of uncoordinated drug distribution and the menace of fake and counterfeit medicines. The flushing outof quacks and charlatans will help reduce the situation. Pharmacists should also be encouraged to move into rural areas. Government should develop the political will to implement the guidelines on drug distribution.

 Are there still some other burning issues?

Yes. There is the problem of fragmentation in the PSN. We should work hard to achieve internal consolidation in the PSN. There is a need for the PSN to be seen as one house, speaking with one voice. A situation where the position of a state branch on an issue conflicts with that of the national body on the same matter does not augur well for us.

Professional jealousy is yet another. The opposition that greeted both the appointment of a pharmacist as Minister of Health in 1993 and the creation of the Pharm. D. programmeare two clear cases. I have already talked about the professional jealousy, in respect of hospital pharmacists.

Another challenge is doctors’ strikes.Should the federal government be negotiating with the NMA, a non-labour body?This is one of the many occasions the government treats doctors as sacred cows. It is rather embarrassing.

 What solution would you proffer to these problems?

To tackle these challenges, the PSN must be seen as one house. Individual Pharmacists must be disciplined, and must develop both professional and political clout. We should avoid fighting back as response to provocation and conflicts, but rather adopt the more effective approach of dialogue and due process. We should understand and respect one another. Above all, more pharmacists should be encouraged to occupy positions of strength.

How would you rate Nigerian pharmacists?

We are not doing badly. You will recall that a pharmacist was appointed Minister of Health in 1993. Same year, Prof. O.K. Udeala was appointed Vice Chancellor,University of Nigeria, Nsukka.The late Prof. Dora Akunyili was D.G. of NAFDAC and later Minister of Information.

Pharmacists are today governors and deputy governors in their states. We also have pharmacists as ambassadors, commissioners, captains of industries and permanent secretaries. I recall that, in 1996, a Nigerian pharmacist represented the third world countries on the executive board of FIPfor community pharmacists. We are doing well. We still pray that more pharmacists occupy these positions of strength.

How best do you think the issue of fake drugs and counterfeit medicines can be curbed?

Many years back, we had a beautiful and reliable supply/distribution system for drugs. This system was destroyed in 1980 when government started issuing import licences to businessmen who are not pharmacists. This led to the involvement of quacks and charlatans in drug distribution, the development of open markets and the circulation of fake drugs.

To curb the circulation of fake and counterfeit drugs, we must evolve a new drug supply/distribution chain that will eliminate the involvement of quacks and charlatans in drug distribution and supply. The open drug markets must be dismantled. The federal government’s”guidelineson drug distribution” is the answer. Government should develop the political will to implement the guidelines.

I expected that, by now, various state governments should have set up StateDrug Distribution Centres (SDDC), as demanded by the guidelines. I also expect the PSN to take the lead in the implementation of the guidelines,as this is the only sure way pharmacists can reclaim the drug business in Nigeria.

The Anambra State PSN has registered a Mega Drug Distribution Centre (MDDC) in Onitsha. The centre is yet to take off because government lacks the political will to enforce compliance.

 What were your key involvements in pharmaceutical activities?

I was appointed State Director of Pharmaceutical Services(DPS) in1997 before I retired in 2007. This implies that, for close to a decade, I was monitoring pharmacists and the practice of Pharmacy. I was chairman of the Pharmaceutical Inspection Committee (PIC), member of National and State Executive Councils of PSN.

As DPS, I was also a member of the governing council of the Pharmacists Council of Nigeria (PCN) for two tenures, and served as a member of the Appointment, Promotion and Disciplinary Committee of the council. I served in the Enugu/Anambra Joint Task Force on Fake and Counterfeit Drugs,and was later appointed chairman of the Task Force in Anambra State. I regularly attended PSN meetings and conferences, both at national and state levels.

 Were there some major awards given to you in recognition of your selfless service?

Aside from my being made a Knight of the Roman Catholic Church in 1999, I was made a Fellow of the Pharmaceutical Society of Nigeria ten years later (2009). In appreciation of my valuable service as a member (1999-2002), the PCNhonoured me with a PCN Certificate. Same recognition was accorded me during the 2003-2006 and August 2006-November 2007 regime,in acknowledgement of my contribution to the PCN. I was also aPSN Anambra State Merit Award Winner in 1998.

I equally have in my possession a PANS Certificate of Honour (UNN 1974-75), in appreciation of my excellent service as a member and secretary of the Pharmaceutical Association of Nigerian Students.

How do you see the annual PSN national conferences?

In the past, the national conference of the PSN was like a ritual. Every year we gathered and discussed matters affecting the profession. In some of the topics, we would fail to reach agreements,and where resolutions were reached, most of them were either partiallyimplemented or not implemented at all. The following year, the same topics would be presented again, and so on.

Today,a lot has changed. Most decisions are followed up. However, one feature of the AGM that has not changed is its rowdy nature, which is a reflection of the fragmentation within the PSN. It is also believed that the South has, for a long time, dominated the leadership of the Society. Efforts should be made at unification of interests, so that we can have a unified Pharmaceutical Society of Nigeria.

Is there an ideal age for a pharmacist to retire?

An active pharmacist should retire at 75 years. He needs some time to rest and reflect on his spiritual life.

 As an elder in the pharmacy profession, what is your advice to young pharmacists?

My advice is simple: Be disciplined, honest; work hard and remain focused. They should adapt to professional advances in clinical pharmacy and pharmaceutical care. I believe that the future of pharmacy lies in specialisation. We should therefore de-emphasise drug trading and emphasise drug consultancy.

Young pharmacists should make themselves relevant to the socio-economic welfare of any community in which they live. As I mentioned earlier, the future of Pharmacy and pharmacists is bright, but we must be committed to the course of Pharmacy.

 

Experts advocate collaboration among health care providers – As NAPA celebrates 30 years of pharmaceutical education

0

In a renewed bid to foster harmony and progress in the health care sector, experts have reiterated the need for cooperation and mutual understanding among the key players.

Speaking at the 1st Annual Scientific Symposium of the National Association of Pharmacists in Academia (NAPA) held at the Lagos University Teaching Hospital, Idi-Araba on 18 August, Prof. Olukemi Odukoya, dean, Faculty of Pharmacy, University of Lagos, Idi-Araba, explained that beyond serving as practice sites, health care systems and organisations are a conduit for expanding access to additional patient populations.

She stressed that to ensure effective collaboration among the various practitioners in the health industry, “the culture on both sides of partnerships must embrace individuals who dedicate their time to the pursuit of innovation.”

Focusing specifically on the relationship between pharmacists in academia and those in other sectors, Odukoya opined that since pharmacists are the most accessible health care personnel in Nigeria today, both parties should recognise where their motivations and visions lie and ensure they support each other in pursuit of the purpose of the partnership.

“Pharmacy has a rich history of advancing practice through innovation,” she said.”These innovations helped to mould Pharmacy into a patient-centred discipline recognised for its contributions to improving medication therapy outcomes. However innovations in Pharmacy have now waned. It is only the growth of academic-practice partnership that could reverse this trend and stimulate innovation among the next generation of pioneering clinical pharmacists.”

While congratulating NAPA on its 30th Pharmaceutical Education Anniversary at the University of Lagos, the dean stated that the number 30 symbolises an age when a person reaches physical and mental maturity and could therefore handle major responsibilities.

In another presentation, themed, “Collaborating with Doctors and Other Health Care Providers to Create Value,” Dr Jane Ajuluchukwu, a professor of medicine also in LUTH, hinted that studies have shown that collaboration between physicians and pharmacists can improve patients’ outcome.

While demonstrating the end result, Ajuluchukwu explained that the word “collaboration” signifies joint communication and decision-making process with a goal of satisfying the patients’ wellness and illness needs, while respecting the qualifications and abilities of each individual.

She further emphasised that this partnership should naturally bring up issues like alerting physicians to possible adverse drug reactions and discussing drug problems detected during dispensing.

The professor also noted that much as the pharmacist often turns out to be the instigator, the same cannot be said of the physician who may not see the relationship as beneficial.She was however quick to interject that younger physicians have more understanding of pharmacists’ expanding roles.

Buttressing the views of the two earlier speakers, Prof. FolaTayo, a retired professor of clinical pharmacy at the University of Lagos and pro-chancellor of Caleb University, statedthat creating value is a very appropriate topic for discussion at this critical stage in the history of our country’s health system.

“Let me congratulate the organisers of this programme for the vision. This is because, presently, our health system does not enjoy the fruits of collaboration,” he observed.

According to him, regardless of the fact that there are many constraints, ranging from inadequate funding by government to lack of passion and a display of arrogance by some practitioners, the greatest disservice healthcare providers can do to their clients is to render unacceptable service,

“What we as healthcare professionals often fail to appreciate is the fact that unto whom much is given, much is expected. Let us appreciate that it is time for change,” he emphasised.

 

Gains of godliness

2

Psalm 84:11 is an exciting and assuring verse of scripture. It says,For the Lord God is our light and protector. He gives us grace and glory. No good thing will the Lord withhold from those who do what is right.

Of course, this assurance only applies to those who do what is right in God’s sight. These are the righteous people. They are the people who love and obey His commandments. He says He will bless and honour them.

This promise is also supported by Job 36:11 which says, If they obey and serve Him, they shall spend their days in prosperity, and their years in pleasures;” as well as Psalm 34:9-10, which says O fear the Lord, ye his saints: for there is no want to them that fear him. The young lions do lack, and suffer hunger: but they that seek the Lord shall not want any good thing.

Certainly, the prosperity and pleasures of life are rewards for those who faithfully serve and obey God. In fact, God is always searching for such people to bless.

Looking at our present society, we may be tempted to say that there are many people who sincerely serve and obey God but seem to lack the good things of life. We wonder why there is virtually nothing to show that they are special people of God. The truth is that our assessment can sometimes be wrong. The person we assume to be righteous may not actually be so in God’s eyes. We are only able to see the outside of a person, while God looks at the heart.

This tendency to hinge our judgement on appearance is, apparently, a general limitation of all mortals. Even God’s anointed prophet, Samuel, made the same mistake of looking at the physical features of Eliab, when God directed him to go anoint one of Jesse’s sons as King Saul’s successor. Samuel was so impressed with Eliab’s broad shoulders and other physical attributes that he quickly concluded that he (Eliab) was the chosen one – until God expressed His disapproval over the decision.

God has said that our thoughts are not His thoughts and our ways are not His ways. This implies that we need to think like God to understand His ways. Now, this cannot be possible without divine help. Only God can transform us from within to enable us conform to His likeness. We also need to feed on His words and allow those words to dwell richly in us before we can think like Him.

We may also sometimes wonder why some people who live in brazen disobedience and opposition to God seem to be flourishing and enjoying the good things of life. Indeed, such decadent people abound everywhere. They are full of evil devices and are involved in all sorts of shady businesses. They are the ones who call the shots and influence the economy. The truth, however, is that while they may seem to be prospering in the eyes of men, God, whose words can never fail, has said in Psalm 37:1-4,Fret not thyself because of evildoers, neither be thou envious against the workers of iniquity. For they shall soon be cut down like the grass, and wither as the green herb. Trust in the Lord, and do good; so shalt thou dwell in the land, and verily thou shall be fed.

God is both warning and advising us against envying wicked people who will perish with their ill-gotten wealth. This will be understood better when one considers how some seemingly green and healthy herbs slowly wither and eventually die off. In such cases, neither watering nor providing manure for them can reverse the trend.

It is also instructive to note that God’s promise of not keeping any good thing from the righteous is equally conditional. Sometimes, our definition of a good thing may not exactly be God’s perception. We all know that Rolls Royce is a very good car. Some rich Nigerians have one or more of it. But supposing I ask God to give me one Rolls Royce car today because He has said will not deny me any good thing, I am sure He would want to know my motive for wanting it. Is my desire for this good thing really justified, or is it merely to let my friends to know that I have arrived?

God does not place great things in the hands of some people because they have the tendency to misuse and monopolise such privileges. Good things are given to people for noble purposes. The purpose for which God supplies good things is not for selfish indulgence but to enable us accomplish the mission He has for us.

How we use our God-given time, talents and treasures determines whether more will be given or even the ones given would be withdrawn. Above all, we are called to devote ourselves to activities that glorify God, in order to continually receive and enjoy the good things divinely provided for us.

 

Ban on movement of corpses over Ebola: How necessary?

0

The federal government recently announced that, as part of measures to check the spread of the deadly Ebola Virus Disease in the country, Nigerians should henceforth bury their dead relatives in the same locality of their death. The decision, according to the Minister of State for Health, Dr Khaliru Alhassan, was taken in the best interest of the citizens. The minister added that security agencies had been instructed not to allow people bring corpses into the country or even move corpses from one state to another, until the disease is contained in the country.

For this edition of VIEWPOINT, our reporter, Adebayo Oladejo sampled the opinions of Nigerians on the decision. Their responses are presented below.

 It is unnecessary

While I commend the Nigerian government, and especially the Lagos State Government, for their swift response in addressing the spread of Ebola and protecting the citizens, I think outright ban on movement of corpses is unnecessary, provided there is a death certificate stating the cause of death. That aside, the federal government should have also devised means of preventing the virus from entering the country.

Patience Sanni

Pharm. Patience Sanni

Ifo, Ogun State

 

Implementation should be limited to affected areas

The decision is a good one, but as we all know, it will really affect our African beliefs concerning burying our dead in foreign lands. So I’m of the opinion that the rule should be more rigid on corpses coming into the country from Ebola affectedareas. But for other unaffected areas, when a death certificate accompanies a corpse, the corpse should be allowed to move.

As at today, Ebola has been restricted to only two states, Lagos and Port Harcourt, and even in those two states, it has been well managed.So there is no cause for fear. It is also interesting to note that all the cases so far recorded are one way or the other linked to Patrick Sawyer, who brought the disease to the country, which also shows that the challenge has been well managed. So I see no reason why such action of banning movement of corpses around the country should be taken. I would rather suggest that the government makes it compulsory for the relatives of deceased persons to obtain the death certificate stating the cause of the death and that solves the problem.

Sanni Rueben

 

 

 

 

 

 

 Sanni Reuben O

Abuja

 

 It’s unAfrican

Considering the current situation, the move is a good one but it’s not the best alternative because the affluent and the powerful may not comply.Or do you think anyone will disturb a convoy conveying the remains of an ex-governor or an ex-president from one place to another? It may eventually not be a balanced policy because only the masses will be left to bear the brunt.

Aside from that, it would be a disadvantage to most of our people from the East, because there is this belief that it is sacrilegiousto bury certain people outside where they hail from.In fact, there is an adage that says, “The head of a king cannot be hanged outside his kingdom.”So the fact that the directive goes contrary to our cultural belief, as Africans, meansmany may not comply.

I think what the Ministry of Health should do in this regard is to ensure there is a proper way of verifying if a deceased person actually died of EVD or not.

Udinankaru Uchenna

 

 

 

 

 

 

Odinankaru Uchenna

Oshodi, Lagos

 

 It’s a good move by the FG

This is a welcome development and a good prevention strategy.We need to leave no stone unturned in ensuring that the ban is obeyed and respected.The man who brought the deadly virus into the country[Patrick Sawyer] contracted it from his dead sister.So the best way of preventing further spread is to bury a dead person where the person dies. In fact, to an extent, this would further reduce the rate at which people spend unnecessarily on burial ceremonies or movement of dead bodies; so the government is right on this.

However, this Ebola epidemic is another eye-opener to the age-long decadence in our health sector. It’s extremely sad to note that this significant sector of the Nigerian society has been so neglected to the extent that ordinary, but extremely important healthcare tools such as Personal Protective Equipment –gowns, googles, glovesetc–requiredfor this period are grossly inadequate and are just being ordered by most state governments at this time of medical emergency. One begins to wonder where all the budgetary allocations have ended up. So, as much as I am in support ofthe FG’s decision, I think there should be a general overhaul of our healthcare system, so that adequate staff and equipment can be provided.

Christiana Ojo

 

 

 

 

 

 

 

Ojo Christiana

Isolo, Lagos

 

 

 

 

FOLGONM seeks better recognition for grassroots nurses

0

The Forum for Local Government Nurses & Midwives (FOLGONM) has called on government at all levels to amend the existing policies which tend to belittle the positions of local government nurses and midwives.

The call was contained in the keynote address presented by the Head of Nursing Administration, Primary Health Care Board (Lagos), Mrs Oluwatoyin Odukoya, at a three-day annual conference and scientific workshop organised by FOLGONM.

Speaking on the topic, “The Optimum Style in Nursing Performance: Managing Patients’ Expectations in Primary Health Care Delivery Services”, Odukoya noted that the insensitivity of the government towards FOLGONM nurses had been a major challenge that must be corrected as a matter of urgency.

“Why do we always have to fight before emoluments given to nurses in other tiers are extended to us?” she queried. “The joke that our money lies in the mouth of the lion is unacceptable. If the three tiers of health services are not ours, there is no reason why we should be made to suffer for working at the grassroots.”

The leading nurse however enjoined participants at the conference to continue to demonstrate best nursing care in managing patients, not minding the several challenges besetting the profession.

She stated that nursing performance in Primary Health Care (PHC) delivery services can be measured in three ways, namely: competences, nursing-sensitive quality indicators, and measures of performance on specific task.

According to her, “competences are assessed right from when nurses are first licensed and thereafter, to ensure that nurses maintain their proficiencies and remain abreast of current issues.”

She added that, as a way of measuring quality, nurses and midwives have to account for all the dimensions of quality which are person-centeredness, safety, effectiveness, efficiency, equity, timeliness, women’s experience, clients’ experience, and satisfaction with care.

Explaining Primary Health Care, as defined by WHO and UNICEF in 1978, she said “Primary Health Care is essential health care, based on practical, scientifically sound, and socially acceptable methods and technology; universally accessible to all in the community through their full participation; at an affordable cost; and geared towards self-reliance and self-determination.”

Odukoya expatiated further on the functions of the PHCs, stating that the PHCs have shifted their emphasis on health care to the people and their needs, reinforcing and strengthening their own capacity to shape their lives. .

She also highlighted some challenges militating against optimal nursing performance such as intra-professional conflicts; inter-professional conflicts; professionally infected limitations; inferiority complexes; strike actions; in-fighting; unhealthy cadre/category supremacy; lack of trust; abuse of privileges; not wanting to take risks; divisive tendencies of mischief makers among others.

She however expressed optimism in limiting these factors, noting that they can easily be checked through continuous education from conferences, as well as Mandatory Continuous Professional Development Programme (MCPDP).

Speaking with Pharmanews at the event, the State Chairman of FOLGONM, Mrs. M. Lateef–Yusuf expressed her delight with the outcome of the group’s conferences, noting that they had always left positive impacts on nurses.

How I built a mega pharmacy with N600 drugs – Pharm Nwachukwu

3

In this exclusive interview with Pharmanews, Pharm. (Mrs) Edith Uchenna   Nwachukwu, founder and managing director of Audion Pharmacy Nigeria Limited, shares some of her experiences from the early days as a struggling community pharmacist to the present day as an established entrepreneur. She also discusses her contributions towards ensuring that the challenge of fake and counterfeit medicines is overcome and what others should do to effectively tackle the menace. Excerpts:

 How long have you been in the practice and how did it all begin?

I have been in the practice for about 30 years now because I graduated from the University of Nigeria, Nsukka, Enugu State in June 1984, and did my internship with the Federal Medical Centre (FMC), Umuahia, Abia State. I served in Kakuri General Hospital, Kaduna State. I came to Lagos after then and someone at the PSN got me a job to work with Galaxy Pharmaceuticals. What we were doing was mainly distribution, and that was how I came into the practice.

I had a driver and an office and we went to companies to distribute to them. We used to cover areas like Bariga, Mushin, Ikeja and Agege. By the way, Idumota was not really a big name then, so I worked with Galaxy for about four years and my salary then was 1000 naira – in fact, it was around 900 naira after deducting tax (laughs).

At a time, a relative of mine in the US asked me to help him sell some drugs in Nigeria and, in doing so, I think I made a profit of about 300 naira. So I started looking for a shop with the money, having discovered that I had the skills to be a good salesperson, and I eventually got one. Incidentally, my boss had been aware of all this[intention to go into community pharmacy] because, as a child of God, I could not hide such a thing from him. He stood by me through it all and even prayed with me inside the shop I rented.

After spending the entire 300 naira in getting the shop, there was no money left to stock it; so I had to go back to God for direction and He told me to go to people I was distributing to and ask them for assistance. And as God would have it, I met some of them, especially those in Bariga and Mushin. The likes of Sabiz, Omike and the rest were my people then; so one of them called Gabiz looked at me and said he was going to give me stocks on credit that I should pay him after selling in order to get more. So I got a stock of six hundred naira from him (laugh) and that was what I started with. In fact after buying the drugs, there was no money to transport the goods. He had to made another sacrifice by helping me to bring the goods in his own car to Mende in Maryland where I opened my first pharmacy. So, Audion Pharmacy Limited started in 1989, while it was incorporated in 1990, but with lots of hard work, coupled with the grace of God, this is where we are today.

 Based on your experience, how would you assess community pharmacy practice in Nigeria?

Pharmacy practice has come a long way because when I started, there were not many practising community pharmacy. There were people like Jaykay in the whole of Apapa and another one in Ikeja then. There was also Olusanya Pharmacy(though the man is late now) and Alpha Pharmacy who was just starting then. So I will say community practice has come a long way.

Many pharmacists in those days preferred to be in the industry because of the money and other benefits involved; but, to say the least, the practice has had its difficult time in the past, unlike nowadays that everybody wants to be in community practice. In those days, before setting up, you had to look for money to get a shop, register it, stock it and there was not much money in the country then and it was difficult getting a loan. So you have to struggle to raise the capital on your own.

 Tell us about some of your challenges and how you were able to surmount them

The first challenge in community pharmacy practice is that of human resource management and pilfering. It’s difficult getting a trustworthy and God-fearing staff nowadays as most of them are after money and when they discover that there is no way to steal, they leave. So, it is a big challenge for us, but God has been helping me.

Another major challenge has to do with transporting of goods from one place to another – unlike in the advanced world where you could source for your goods online and they could even be transported to your pharmacy.

However the main challenge is still that of staffing. Imagine when I came back from the last ACPN conference in Ilorin, four of my staff left on the same day without any prior notice and I was helpless to the extent that I had to be at the pharmacy throughout that period before I managed to get another set of staff.

 What is your view about the growing concern that newly graduating pharmacists are running away from community practice?

I have also noticed that in recent times. I think the young people of nowadays are after nothing than instant money and they are not ready to be patience about it. It’s like the inscription I read somewhere where somebody said, “God give me patience, but give it to me now.”

The challenge is impatience. Since they want to make money at all cost, they feel going into community practice may not satisfy their quest for making quick money. But community practice is not all about money-making; it’s about rendering service to humanity.

Another challenge is that of our pharmacy schools. The schools are no longer living up to expectations. Imagine a Pharmacy graduate that cannot face a patient. In fact, I take my time to correct some of them on many occasions here when I discover that the services they render are not up to expectation. But the saddest thing is that they have no patience to be trained.

 

Tell us about your relationship with the people of this community and the most common health conditions that bring them to your pharmacy.

I have been in this community in Ogba-Ijaiye since 1998, and I have never had a problem with any of the people. They love me and I also love them. In fact, I do to go to their homes to treat them while some of their old one soften come here sit and chat with me. Most times, they don’t leave until they discover that another set of people has arrived. In fact, there was a time May & Baker sponsored a free community typhoid vaccination programme here and they all came here to benefit from it.

Actually, the major people I deal with here are the elderly, those who get bored sitting alone and those who have nobody to talk to at home. And I take it as a duty to keep talking with them about their health and also pray with them.

The major health challenges that bring people to this place are hypertension and diabetes and the reason they come here is because they are assured of good pharmaceutical care and they feel they can talk to us. I am happy today that, at least, I’m a blessing to my community and, looking back, I am happy to be a pharmacist.

 

How active are you at ACPN-related activities?

I am very active at the level of the ACPN. At a time, I was made chairman, Pharmacists Day. Another time I was made a member of the planning committee for the national conference in Port Harcourt and Calabar. And, just recently, I was made chairman of the planning committee for the national conference in Ilorin.

I want others [community pharmacists] to know that if they are not there, there is no how they will know how it is being done. They should all get involved and add their quotas to the success of the profession.

 

How do you see the war on fake drugs and what strategy do you think can be adopted to effectively tackle the menace?

Pharmacy has come a long way and we are doing well, but it is unfortunate this war on fake drugs is proving difficult to be won because the people we are dealing with are people who want to make money by all means. But what baffles me is why we are finding it difficult to arrest those who are producing these substandard drugs. Are they not human beings and, so, can’t be arrested?

Imagine, these fake products come into the country on daily basis and pass through our borders and ports and yet we find it difficult to stop them despite the security measures in these places. What we need is total overhauling of our system. We also need to pray that God helps us.

Let me give you an example of what happen when I was at Maryland. A certain drug expired on my shelf and a boy came to my pharmacy to ask for the same drug. I told him it had expired, but he insisted that I should sell the drug to him at half price. I was amazed, but the Spirit of God told me he wanted to buy it and backdate it so he could resell it. So I went into my office, brought out a bucket of water and the products and started opening the products and pouring them into the water. That shows how bad it is in this country. I think until we all have change of mind and have the fear of God…We pharmacists should also maintain our stand and say no to stocking and selling of fake drugs.

Also, those who are non-pharmacists should also have the fear of God and accept Jesus as their Saviour (I love bringing gospel teaching into whatever I say).They should know that it is not safe to throw stones when they are in a glass house, because they can’t say who might be hit.

 What is your advice to young pharmacists who are willing to come into the practice?

They should understand that ‘Rome was not built in a day.’ They should be patient and ready to learn. I told you I started with 600 naira and God, in His infinite mercies, has taken us this far and I am very sure He will do much more. So they should be calm and ready to learn. Even the Bible talks about learning; so they should be ready to learn and apply what they have learnt.

Also, they should be prudent in their spending – not that they will be thinking about cars today, house tomorrow and all that. I am worried that with the way we are going in this profession, in the next few years, there may no serious-minded pharmacists again in this country if we don’t check what these young ones are doing. They must set goals for themselves and ensure they follow such goals.

Our priority is saving lives – ALPs chairperson

0

In this exclusive interview with ADEBAYO OLADEJO, Pharm. Susan Olusola Ayetoro, chairperson of Association of Lady Pharmacists (ALPs) in Kwara State, discusses the activities of lady pharmacists in the state, while also calling for stiffer penalties for drug counterfeiters in the country. Excerpts:

Tell us a bit about yourself, including your academic background

I am Pharm (Mrs) Susan Olusola Ayetoro. I am a Merit Award Winner of the Pharmaceutical Society of Nigeria, Kwara State Branch, and Fellow of the West African Postgraduate College of Pharmacists (FPCpharm).I am from Osun State. I got married to an Ondo State man. I had both my primary and secondary education in Ogbomoso and Ibadan (both in Oyo State), respectively. After that, I proceeded to the University of Ife (now Obafemi Awolowo University) Ile-Ife, Osun State, to study Pharmacy.

I had my B.Pharm (Hons) in 1986, after which I did my internship (pupil pharmacist) at Trex Chemists, Ibadan, and my NYSC programme at Children Specialist Hospital, Ministry of Health, Ilorin, Kwara State.

 Since your election as ALPs chairperson in Kwara State, what changes have you brought to the association?

First, I will like to acknowledge the full support of the executives and members of the Pharmaceutical Society of Nigeria (PSN), Kwara State, for their consistent encouragement and backing. ALPs Kwara, as an interest group, has been doing its best to support PSN in all the state programmes and national conferences. There is enthusiasm and commitment of members to all ALPs programmes at the national and state levels. We are doing our best to assist the First Lady of Kwara State in her project, LEAH Charity Foundation and we go along with her anytime there is a campaign, the current one being the Cancer Awareness Programme for women in the state.

ALPs Kwara is a registered women’s group in the Ministry of Women Affairs and it also collaborates with other women professionals in the state. Most of our outreaches are usually covered by state electronic media and widely read in the local and national newspapers.

 Presently, what are the major challenges facing lady pharmacists in your state?

The major challenge we are facing as ALPs in the state is funding. Most of our activities are funded by members, as God grants us the grace to do them, and we get the full support of our men in PSN Kwara State. This notwithstanding, we are moving forward and not discouraged.

 In terms of membership participation, have you been getting the needed cooperation?

Membership participation is wonderful because they are always ready to come for programs and outreaches, no matter their age or status in their places of work. Our programmes are very interesting and our members are eager to make an impact in the lives of people positively. In view of this, we embark on so many programmes, such as school children deworming exercises, career talks for secondary school students, education of teenagers and youths on the implication of drug misuse and abuse, lectures on HIV/AIDS and donation of first aid boxes to secondary schools, just to mention a few.

We also collaborate with the Federation of Sickle Cell Clubs in the state, holding meetings with them and routinely donating drugs and Insecticide-treated mosquito nets. We also visit and make donations of drugs, food items and clothing to the children reception centre of the Ministry of Social Welfare, children with special needs and prison inmates.

 What would you say about the campaign against fake drugs in the country?

It is disheartening that most of the medicines counterfeited are those used for the treatment of life-threatening conditions and have high public health impact. These include antimalarial drugs, antibiotics, antihypertensive and antiretroviral drugs. Selling or distributing fake drugs is a health-related crime, which poses a great threat to public health and the economy of the nation; therefore, pharmacists should be involved in the campaign against it.

In Kwara State, the Pharmaceutical Inspection Committee of the PSN has been collaborating with the government’s taskforce on fake and counterfeit drugs. They do regular inspection of premises and refer serious cases to NAFDAC for necessary action. NAFDAC also does routine post-marketing surveillance and mops up substandard/fake or counterfeit medicines displayed.

However, innovation and the use of cutting-edge technology, in combination with regulatory measures, have improved detection of fake drugs. Such innovations include the Mobile Authentication Service (MAS), which is free, easy, simple, available anywhere there is a mobile network and places the power to detect counterfeit products in the hands of the consumers.

Additionally, public enlightenment, through the print and electronic media, has been sustained in the campaign against fake drugs. Pharmacovigilance has been helpful also.

 Many people have canvassed for stiffer penalties for drug counterfeiters. What’s your take on this?

It is a crime against humanity for anyone to knowingly procure and distribute fake or counterfeit drugs that can be detrimental to people’s health in the quest for profit making. In fact, the consequences of fake drugs also include loss of money on the part of the consumers because whatever money invested in buying fake drugs is a loss. Many pharmaceutical companies are also deprived of their profits, due to the unjust competition from counterfeiters, which may result in the collapse of some of the companies. In view of these, stiffer penalties should truly be meted out to drug counterfeiters.

 What are those things you hope to achieve before the end of your tenure as ALPs chairperson?

By the grace of God, some of the important projects I hope to embark on before the end of my tenure as chairperson include: Mass enlightenment on the pharmacy profession among secondary school students in Kwara State. The programme aims at educating the students more on what the pharmacy profession represents and its importance.

I also hope to increase membership participation in all our meetings and programmes.

 What is your advice to young pharmacists who are willing to come into the practice?

The young ones out there should know that our top priority in pharmacy profession is not money making, but saving lives. We, pharmacists, are men of honour and we tread that path always. So the thinking of adding value to people’s lives should be the most paramount in their minds. We also need to take the issue of fake drugs seriously. All hands must be on deck to tackle and curtail this menace of fake drugs in our society, at all cost.

Leadership of health care systems: Understanding health insurance

0

An Overview of Health Financing by Dr. ChidiUkandu

(By Dr Chidi Ukandu)

Leadership and management of health care systems are increasingly receiving attention from countries and international organisations. In 2007, while acknowledging that the achievement of the Millennium Development Goals would generally require additional international resources, the Secretary General of the United Nations stressed that leadership and management were key to using these resources effectively to achieve measurable results.

Good leaders set the strategic vision and mobilise efforts towards its realisation; good managers ensure effective organisation and utilisation of resources to achieve results and meet aims. However, the challenge for many countries (both developed and developing) is how to provide this much needed leadership and management within resource constraints and peculiar country contexts.

In 2003, Kane and Turnbull proposed a framework for managing health systems which argued that most health systems were managed care entities and, thus, could be successfully managed by employing managed care tools such as:

  • Managing cost (managing insurance risk, provider and supplier prices and utilisation of services)
  • Managing care (developing and managing community-wide practice guidelines, care pathways, case management processes, and disease management across the continuum of care)
  • Managing health (development and management of population-based interventions and pooling/shifting resources among health and other sectors).

They, however, emphasised that the success of these tools depend on some features of a country’s health system which include:

  1. Level of system funding
  2. Structure of provider market
  3. Proportion of population covered by health insurance
  4. Information and communication system infrastructure
  5. Consumer expectations
  6. Socio-political values

While all of the managed care tools may not apply in all the systems in the overall health system of a country like Nigeria, they do provide a useful basis for analysing the leadership and management of health systems generally.

Overview of health insurance

Health insurance is insurance against the risk of incurring medical expenses among individuals. According to the Health Insurance Association of America, health insurance is defined as “coverage that provides for the payments of benefits as a result of sickness or injury. It includes insurance for losses from accident, medical expense, disability, or accidental death and dismemberment”

By estimating the overall risk of health care and health system expenses, among a targeted group, an insurer can develop a routine finance structure, such as a monthly premium or payroll tax, to ensure that money is available to pay for the health care benefits specified in the insurance agreement.

In Nigeria, subscribers to health insurance mostly pay a premium, whereas in the UK and in many other European countries, funding is from payroll tax.The benefit is administered by a central organisation such as a government agency, private business, or not-for-profit entity.

NHIS Pie Chart

 Types of health insurance

1)  Social Health Insurance

2)  Community-Based Health Insurance

3)  Private Health Insurance

Social Health Insurance (SHI)

SHI is a method of health financing where contributions for health services are collected from workers, self-employed people, enterprises and the government. Collections through SHI are often mandatory and backed by a legal act.

Contributions under SHI are usually based on the average expected cost of health service use by the entire insured group and not by that of an individual or sub-group; in other words, it is community rated. Here, the nation decides on what to collect based on what it would need to provide care for her citizens. The NHS in the United Kingdom is a good example.

Studies indicate that about 60 countries all over the world are using SHI as the predominant method for raising money for health services.27 countries have achieved universal coverage for their populations through this method.

In recent times, multilateral and bilateral organisations, such as the WHO, World Bank, and the German Agency for Technical Cooperation, have been promoting social health insurance as an alternative way to mobilise additional funds for the health system especially in developing countries. They suggest that SHI is a suitable alternative when low-income countries do not have adequate tax revenues to fund health care of reasonable quality for everybody.

Here, the target is to utilise public funds to subsidise premiums for health services,thereby shifting public subsidies from supply side to the demand side to improve efficiency and quality of health services. In fact, the World Health Assembly adopted a resolution recommending SHI as an effective strategy for financing health systems. In SHI, the premiums of the poorest can be cross subsidised by government or the local community.

The problem of adverse selection – where low risk people drop out – can be countered by trying to make insurance cover universal. However, some of the other problems of private insurance, notably moral hazard (explained below), will remain.

 Community-Based Health Insurance (CBHI)

CBHI is a non-profit health insurance programme for a cohesive group of households/individuals or occupation-based groups, formed on the basis of the ethics of mutual aid and collective pooling of health risks, in which members take part in its management

CBHI has, in recent times, been advocated as a complementary method for mobilising funds for the health system especially in low-income countries. However, evaluations by the World Bank, the International Labour Organisation and others conclude that in low-income settings, CBHI schemes make only modest contributions to overall coverage and only as a complement to other formal schemes.

Studies indicate that coverage with CBHI rarely exceeds 10 per cent of the population because voluntary contributions of poor people are usually insufficient to make it viable.

Some experts, however, argue that in situations where government taxation is weak, formal mechanisms for social protection for vulnerable populations absent, and government oversight of the informal sector lacking, community health financing provides the first step towards improved financial protection against the cost of illness and improved access to priority health services.

 

Private Health Insurance

This is health Insurance cover provided to individuals or groups based on an assessment of the risks they carry.It differs from social health insurance because it is usually voluntary, can be very expensive and is usually not equitable. Private health care insurance confronts various problems, notably moral hazard and adverse selection.

Moral hazard is a change in behaviour towards an insurable event as a consequence of being insured. Here, the insured could become more careless or visit the clinic more often because he has been insured.

Adverse selection, on the other hand, occurs when a potential subscriber decides he is healthy enough, hence, needs not pay the amount of premium the insurer believes he should pay. Both scenarios would result in market failure.

 Overview of health financing in Nigeria

Health care sector funding in Nigeria is primarily sourced from government (federal, stateand local) revenues, private sources (households and firms), and donoragencies.

Between 1998 and 2002, total health expenditure in Nigeria was US$2121 million. This corresponds to a Total Health Expenditure (THE) per capita of US$17 and 4.9 per cent of GDP. Disaggregation of this data indicates that government sources accounted for 20.6 per cent of THE, with the federal government, state governments and local governments expending 12.4 per cent, 6.2 per cent, and 2 per cent respectively.

 Private sources accounted for an average of 69.1 per cent of THE; with households accounting for 64.2 per cent; firms,

4.9 per cent, and donor agencies, 10.3 per cent.

Comparatively, the total government expenditure on health as proportion of GDP is lower than that of some poorer African countries such as Rwanda, Kenya, Zambia (6.2 per cent), Tanzania and Malawi. Without considering the efficiency of fund deployment, the average THE per capita of US$ 17 is far lower than the $34 per capita that is estimated to be the cost for providing a minimum package of health intervention by the WHO commission on macroeconomics and health. This suggests that the Nigeria health sector is underfunded.

The National Health Insurance Scheme (NHIS)

The Nigerian NHIS was established in 1999 by Act 35 of the Federal Republic of Nigeria with the overall goal of enhancing access to quality and affordable health care to all Nigerian citizens. It became operational in 2005 and targets universal coverage of all Nigerians by 2015. The Scheme comprises schemes that cover formal sector workers, the urban self-employed, families and individuals in rural areas; children under five years of age, disabled persons and prison inmates.

 Formal sector programme

The formal sector programme is expected to be mandatory for firms employing ten or more workers and covers workers of the federal, state and local governments; organised private sector; and military personnel.

Employees are required to contribute 5 per cent of their basic salary, which is matched by 10 per cent by the employer. Membership covers the contributor, spouse and a maximum of four biological dependants. The benefit package for the scheme is enshrined in the NHIS Act and covers basic out and in-patient care, including maternity care and basic surgery.

Basic eye and dental care are covered while expensive and complex medical and surgical care is excluded. Cover for HIV/AIDS is limited to treatment for opportunistic infections.Contributors may enjoy more benefits on payment of an additional premium.

 

  • Service provision

Services are provided through a network of registered private and public health providers.Providers are paid fixed monthly capitations for primary care services, fee-for-service for secondary care and per diem for in-patient care. Beneficiaries are expected to choose one health care provider who provides primary care services and coordinates health care across the secondary and tertiary levels

 

  • Administration

Administration of the NHIS is effected through the National Health Insurance Scheme, Health Maintenance Organisations (HMO) and Health Care Providers (HCP).

NHIS is the regulator for the Scheme (private sector programme) and is responsible for registering HMOs and HCPs; issuing appropriate guidelines for the scheme; approving format of contracts proposed by the health maintenance organisations for all health care providers; determining, after negotiation, capitation and other payments due to HCPs, by the HMOs.

 HMOs and HCPs

The HMOs are private or public limited liability companies established solely for the Scheme. They are responsible for the collection of contributions from eligible employers and voluntary contributors; payment of HCPs; and establishing quality assurance systems for the HCPs. The relationship between HMOs, the scheme and HCPs is formalised through contracts. Each HMO is expected to market itself to registered subscribers in competition with other HMOs.

HCPS are public and private providers of health care services and include primary, secondary and tertiary care providers, pharmacies, laboratories and diagnostic centres.

Primary Care Providers (PCPs) serve as gatekeepers to the scheme and coordinate access to the secondary and tertiary levels of care on behalf of the beneficiary.

PCPs are paid a fixed capitation fee per beneficiary per month for primary care services. Secondary and tertiary care providers are paid on a fee-for-services basis based on NHIS approved tariffs for drugs, diagnostic investigations and specific procedures. In-patient stay is covered under the capitation up to a maximum of 15 cumulative days in a year and thereafter the beneficiary pays.

 Progress so far

The Scheme commenced on 6 June, 2005 and services started in September 2005. 77 HMOs, 5949 HCPs, 24 banks, 5 insurance companies and 3 insurance brokers have been registered.

Four schemes have been launched, namely – Formal Sector Social Health Insurance Programme; Tertiary Institutions Social Health Insurance Programme; Community-Based Social Health Insurance Programme; and the Voluntary Contributors Social Health Insurance Programme.

About five million persons are reported to have been registered in the Scheme representing just about three per cent of the population.

 Opportunities

Nigeria has a large population of over 160 million people with a growing economy at over 6per cent GDP and a relatively stable democracy. There is a strong political will especially at the federal level and a very huge out-of-pocket expenditure. These present a good environment for health facility growth and expansion for managed care provision.

 Challenges

Nigeria has a very large informal sector – over 70per cent of the population; hence these are not covered in the formal sector scheme which accounts for the majority of subscribers.

Poverty also poses a serious challenge as over 60per centof Nigerians live on less than one dollar/day; though the relatively large out-of-pocket expenditure by individuals would also have contributed to these poverty rates.

There is a relatively low awareness of the operations of the Scheme even among care givers, coupled with a perceived poor quality of care.

The prevailing weak provider network has also posed limitations on access to care.

More importantly, the voluntary nature of the Scheme has limited access to a larger resource pool which could lead to increased efficiency. Also, weak support from state governments has not been helpful.

 Way forward

The Scheme should be made mandatory and awareness increased. Provider networks should be strengthened especially at the primary care level. Also health should be placed on the executive list and alternatives sources of funding found for the Scheme, e.g. Sin tax, Sales tax etc. This is needed considering the high level of poverty.

 References

  • Ashley, Allan and Jayen B. Patel: The Impact of Leadership Characteristics on Corporate Performance. International Journal of Value-Based Management 16:211-222, 2003.
  • Tubbs, Stewart L., and Eric Schultz: “Leadership Competencies: Can They Be Learned? The Business Review, Cambridge. 3(2)7-12, Summer 2005.
  • Kane, N.M. and TurnBull, N.C. (2003). Managing Health: An International Perspective. U.S.A: Jossey-Bass

 

 

Taming malaria in Nigeria

4080

Malaria has been a major threat in Africa, ravaging most of its population. According to recent figures from the World Health Organisation (WHO), about 3.4 billion people – half of the world’s population – are at risk of malaria. In 2012, there were about 207 million malaria cases (with an uncertainty range of 135 million to 287 million) and an estimated 627,000 malaria deaths (with an uncertainty range of 473,000 to 789,000). While increased prevention and control measures have led to a reduction in malaria mortality rates by 42 per cent globally, since 2000, and by 49 per cent in the WHO African Region.

Worried by the surge in malaria cases in Nigeria, the Federal Ministry of Health had launched various programmes, including the Roll Back Malaria campaign and other programmes aimed at controlling the disease in the country.

While deaths from malaria in Nigeria, as at 2010, were the highest recorded worldwide, the National Malaria Control Strategic Plan shifted the set date for the achievement of its redefined goals to 2013. One of the goals was that by the end of 2013, at least 80 per cent of patients attending any health facility would get appropriate testing and treatment for malaria, according to national guidelines.

Though the population of Nigerians who eventually received the planned treatment for malaria was not up to the projected percentage, many infected individuals actually got some treatment. However the war against is far from being won.

Malaria Consortium Ad 2010 Child Health

Facts about the disease

Malaria is a potentially fatal mosquito-borne parasitic disease that kills an estimated 655,000 people, mostly children, worldwide each year. It is transmitted through the bites of infectious female Anopheles mosquitoes. Only female mosquitoes bite, and when feeding, they can pick up malaria parasites from an infected person. After a development cycle in the mosquito lasting from seven to ten days, the mosquito becomes infectious and transfers malaria into the next human host, when feeding.

Malaria is probably the only infection that can be treated in just three days but still kills millions every year. Without prompt and appropriate treatment, malaria may become a medical emergency by rapidly progressing to complications and death. Malaria can also aggravate certain pre-existing illnesses and may even prove fatal for patients with end stage organ disease.

Malaria causes periodic fever, anaemia, and low birth weight. It can be particularly fatal in children under five years of age and pregnant women. Nigeria has the world’s largest malaria burden, containing nearly one-third of the cases in Africa. Nearly all Nigerians (97 per cent) are at risk of contracting the disease and half of the population will have at least one malaria attack per year. Malaria is also the leading cause of clinic attendance and absenteeism in Nigeria.

Malaria is caused by protozoan parasites called Plasmodia, belonging to the parasitic phylum Apicomplexa. More than 200 species of the genus Plasmodium (=plasma + eidos, form) have been identified that are parasitic to reptiles, birds and mammals. Four Plasmodium species have been well known to cause human malaria, namely, P. falciparum, P. vivax, P. ovale, and P. malariae. A fifth one, P. knowlesi, has been recently documented to cause human infections in many countries of Southeast Asia. Very rare cases of malaria have been reported due to other species such as Plasmodium brasilianum, Plasmodium cynomolgi, Plasmodium cynomolgi bastianellii, Plasmodium inui, Plasmodium rhodiani, Plasmodium schwetzi, Plasmodium semiovale, Plasmodium simium and Plasmodium eylesi. All malaria parasites infecting humans probably jumped from the great apes (in case of P. knowlesi, macaques) to man.

It is very important to remember that malaria is not a simple disease of fever, chills and rigors. In fact, in a malarious area, it can present with such varied and dramatic manifestations that malaria may have to be considered as a differential diagnosis for almost all the clinical problems! Malaria is a great imitator and trickster, particularly in areas where it is endemic.

All the clinical features of malaria are caused by the erythrocytic schizogony in the blood. The growing parasite progressively consumes and degrades intracellular proteins, principally haemoglobin, resulting in formation of the ‘malarial pigment’ and haemolysis of the infected red cell. This also alters the transport properties of the red cell membrane, and the red cell becomes more spherical and less deformable. The rupture of red blood cells by merozoites releases certain factors and toxins (such as red cell membrane lipid, glycosyl phosphatidyl inositol anchor of a parasite membrane protein), which could directly induce the release of cytokines such as TNF and interleukin-1 from macrophages, resulting in chills and high grade fever. This occurs once in 48 hours, corresponding to the erythrocytic cycle.

In the initial stages of the illness, this classical pattern may not be seen because there could be multiple groups (broods) of the parasite developing at different times, and as the disease progresses, these broods synchronise and the classical pattern of alternate day fever is established.

It has been observed that in primary attack of malaria, the symptoms may appear with lesser degree of parasitemia or even with submicroscopic parasitemia. However, in subsequent attacks and relapses, a much higher degree of parasitemia is needed for onset of symptoms. Further, there may be great individual variations with regard to the degree of parasitemia required to induce the symptoms.

Stages and symptoms of malaria development

The first symptoms of malaria after the pre-patent period (period between inoculation and symptoms, the time when the sporozoites undergo schizogony in the liver) are called the primary attack. It is usually atypical and may resemble any febrile illness. As the disease gets established, the patient starts getting relapse of symptoms at regular intervals of 48-72 hours.

The primary attack may spontaneously abort in some patients and the patient may suffer from relapses of the clinical illness periodically after eight to ten days, owing to the persisting blood forms of the parasite. These are called short term relapses (recrudescences). Some patients will get long term relapses after a gap of 20-60 days or more and these are due to the reactivation of the hypnozoites in the liver in case of vivax and ovale malaria. In falciparum and malariae infections, recrudescences can occur, due to persistent infection in the blood.

While most of the clinical manifestations of malaria are caused by the malarial infection per se, high grade fever, as well as the side effects of anti malarial therapy, can also contribute to the clinical manifestations. All these may act in unison, further confusing the picture. In some cases, secondary infections like pneumonia or urinary tract infection can add to the woes. All these facts should always be kept in mind.

Typical features of malaria

The characteristic, textbook picture of malarial illness is not commonly seen. It includes three stages, namely: the cold stage, the hot stage and the sweating stage. The febrile episode starts with shaking chills, usually at mid-day between 11am to 12 noon, and this lasts from 15 minutes to one hour (the cold stage), followed by high grade fever, even reaching above 1060 F, which lasts two to six hours (the hot stage). This is followed by profuse sweating and the fever gradually subsides over two to four hours.

These typical features are seen after the infection gets established for about a week. The febrile paroxysms are usually accompanied by headaches, vomiting, delirium, anxiety and restlessness. These are, as a rule, transient and disappear with normalisation of the temperature.

In vivax malaria, this typical pattern of fever recurs once every 48 hours and this is called benign tertian malaria. Similar pattern may be seen in ovale malaria too (ovale tertian malaria). In falciparum infection (malignant tertian malaria), this pattern may not be seen often and the paroxysms tend to be more frequent (sub-tertian). In P. malariae infection, the relapses occur once every 72 hours and it is called quartan malaria.

Diagnosis of malaria

Diagnosis of malaria involves identification of malaria parasite or its antigens/products in the blood of the patient. Although this seems simple, the efficacy of the diagnosis is subject to many factors. The different forms of the four malaria species; the different stages of erythrocytic schizogony; the endemicity of different species; the population movements; the inter-relation between the levels of transmission, immunity, parasitemia, and the symptoms; the problems of recurrent malaria, drug resistance, persisting viable or non-viable parasitemia, and sequestration of the parasites in the deeper tissues; and the use of chemoprophylaxis or even presumptive treatment on the basis of clinical diagnosis can all have a bearing on the identification and interpretation of malaria parasitemia on a diagnostic test.

The diagnosis of malaria is confirmed by blood tests and can be divided into microscopic and non-microscopic tests.

  •  Microscopic tests

These include:

  1. Peripheral smear study
  2. Quantitative Buffy Coat (QBC) test
  •  Peripheral smear study

Light microscopy of thick and thin stained blood smears remains the standard method for diagnosing malaria. It involves collection of a blood smear, its staining with Romanowsky stains and examination of the Red Blood Cells for intracellular malarial parasites. Thick smears are 20–40 times more sensitive than thin smears for screening of Plasmodium parasites, with a detection limit of 10–50 trophozoites/ìl. Thin smears allow one to identify malaria species (including the diagnosis of mixed infections), quantify parasitemia, and assess for the presence of schizonts, gametocytes, and malarial pigment in neutrophils and monocytes. The diagnostic accuracy relies on the quality of the blood smear and experience of laboratory personnel.

Before reporting a negative result, at least 200 oil immersion visual fields at a magnification of 1000× should be examined on both thick and thin smears, which have a sensitivity of 90 per cent. The level of parasitemia may be expressed either as a percentage of parasitised erythrocytes or as the number of parasites per microlitre of blood.

In nonfalciparum malaria, parasitemia rarely exceeds two per cent, whereas it can be considerably higher (>50 per cent) in falciparum malaria. In nonimmune individuals, hyperparasitemia (>5 per cent parasitemia or >250,000 parasites/ìl) is generally associated with severe disease.

In falciparum malaria, parasitised erythrocytes may be sequestered in tissue capillaries resulting in a falsely low parasite count in the peripheral blood (‘visible’ parasitemia). In such instances, the developmental stages of the parasite seen on blood smear may help to assess disease severity better than parasite count alone. The presence of more mature parasite forms (>20 per cent of parasites as late trophozoites and schizonts) and of more than 5 per cent of neutrophils containing malarial pigment indicates more advanced disease and a worse prognosis. One negative blood smear makes the diagnosis of malaria very unlikely (especially the severe form); however, smears should be repeated every six to 12 hours for 48 hours if malaria is still suspected.

The smear can be prepared from blood collected by venipuncture, finger prick and ear lobe stab. In obstetric practice, cord blood and placental impression smears can be used. In fatal cases, post-mortem smears of cerebral grey matter obtained by needle necropsy through the foramen magnum, superior orbital fissure, ethmoid sinus via the nose or through fontanelle in young children can be used.

Sometimes no parasites can be found in peripheral blood smears from patients with malaria, even in severe infections. This may be explained by partial antimalarial treatment or by sequestration of parasitised cells in deep vascular beds. In these cases, parasites, or malarial pigment may be found in the bone marrow aspirates. Presence of malarial pigment in circulating neutrophils and monocytes may also suggest the possibility of malaria.

 

  • Non-microscopic tests

Several attempts have been made to take the malaria diagnosis out of the realm of the microscope and the microscopist. Important advances have been made in diagnostic testing, including fluorescence microscopy of parasite nuclei stained with acridine orange, rapid dipstick immunoassay, and Polymerase Chain Reaction assays.

These tests involve identification of the parasitic antigen or the antiplasmodial antibodies or the parasitic metabolic products. Nucleic acid probes and immunofluorescence for the detection of Plasmodia within the erythrocytes; gel diffusion, counter-immunoelectrophoresis, radio immunoassay, and enzyme immunoassay for malaria antigens in the body fluids; and hemagglutination test, indirect immunofluorescence, enzyme immunoassay, immunochromatography, and Western blotting for anti-plasmodial antibodies in the serum have all been developed. These tests have found some limited applications in research, retrograde confirmation of malaria, investigation of cryptic malaria, transfusion blood screening, and investigation of transfusion acquired infections.

Rapid Diagnostic Tests (RDTs) detect species-specific circulating parasite antigens targeting either the histidine-rich protein-2 of P. falciparum or a parasite-specific lactate dehydrogenase. Although the dipstick tests may enhance diagnostic speed, microscopic examination remains mandatory in patients with suspected malaria, because occasionally these dipstick tests are negative in patients with high parasitemia, and their sensitivity below 100 parasites/ìl is low. Tests based on polymerase chain reaction for species-specific Plasmodium genome are more sensitive and specific than are other tests, detecting as few as 10 parasites/ìl blood. Antibody detection has no value in the diagnosis of acute malaria. It is mainly used for epidemiologic studies.

Therefore, the simplest and surest test is the time-honoured peripheral smear study for malarial parasites. None of the other newer tests have surpassed the ‘gold standard’ peripheral smear study.

 Malaria prevention

Mosquito control is an important component of malaria control strategy, although elimination of malaria in an area does not require the elimination of all Anopheles mosquitoes. In North America and Europe for example, although the vector Anopheles mosquitoes are still present, the parasite has been eliminated. Socio-economic improvements (e.g., houses with screened windows, air conditioning) combined with vector reduction efforts and effective treatments have led to the elimination of malaria without the complete elimination of the vectors.

On the other hand, controlling these highly adapted, flying and hiding vectors is indeed a formidable task. Development of resistance to insecticides has compounded the problem. Ban on non-biodegradable and non-eco-friendly insecticides like DDT also may have contributed to the resurgence of malaria.

 Mosquito control measures

The following are the steps in mosquito control:

  • Discourage egg laying
  • Prevent development of eggs into larvae and adults
  • Kill the adult mosquitoes
  • Do not allow adult mosquitoes into places of human dwelling
  • Prevent mosquitoes from biting human beings and deny blood meal

 Treatment of Malaria

     The effectiveness of early diagnosis and prompt treatment, as the principal technical components of the global strategy to control malaria, is highly dependent on the efficacy, safety, availability, affordability and acceptability of antimalarial drugs. The effective antimalarial therapy not only reduces the mortality and morbidity of malaria, but also reduces the risk of resistance to antimalarial drugs. Therefore, antimalaria chemotherapy is the KEYSTONE of malaria control efforts.

On the other hand, not many new drugs have been developed to tackle malaria. Of the 1223 new drugs registered between 1975 and 1996, only three were antimalarials! Hence the need for a national antimalaria treatment policy.

Antimalarial drugs can be classified according to antimalarial activity and structure.

 Classification according to antimalarial activity

  1. Tissue schizonticides for causal prophylaxis: These drugs act on the primary tissue forms of the plasmodia which, after growth within the liver, initiate the erythrocytic stage. By blocking this stage, further development of the infection can be theoretically prevented. Pyrimethamine and Primaquine have this activity. However since it is impossible to predict the infection before clinical symptoms begin, this mode of therapy is more theoretical than practical.
  2. Tissue schizonticides for preventing relapse: These drugs act on the hypnozoites of P. vivax and P. ovale in the liver that cause relapse of symptoms on reactivation. Primaquine is the prototype drug; pyrimethamine also has such activity.
  3. Blood schizonticides: These drugs act on the blood forms of the parasite and thereby terminate clinical attacks of malaria. These are the most important drugs in anti malarial chemotherapy. These include chloroquine, quinine, mefloquine, halofantrine, pyrimethamine, sulfadoxine, sulfones, tetracyclines etc.
  4. Gametocytocides: These drugs destroy the sexual forms of the parasite in the blood and thereby prevent transmission of the infection to the mosquito. Chloroquine and quinine have gametocytocidal activity against P. vivax and P. malariae, but not against P. falciparum. Primaquine has gametocytocidal activity against all plasmodia, including P. falciparum.
  5. Sporontocides: These drugs prevent the development of oocysts in the mosquito and thus ablate the transmission. Primaquine and chloroguanide have this action.

Essentially, therefore, treatment of malaria would include a blood schizonticide, a gametocytocide and a tissue schizonticide (in case of P. vivax and P. ovale). A combination of chloroquine and primaquine is thus needed in all cases of malaria.

 

Classification according to the structure

  • Aryl amino alcohols: Quinine, quinidine (cinchona alkaloids), mefloquine, halofantrine.
  • 4-aminoquinolines: Chloroquine, amodiaquine.
  • Folate synthesis inhibitors: Type 1 – competitive inhibitors of dihydropteroate synthase – sulphones, sulphonamides; Type 2 – inhibit dihydrofolate reductase – biguanides like proguanil and chloroproguanil; diaminopyrimidine like pyrimethamine
  • 8-aminoquinolines: Primaquine, WR238, 605
  • Antimicrobials: Tetracycline, doxycycline, clindamycin, azithromycin, fluoroquinolones
  • Peroxides: Artemisinin (Qinghaosu) derivatives and analogues – artemether, arteether, artesunate, artelinic acid
  • Naphthoquinones: Atovaquone
  • Iron chelating agents: Desferrioxamine

 

Report compiled by Temitope Obayendo with additional information from: World Health Organisation, Africa; Malaria site; Annals of African Medicine and The Nigeria Voice

 

 

 

MDCN canvasses resettlement of Igbinedion varsity health students

6

The Medical and Dental Council of Nigeria (MDCN) has called for the transfer of students of the Oba Okunade Sijuade College of Health Sciences, Igbinedion University, Okada, Edo State, to other schools.

This follows the suspension of academic activities and the subsequent ban on admission of fresh students in the college.

In a press release issued at the end of its 3rd plenary meeting, held at the council house in Kaura District, Abuja, recently, Dr Abdulmumini Ibrahim, registrar of the council, disclosed that the MDCN had directed the institution to transfer all the existing students to other accredited medical schools.

“The decision is to help the students complete their programmes as they will no longer be allowed to participate in the council’s assessment examination. This resolution supersedes the MDCN’s advertisement on the list of medical schools recently published in the dailies,” he said.

According to him, the suspension placed on Oba Okunade Sijuade College of Health Sciences will last until all the identified inadequacies are corrected and the college is ready to resume the training of medical students.

L-R: Dr Abdulmumini Ibrahim, registrar MDCN; Professor J. C. Azubuike of Medical and Dental Council of Nigeria (MDCN) and Professor Eugene Okpere of Nigeria Universities Commission (NUC), during a recent event
L-R: Dr Abdulmumini Ibrahim, registrar MDCN; Professor J. C. Azubuike of Medical and Dental Council of Nigeria (MDCN) and Professor Eugene Okpere of Nigeria Universities Commission (NUC), during a recent event

It would be recalled that the news of the college’s suspension was announced to the public by Dr Ibrahim in April during the induction of 395 medical doctors and dentists in Abuja. The medical doctor told newsmen that MDCN revoked the accreditation of the medical school for failing to meet the required standards.

In another development, the MDCN has also reiterated its guidelines on registration of expatriate medical and dental doctors who are expected to complete their registration with the council before they are allowed to undertake any clinical duty in Nigeria.

“We cannot do this alone. Therefore we are using this opportunity to appeal to the chief executive of each state and other stakeholders to join the MDCN to enforce this regulation,” it noted.

Atueyi, Mohammed become NIM Fellows

0
L-R: Pharm. NAE Mohammed, registrar, Pharmacists Council of Nigeria (PCN) and Fellow, NIM; Pharm. (Dr) UNO Uwaga, president and chairman of council, Nigerian Institute of Management (NIM) and Pharm. (Sir) Ifeanyi Atueyi, managing director, Pharmanews Ltd and Fellow, NIM during the Awards, Fellows & Spouses’ Day Luncheon, organised by NIM and held at Muson Centre, Lagos, recently.
L-R: Pharm. NAE Mohammed, registrar, Pharmacists Council of Nigeria (PCN) and Fellow, NIM; Pharm. (Dr) UNO Uwaga, president and chairman of council, Nigerian Institute of Management (NIM) and Pharm. (Sir) Ifeanyi Atueyi, managing director, Pharmanews Ltd and Fellow, NIM during the Awards, Fellows & Spouses’ Day Luncheon, organised by NIM and held at Muson Centre, Lagos, recently.

Managing Director of Pharmanews Limited, Pharm. (Sir) Ifeanyi Atueyi, and Registrar, Pharmacists Council of Nigeria (PCN), Pharm. N.A.E. Mohammed, were among 48 eminent Nigerians who recently became Fellows of the Nigerian Institute of Management (NIM).

The memorable NIM Fellowship investiture ceremony tagged: “Awards, Fellows & Spouses’ Day Luncheon”, was held 28 August, at the Shell Hall, Muson Centre, Onikan, Lagos.

In his welcome address at the occasion, Pharm. (Dr) Nelson U. O. Uwaga, president and chairman of NIM, congratulated the new Fellows, joining the 709 existing ones, for being found worthy of the highest professional membership grade of the Institute.

Uwaga stated that the tradition which started in February 1963, when the first three Fellows of the Institute were inducted, is a great honour and privilege, adding that the Institute guards its Fellowship jealously and is always meticulous in applying criteria for the upgrade.

This, he hinted, accounts for the meagre number of Fellows of the Institute, out of a total individual membership strength of over 200,000.

The NIM boss urged the new Fellows not to be contented with just adding the designation, FNIM, to their names but to see it as a call to higher service to the Institute, the management profession, and the nation as a whole.

While presenting the NIM Fellowship plaque and certificate to Pharm. Atueyi at the occasion, Dr Uwaga commended the Pharmanews publisher for his contributions to pharmaceutical journalism in Nigeria.

Also speaking at the event, Mr Akinbayo A. Adenubi, FNIM, chairman of P + F Ventures Limited, noted that the NIM Fellows’ Information Booklet places a big burden on Fellows, as they are expected to play critical roles in the Institute’s strategic goals of being a prime driver of management values, management standards and management professionalism.

Speaking on the topic “Random Thoughts on NIM and its Fellows”, which he modified to “NIM (Chartered) Fellows: Debtors and Creditors to the Institute,” Adenubi said Fellows should also contribute their talents, time and treasures towards generating desirable ideals that will impact on the Nigerian society, adding that Fellows as senior members of professional management should challenge themselves and participate actively in the affairs of the Institute at all strata of its informal structure.

The highlight of the occasion was the conferment of awards to some NIM members and the presentation of plaques and certificates to new Fellows

 

Improving maternal and infant care in Nigeria

0
A cross-section of nursing mothers at a clinic
A cross-section of nursing mothers at a clinic

Against the backdrop of meeting the Millennium Development Goals (MDGs) target of reducing child mortality rates by a third in 2015, which is less than four months from now, there are indications that Nigeria is far from reaching the goal, as the country ranks the second largest contributor to the under-five and maternal mortality rates in the world, according to UNICEF.

Although analyses of trends show that the country is making relative progress in reducing infant and under-five mortality rates, the pace is still too significantly slow to achieve the MDG of reducing child mortality by a third by 2015.

Maternal mortality, according to the World Health Organisation (WHO), “is the death of a woman while pregnant or within 42 days of termination of pregnancy, irrespective of the duration and site of the pregnancy, from any cause related to or aggravated by the pregnancy or its management but not from accidental or incidental causes.”

Infant mortality, on the other hand, refers to the death of infants and children under the age of five. In 2011, 6.9 million children under five reportedly died down from 7.6 million in 2010, 8.1 million in 2009 and 12.4 million in 1990. Global statistics on the challenge reveal that child mortality is more prevalent in the sub-Saharan Africa with about half of child deaths being recorded there.

Lending its voice to that of UNICEF, the Nigeria Human Rights Commission (NHRC) recently hinted that Nigeria was one of the countries in the world with high maternal and infant death rates with a ratio of 545-630 per 100,000 live births, or 75 per 1,000 live births on the infant mortality index, according to the United Nations, UN.

According to the UNICEF statement, “Every single day, Nigeria loses about 2,300 under-five year olds and 145 women of childbearing age; this makes the country the second largest contributor to the under–five and maternal mortality rate in the world.”

Relevant questions

The question that should arise from the facts and figures presented so far is, having received the charge to achieve these maternal and infant MDG goals for the past 14 years, what has kept Nigeria lagging behind in meeting the 2015 deadline? Or more specifically, one should be compelled to ask stakeholders in the country, “Whose responsibility it is to reduce the alarming rate of maternal and child mortality to the barest minimum?”

The most relevant group of persons to answer the first question are those at the helms of affairs of both federal and state ministries of health, because they are accountable for all the funds released into the ministries for this singular purpose. In fact, it is an open secret that, so far, several international agencies have donated large chunk of dollars to Nigeria for the reduction of mortality in this area; yet Nigeria still ranks the second largest contributor to maternal and child mortality rate globally.

The other question raised about the commitment of practitioners in the health care industry to this cause is also very crucial. If all stakeholders had taken it as a priority to decisively tackle the challenge of infant and maternal mortality, we should be basking in the euphoria of successful accomplishment by now. Observations, however, clearly suggest that most members of the health care team have left the responsibility to doctors and nurses. Only when a case becomes complicated and menacing do others start making frantic efforts to make their services count.

Rational steps

Now that it is evident that we may not meet the MDGs deadline, should we discontinue the quest to achieve the laudable goals, while countless infants and their poor mothers succumb to the cold hands of death? The obvious answer is no – we mustn’t throw the baby away with the bathwater. Rather, we should be thinking of what steps to take to accelerate our pace.

We may borrow a leaf from the strategic partnership between the Nigeria Human Rights Commission (NHRC) and the White Ribbon Alliance for Safe Motherhood in Nigeria (WRAN), which was engendered by the need to protect the rights of mothers in Nigeria. In a recent conference organised by the partners, a Memorandum of Understanding was drafted to spell out a working relationship for the implementation of respectful maternity care in Nigeria. They called it the “Respectful Maternity Care Charter”.

The challenge here is, if human rights organisations could form a partnership on issues relating to maternal and child health care in Nigeria, then health care practitioners cannot be excused in any way for not doing even more, having sworn to commit themselves to the task of saving lives.

 Removing barriers

Barriers to progress also have to be dislodged if we expect to fulfil our mission in good time. A technical partner of the Lagos State Civil Society Partnership (LACSOP), Mrs Dede Kadiri, after surveying the environments of some Primary Health Centres (PHCs) in Lagos, said, “We were able to assess 30 PHCs in 2013 and found out four critical issues, firstly, postpartum haemorrhage; out of the 30 PHCs we went to, we found out that almost all of them were unable to handle postpartum haemorrhage. And most times, they don’t have equipment and ambulances for referral processes to send patients to the general hospital for attention.

“Secondly, to generate power supply, most PHCs still make use of candles and lanterns in the labour room; and thirdly, the attitudes of staff are resenting people off to use other alternatives such as private hospitals and traditional birth attendants. Finally, the problem of water supply and dirty boreholes are still very conspicuous.”

Also, a recent report by the Lagos State Chairman of the Society of Gynaecology and Obstetrics of Nigeria Dr Oluwarotimi Akinola, stated that the major causes of high maternal mortality rates in Nigeria are haemorrhage, infection, hypertensive disorder of pregnancy, obstructed labour and anaemia. He added that any efforts by the government to reduce maternal mortality rates in the country must address the root cause of delays in seeking health care, accessing it and receiving help at any centre.

There are also other barriers that are specific to rural areas as identified by stakeholders. Delivering a paper recently at an event organised by the National Council of Women Societies of Nigeria (NCWS), Hajiya Khadijat Mustapha Giwa of the FCT Health Department said the problems include lack of proximity of health care posts to people at the grassroots, non-functional health centres, unqualified health care personnel and illiteracy among the target groups which make them to resort to traditional birth attendants (TBAs).

 Remedial strategies

There is no gainsaying the fact that the coverage and quality of health care services in Nigeria have continued to fail women and children. Presently, less than 20 per cent of health facilities offer emergency obstetric care and only 35 per cent of deliveries are attended by skilled birth attendants.

To remedy the current situation, experts have suggested that maternal health conditions can only be improved by a three-stage programme, namely:

  • Child spacing by self-determination of periods between the childbirths
  • Professional care during pregnancy and childbirth
  • Timely access to hospitals where complications can be treated by Caesarean cut.

It is also necessary to add that stakeholders must collaborate to form workable partnerships, with the objectives of implementing this programme, as well as providing conducive social and infrastructural environments for the improvement of the health of both mother and child.

Celebrations as May & Baker clocks 70

0

It was a great moment at the Muson Centre, Lagos, as leading stakeholders and notable personalities in the health sector converged in Lagos on 11 September, 2014 to felicitate with the management of May & Baker Nigeria Plc., at an event organised to celebrate the company’s 70th anniversary.

Among the dignitaries who graced the colourful dinner were Prof. Onyebuchi Chukwu, minister of health; Mrs Olufunsho Amosun, first lady of Ogun State; Lt-General Theophilus Danjuma, chairman, May &Baker Plc.; Pharm. Nnamdi Okafor, managing director, May and Baker Plc.; Pharm. (Mrs) Vera Nwanze, head of Novartis Pharma (Nigeria & Ghana); Pharm. Lekan Asuni, managing director of GlaxoSmithKline (Pharma) Nigeria; David Dankaro, former chairman of May & Baker; and Prof. Ibiyemi Olatunji-Bello, deputy vice chancellor of Lagos State University (LASU) representing the first lady of Lagos State; and Pharm. Kayode Aiyegbajeje, chairman, Lagos branch of Nigerian Association of Hospital and Administration Pharmacists (NAHAP).

L-R: Prof. Onyebuchi Chukwu, minister of health; Lt-General Theophilus Danjuma, chairman of the company, and his wife, Senator Daisy Danjuma, at the May & Baker 70th Anniversary dinner.
L-R: Prof. Onyebuchi Chukwu, minister of health; Lt-General Theophilus Danjuma, chairman of the company, and his wife, Senator Daisy Danjuma, at the May & Baker 70th Anniversary dinner.

May &Baker MD, Pharm. Nnamdi Okafor, disclosed that the company was celebrating the milestone for three reasons.

“First reason is that 70 is a landmark age that deserves to be celebrated. Second, May& Baker has during the long years saved the lives of millions of Nigerians through its quality and efficacious medicines. The last reason is because this is the moment M&B has turned full circle – moving from a distributor of products imported from its principals to a local manufacturer of quality medicines for the Nigerian market,” he said.

Buttressing the MD’s notion, Lt-General Danjuma disclosed that, within the last 70 years, many companies had collapsed due to the harsh operating environment but May&Baker had been fortunate to survive it all.

He also revealed the secret of the company’s success over the years.

“We built trust and confidence through quality products offering and a commitment to saving lives,” he said. “What we are celebrating today is the story of a great corporate legend that did not only introduce western medicine into Nigeria but equally has for seven decades been consistent in providing quality drugs that have saved millions.”

The chairman equally commended the efforts of the government through the Federal Ministry of Health and the National Agency for Food Drugs Administration and Control (NAFDAC) in assisting growth in the pharmaceutical industry.

He however noted that government needed to do more in the area of promoting private sector capacity building, as well as technological development to handle critical diseases like cancer and HIV/AIDS, and to produce vaccines for preventable health disorder.

“That way, companies can become relevant in combating epidemics such as Ebola Virus Disease (EVD),” he stressed.

Minister of Health, Prof. Chukwu said the federal government was delighted to note the giant and pioneering strides May&Baker had made in the development of the nation’s pharma sector since inception.

“All these can be attributed to the ingenious of the leadership of the company which has continued to ensure safe, efficacious and quality drugs,” he said.

Chukwu acknowledged that it was the vital role played by May&Baker and other indigenous companies that made government give support for WHO prequalification, patronage of local pharma companies in line with provision of Procurement Act 2007, facilitation of access to cheap funds, approval of the national health bill, as well as the national drug distribution policy.

Applauding the feat attained by May&Baker, Pharm. Vera Nwanze described it as significant and laudable milestone.

“As a young pharmacist then, May & Baker was one of the few foremost pharmaceutical companies around,” she recalled. “I am glad the legacy is sustained especially here in Nigeria where we know companies come and go. It has lived up to his slogan of “Strong & Reliable.”

Sharing same view, Pharm. Kayode   Aiyegbajeje of NAHAP, said, “This is what 70 years of celebration should look like. It is quite good. May&Baker has been there before I was born. In fact, I grew up to know that M&B was not even a drug but a brand. I work in hospital pharmacy and can tell what the majority of the patient needs are. Over the years, May & Baker has since diversified from vaccine to other areas and has continued to be consistent and focused.”

In his own view, Pharm. Asuni of GlaxoSmithKline noted that it was expected that 70th anniversary should mean so much to a company like May&Baker.

“It shows the company has gone through transformation and it calls for celebration,” he said.

Bright tasks traditional birth attendants on mortality reduction…As Lagos ALPs marks ALPs Day

1

As part of efforts to reduce maternal mortality in the country, traditional birth attendants (TBA) have been charged to encourage pregnant women in their communities to go for regular antenatal check-ups, as well as patronise only registered health facilities for their deliveries.

The call was recently made by the Vice President of Livewell Initiative, Pharm. (Mrs) Bisi Bright, while speaking at the sensitisation programme for the Faith Based and Traditional Birth Attendants, Ikosi/Isheri Local Council Development area, as part of activities marking the 2014 Association of Lady Pharmacists (ALPs), Lagos State Chapter, Day.

Bright, who was a guest speaker at the event, held at the Ikosi/Ketu LGA Primary School, Ketu, explained that the TBA should realise that they were free to practise, for as long as they were aware of their limits and willing to work with the qualified health officials.

She added, by way of example, that a traditional birth attendant had no business attending to a woman that had undergone caesarean section, adding that “a woman that is hypertensive, a woman that has never given birth and a woman that has had more than five pregnancies are high risk patients and should be attended to by an expert.”

According to the Livewell VP, about145 women die in Nigeria daily, due to pregnancy-related complications. She therefore urged the TBA toen roll for further professional training, which would enhance their effectiveness and competitiveness.

Earlier in her welcome address at the event, Pharm. (Mrs) Modupe Ologunagba, chairperson of ALPs, Lagos, hinted that the reason for the annual “ALPs Day” was to create additional avenue for acquainting the public with the vital roles of lady pharmacists in healthcare delivery and social developmental work, adding that the group was delighted to celebrate the 2014 edition with the grassroots maternal caregivers in Kosofe Local Government of Lagos State.

Ologunagba also noted that the reason for picking out the traditional care givers was based on ALPs concern and desire for improvement in the country’s health indices, especially as regards maternal and child mortality.

“The current global trend in healthcare practice is collaboration and it is in this regard that we seek to promote this trend through the invitation of other stakeholders such as female medical doctors, community pharmacists, medical laboratory scientists, community health volunteers and others in the health care delivery system to the sensitisation programme,” Ologunagba said, adding that “it is our desire that this programme will initiate a change in health care practices in Kosofe Local Government Area and Lagos State, in general.”

While speaking with journalists after the event, Chairman of TBA, Ikosi/Isheri LCDA, Alhaji Rasheed Shodehinde,said the ultimate facilitator of safe delivery is God, noting that both traditional care givers and medical practitioners were mere instruments in his hand.

“What we usually do at our own end whenever we are faced with any complicated case is that we pray to God and we do everything humanly possible to save the lives of the mother and child,” he said.

The veteran traditional birth attendant also noted that the traditional care givers possess some vital skills and experiences that medical doctors may imbibe.

“Imagine if the placenta of the baby comes first and there is severe bleeding, they [medical doctors] will quickly resort to surgery, but all this would have been monitored from the beginning by the traditional birth attendant; however in severe cases, we also refer to the hospital for operation, but that will not be the first option,” he said.

Shodehinde further stated that one of the biggest challenges facing the association was unhealthy competition and discrimination from some medical practitioners.

Association of Lady Pharmacists (ALPs), Lagos State Chapter members and Traditional Birth Attendants, Kosofe Local Government Unit, at the ALPs Day of the Pharmacy Week, held at Ikosi Ketu Primary School, Ketu, Lagos.
Association of Lady Pharmacists (ALPs), Lagos State Chapter members and Traditional Birth Attendants, Kosofe Local Government Unit, at the ALPs Day of the Pharmacy Week, held at Ikosi Ketu Primary School, Ketu, Lagos.

Legal expert urges amendment of PCN Act

0

Foremost lawyer, Barrister Ebun-Olu Adegboruwa, has called on the Pharmacists Council of Nigeria (PCN) to initiate an amendment process of Act 91 of 1992, which established it as a regulatory body for all pharmaceutical activities in the country.

Adegboruwa said this was necessary to accommodate pharmacists’ rights as well as other employment terms.

The legal icon, who made the submission while addressing members of the Nigerian Association of Hospital and Administrative Pharmacists (NAHAP) Lagos State Chapter, during the NAHAP Day held recently, stressed the need for the council to collate and establish a set of rights for practitioners in the industry.

He maintained that it was the responsibility of the PCN to state the conditions of employment of pharmacists beyond what is stated in sections 11 and 12 of the Act.

“It is not enough to practise and make money, but the environment of the practice must guarantee the safety and retirement benefits of practitioners”, Adegboruwa said.

He also suggested that a more meaningful and precise definition of a pharmacist should be included in the amendment as this would further help to rid the profession of quacks.

Speaking on the topic, “Emerging Global Trends in Patients Care: The Rights of Stakeholders”, the barrister highlighted the rights of pharmacists to include right to protection, insurance, confidentiality, association, job security, refusal, among others.

Citing the example of First Foundation Hospital, where some Ebola caregivers lost their lives in the course of duty, Adegboruwa explained that recent trends in the health care system have made it crucial for practitioners to have these rights established, adding that the level of protection must be commensurate with the risk of the environment.

The legal practitioner also spoke on patients’ rights, including the right to be treated in a dignified and friendly manner; right to effective communication in preferred language; right to cultural value; right to privacy; right to system of information of data; right to accommodation of religion; right to participate in decision about care; right to refuse care and leave the facility contrary to management decision; right to know names of practitioners in the health facility; and right to explanation for bill to services rendered.

He however decried the Nigerian situation where there is no legislation guaranteeing the enforcement of the rights of patients, thereby leaving patients at the mercy of doctors and health care givers.

“Of what essence are patients’ rights without the laws to enforce them?” he queried, while calling on the legislative arms of the government to consider working towards the establishment of patients’ rights in Nigeria.

He also called on pharmacists to always educate their patients properly on every issue, in order for them to be exempted from any eventuality that may arise from the treatment given.

Chairman of NAHAP (Lagos), Pharm. Kayode Aiyegbajeje, earlier noted that the association was doing its best to keep its members abreast fn trends in pharmaceutical care. He said the association also played a major role in sensitising the public on the prevention of Ebola Virus Disease (EVD) through health campaigns and distributed large quantities of hand sanitisers to the people at Yaba bus-stop.

 

SNNLive – Innovus Prescription drugs, Inc.

0



SNNLive spoke with Bassam Damaj, President & CEO of Innovus Prescription drugs, Inc. (OTCQB: INNV) on the Aegis Capital Corp. Healthcare & Expertise Convention 2014 in Las Vegas, NV.

For extra info: http://innovuspharma.com/

supply